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Summary
Introduction. Autophagy is a dynamic process that is responsible for cel-
lular protein degradation, which involves sequestering of bulk cytoplasm and its
delivery to lysosomes where degradation and recycling occurs. Autophagy is vital
for cellular function and can be induced during periods of nutrient deprivation
for the recycling of proteins and for removing potentially harmful proteins and
organelles. A reduction in the autophagic degradative capacity has been linked to
several diseases such as those associated with neurodegeneration. These attributes
make autophagy an attractive therapeutic target; clinical trials using autophagy
inducers have already shown promising results. In order to successfully exploit au-
tophagy, it is crucial to determine whether the autophagic flux is too high or too
low, and adjust it accordingly. However, the accurate measurement of autophagic
flux still remains a challenge.
Aims. The aim of this project was therefore, first, to develop a novel method
to accurately measure autophagic flux. Second, to assess autophagy using con-
ventional techniques and compare it with the new approach. Our third aim was
to construct a kinetic model of the autophagic system that could simulate our
experimentally generated data and thereby help us understand the contribution of
the different processes involved in autophagy and its dynamic behaviour.
Methods. We made use of fluorescent-based imaging to acquire z-stack im-
ages of mouse embryonic fibroblasts that stably express GFP-LC3. Images were
processed and the total autophagic vesicles pool size was measured using ImageJ
with the WatershedCounting3D plugin. Cells were cultured in the presence of
xv
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an acidotrophic fluorescent dye that allows (in-combination with GFP-LC3) the
visualisation of autophagosomes, autophagolysosomes and lysosomes. Cells were
encased in a humidified atmosphere in the presence of 5% CO2 at 37
◦C in a micro-
scope slide of the IX81 Olympus microscope. First we determined the concentra-
tion of bafilomycin A1 required for the complete inhibition of the autophagosome
and lysosome fusion process. We calculated the autophagic flux as the initial rate
of increase in the number of autophagosomes after inhibition of fusion. Second, we
increased autophagosomal synthesis through induction with 25 nM rapamycin and
again calculated the autophagic flux from the initial rate of increase in autophago-
somes after fusion inhibition. In parallel, we assessed changes in the autophagic
markers LC3-II and p62 with Western blot analysis and in the morphology of au-
tophagic vesicles with electron microscopy at time points suggested by the fluores-
cent experimental data. A kinetic model of the autophagic system was constructed
and parameterised so as to fit the experimental data. Computational modelling
was done with the Python Simulator for Cellular Systems (PySCeS).
Results. Although we found that 100 nM bafilomycin A1 was sufficient to
inhibit the fusion of autophagosomes and lysosomes, we chose to use 400 nM
bafilomycin A1 in order to be absolutely sure the inhibition was complete. Induc-
tion of autophagosomal synthesis with 25 nM rapamycin increased the autophagic
flux in MEF cells from its basal value of 25.4 autophagosomes/cell/hr to 105.4
autophagosomes/cell/hr. The transition time, i.e., the time required to clear the
autophagosomal pool, decreased from its basal value of 0.53 hr to 0.16 hr after
induction. Similarly the transition times for the basal and induced autophagolyso-
somal pools were 6.7 hr and 2.4 hr. Whereas with our fluorescence microscopy
method we measured a four-fold increase in autophagic flux from the basal to
the induced state, traditional approaches such as Western blot analysis measure
only a two-fold increase; electron microscopy proved to be inadequate for assess-
ing autophagic vesicles. Autophagosomes constituted a small percentage of the
total GFP-LC3-positive vacuoles. Upon induction with rapamycin the number
of autophagosomes/cell increased slightly from 13 to 17, whereas the number of
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autophagolysosomes/cell increased considerably from 165 to 251. Autophagosomal
size was about four times smaller than autophagolysosomal size. Simulating the
autophagic system with our kinetic model provided an excellent fit to the experi-
mental data.
Conclusion. Our novel approach quantifies autophagic variables such as the
flux and the number of the different types of autophagic vesices accurately at
single cell level, and, used in combination with kinetic modelling of the dynamics
of autophagy, hold promise for future therapeutic application.
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Opsomming
Inleiding. Autofagie is ’n dinamiese proses wat verantwoordelik is vir sel-
lulêre protëıen degradasie, ’n proses waarin sitoplasma in vesikels gesekwestreer
word en na lisosome afgelewer word waar degradasie en herwinning plaasvind.
Autofagie is noodsaaklik vir sellulêre funksie en kan gëınduseer word tydens pe-
riodes van voedingstoftekorte vir die herwinning van protëıene vir energiedoelein-
des en as ’n meganisme vir die verwydering van potensieel skadelike protëıene
en organelle. ’n Afname in die autofagiese degradasiekapasiteit is al geassosieer
met verskeie siektes soos neurodegenerasie. Hierdie eienskappe maak autofagie ’n
aantreklike terapeutiese teiken. Studies met induseerders van autofagie het reeds
belowende resultate in kliniese proewe getoon. Om autofagie suksesvol te benut
is dit noodsaaklik om te bepaal of die autofagiese fluksie te hoog of te laag is, en
om dit dan dienooreenkomstig aan te pas. Die akkurate meting van autofagiese
fluksie was egter tot nou toe ’n uitdaging.
Doel. Die doel van hierdie projek was om, eerstens,’n nuwe metode te on-
twikkel om autofagiese fluksie akkuraat te meet. ’n Tweede doel was om autofagie
met konvensionele tegnieke te assesseer en dan met die nuwe benadering te verge-
lyk. Die derde doel was om ’n kinetiese model van die autofagie sisteem te bou wat
die eksperimentele data kan simuleer en ons sodoende help om die bydrae van die
verskillende prosesse betrokke by autofagie tot die dinamiese gedrag van autofagie
te verstaan.
Metodes. Fluoressensie-gebaseerde afbeelding is gebruik om z-stapel beelde
van muis embrioniese fibroblaste wat stabiele GFP-LC3 uitdruk te verkry. Hierdie
xviii
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beelde is verwerk en die totale autofagiese vesikelpoelgrootte is bepaal met ImageJ
en die WatershedCounting 3D sisteem. Selle is gekweek in die teenwoordigheid van
’n asidotrofiese fluoresserende kleurstof wat, in kombinasie met GFP-LC3, die vi-
sualisering van autofagosome, autofagolisosome en lisosome moontlik maak. Selle
is omhul in ’n gehumidifiseerde atmosfeer in die teenwoordigheid van 5% CO2 by
37◦C in ’n mikroskoopskyfie van die Olympus IX81 mikroskoop. Ons het eers die
konsentrasie van bafilomisien A1 nodig om die fusie van autofagosome en lisosome
volkome te inhibeer bepaal. Die autofagiese fluksie is toe bereken as die aanvank-
like snelheid waarmee autofagosome toeneem na inhibisie van fusie. Daarna het
ons autofagosomale sintese verhoog deur induksie met 25 nM rapamisien en weer
die fluksie gemeet as die aanvanklike snelheid waarmee autofagosome toeneem na
inhibisie van fusie. Parallel aan hierdie eksperimente het ons die veranderings
in die autofagiese merkers LC3-II en p62 met Westernklad analise en die veran-
derings in die morfologie van autofagiese vesikels met elektronmikroskopie bepaal
by tydspunte afgelei uit die fluoressensie eksperimentele data. Rekenaarmatige
modellering is gedoen met die Python Simulator for Cellular Systems (PySCeS).
Resultate. Alhoewel ons gevind het dat 100 nM bafilomisien A1 voldoende
was om die fusie van autofagosome en lisosome te inhibeer, het ons 400 nM
bafilomisien gebruik om absoluut seker te maak dat die inhibisie volledig was.
Induksie van autofagosomale sintese met 25 nM rapamisien het die autofagiese
fluksie in MEF selle van die basale waarde van 25.4 autofagosome/sel/uur na
105.4 autofagosome/sel/uur verhoog. Die transisietyd, nl. die tyd nodig om die
autofagosomale poel te vervang, het verminder van die basale waarde van 0.53 uur
na die gëınduseerde waarde van 0.16 uur. Soortgelyk het die transisietyd vir die
autofagolisosomale poel afgeneem van 6.7 uur voor induksie and 2.4 uur na induk-
sie. Waar ons met die fluoressensie mikroskopie metode ’n viervoudige toename in
autofagiese fluksie gemeet het van basale na gëınduseerde vlakke, het tradisionele
metodes soos Westernklad analise slegs ’n tweevoudige verhoging gemeet; elektron-
mikroskopie was nie bevoeg om autofagiese vesikels te assesseer nie. Autofagosome
het maar ’n klein persentasie van die totale GFP-LC3-positiewe vakuole uitgemaak.
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Na induksie met rapamisien het die aantal autofagosome/sel effens verhoog van
13 na 17, terwyl die aantal autofagolisosome/sel aansienlik verhoog het van 165
na 251. Die grootte van autofagosome was ongeveer vier maal kleiner as die van
autofagolisosome. Simulering van die autofagiese sisteem met ons kinetiese model
het uitstekend op die eksperimentele data gepas.
Gevolgtrekking. Ons nuwe benadering kwantifiseer autofagiese verander-
likes soos fluksie en die aantal van die verskillende tipes autofagiese vesikels akku-
raat op enkelselvlak, en hou, in kombinasie met kinetiese modellering van die
dinamika van autofagie, belofte in vir toekomstige terapeutiese toepassings.
Stellenbosch University  https://scholar.sun.ac.za
Chapter 1
Introduction
Autophagy was first observed in the 1950’s by Clark [34] and Novikoff [187], and
later in the 1960’s the term autophagy was coined by de Duve [39]. Initially the
role of autophagy was perplexing, but as time progressed it became clear that
autophagy serves as a cellular degradation system. With the advent of the second
millennium, new molecular tools made it possible to identify the molecular machin-
ery as well as the regulatory mechanisms of autophagy. Soon it became apparent
that autophagy maintains cellular integrity by providing a means of removing po-
tentially harmful proteins and organelles. During periods of starvation autophagy
supplies amino acids for energy production by increasing protein degradation. Im-
paired autophagy has been implicated in the progression of several diseases, most
notably neurodegeneration, since it leads to the build-up of harmful proteins and
organelles that would otherwise be degraded via autophagy. These attributes of
autophagy make it an attractive therapeutic target.
Chapter 2 is an extensive literature review of autophagy that includes its his-
tory, its biological roles, its molecular machinery, and its regulation. To exploit
autophagy for therapeutic purposes, it is crucial to determine whether or not au-
tophagic flux is too high or too low, and adjust it accordingly.
Conventionally, autophagy is assessed with Western blot analysis and electron
and fluorescence microscopy, which still remain the gold standards in autophagy
research. These techniques are discussed in depth in Chapter 2. Although they do
1
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generate invaluable information about the internal workings of the autophagic ma-
chinery and its regulatory components, they are not really suitable for measuring
the autophagic flux, which we have defined as the rate of flow through the pathway
at steady state [142]. The main aim of this project was therefore to develop a novel
method that accurately measures the autophagic flux. In Chapter 3 we describe
the fluorescence microscopy technique with which we quantitatively could measure
the changes with time in the number of autophagosomes, autophagolysosomes and
lysosomes in a single cell during basal and rapamycin-induced autophagy. Inhibit-
ing the fusion of autophagosomes and lysosomes with bafilomycin and measuring
the initial rate of accumulation of autophagosomes allowed us to calculate the
steady-state autophagic flux. These results are described in Chapter 4. An addi-
tional aim of this project was to compare our novel technique with the traditional
techniques under the same conditions. We assessed changes in the autophagic
markers LC3-II and p62 with Western blot analysis and in the morphology of
autophagic vesicles with electron microscopy at time points suggested by the flu-
orescence microscopy experimental data.
Cytoplasmic proteins serve as substrates for the autophagic system; amino
acids are the end products of the degradation of proteins through autophagy. We
therefore also assessed total amino acid and total cellular protein levels during
basal and rapamycin-induced autophagy to supplement our autophagic flux data.
The results of these investigations are also described in Chapter 4. One of the
important conclusions was that the traditional techniques do not measure the
autophagic flux accurately.
A great deal is known about the individual processes involved in autophagy,
but the degree of control that each of these processes exerts over the autophagic
system is not known. In order to successfully exploit the autophagic system for
therapeutic purposes, it is not only necessary to be able to numerically quantify
autophagic flux, but also to be able to determine the degree of control each step
exerts over the autophagic system. One of the ways of gaining this type of insight
is to construct a mathematical model of the autophagic system with which the
dynamic and steady-state behaviour of the system can be studied. In Chapter 5
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we describe the initial development of such a kinetic model, similar to the type of
model used to study metabolism, that simulates the time-course of the autophagic
vesicles during the process of autophagy.
Chapter 6 is a general discussion that places our results in the context of related
published work and maps out future studies that will build on the foundation laid
by our study.




Autophagy is a highly dynamic metabolic process whereby a cell digests parts
of itself, hence the origin of its name autophagy, from the Greek auto meaning
‘self’ and phagen meaning to ‘eat’. This ‘self-eating’ process is an evolutionary
conserved process in eukaryotes by which cytoplasm is sequestered in a double
membraned vesicle that subsequently fuses with a lysosome resulting in the degra-
dation of the cytoplasmic cargo. More than 50 years ago, when autophagy was
initially discovered, the question as to why the cell would self-digest its own com-
ponents was perplexing. The leading explanation was that autophagy serves as a
cellular degradation system. However, since then we have learnt that autophagy is
more than that, not only degrading long-lived proteins, misfolded/damaged pro-
teins as well as organelles and invading micro-organisms, but also acting as an
adaptive response to provide energy and nutrients to the cell during periods of
stress. As our knowledge about autophagy expands it has been shown to be impli-
cated in far-reaching fields such as cancer, immune response, neurodegeneration,
atherosclerosis, cardiomyopathy, human development and ageing. Recent develop-
ments in molecular techniques and microscopy allowed the elucidation of invaluable
information about the molecular workings of autophagy. Currently much is known
about the regulatory mechanism, but little is known about the degree of control
4
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these regulatory mechanism have over the autophagic system. In this literature
review, we will therefore highlight key advances that lead to our current under-
standing of the autophagy process, as well as the molecular machinery involved.
Furthermore we will consider the current methodologies used in autophagic re-
search, focussing on their advantages and pitfalls, as well as a systems biological
approach that accurately measures autophagy activity thereby allowing a better
understanding of the dynamic nature of the autophagic process.
2.1.1 History of autophagy
2.1.1.1 The early years of the autophagy concept
In the late 1950s both Clark and Novikoff, using electron microscopy, observed
membrane-bound compartments which they termed ’dense bodies’ that encased
mitochondria in mouse kidney cells. Little was however known about their func-
tion [34, 187, 188]. It was only later shown that these ‘dense bodies’ include
lysosomal enzymes, and therefore play a part in a degradation system. A few
years later Ashford and Porter described membrane-bound vesicles in rat hepa-
tocytes containing semi digested mitochondria and endoplasmic reticulum after
being exposed to glucagon [6]. In the same year Novikoff and Essner also observed
that these ‘dense bodies’ contained semi-digested mitochondria and a lysosomal
hydrolase [188]. One year later at a symposium on lysosomes in 1963, de Duve
coined the term ‘autophagy’ for a process that produces single or double membrane
vesicles in various states of disintegration that contain parts of the cytoplasm and
organelles [39]. He suggested that the sequestering vesicles that contain cytoplasm
or mitochondria be called ‘autophagosomes’, that they were related to lysosomes
and that they were part of a naturally occurring process. However, the origin of
the membranes of these sequestering vesicles was controversial, and it was sug-
gested by de Duve that these membranes were derived from smooth endoplasmic
reticulum [39].
In the early 1960s it was known that autophagy occurs in normal rat liver cells
and that, if these rats were starved, the numbers of autophagosomes present in the
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hepatocyte cytoplasm would increase [184]. In 1967 de Duve and his colleagues
demonstrated that glucagon can induce autophagy [41]. In the late 1970s Pfeifer
reported the converse, that insulin receptor signalling inhibits autophagy [198].
Ground-breaking work by Mortimore and Schworer in 1977 further demonstrated
that amino acids that are the end product of autophagic degradation have an in-
hibitory effect on autophagy in rat liver cells [175]. Early studies on autophagy
from the 1950s to the late 1980s were mainly based on morphological analyses
derived from electron microscopy. Novikoff and the early pioneers in the field all
examined the matured stage of these vesicles just prior to fusion with the lysosome,
as well as the subsequent phase just after fusion that resulted in the degradation of
the cytoplasmic cargo. However, it was Gordon and Seglen that in 1988 started us-
ing electro-injected radioactive probes to further examine the autophagic process;
this study ultimately lead to the identification of the phagophore (the initial se-
questering vesicle that matures into an autophagosome), as well as the amphisome
(the result of the fusion between an autophagosome and an endosome) [64].
In the early 1960s de Duve proposed the existence of a mechanism for non-
specific bulk degradation of cytoplasm as a means to maintain cellular homoeosta-
sis, as well as the need for a more selective proteolytic mechanism to degrade
cellular organelles and proteins that would otherwise not be degraded by the bulk
acquisition of cytoplasm [39]. The first evidence of organelle specific degradation
by autophagy was provided in 1973 when Bolender and Weibel found evidence
that the smooth endoplasmic reticulum can be engulfed [17]. In the following
years more evidence arose with regards to organelle specific degradation, for ex-
ample mitochondria that are selectively cleared during insect metamorphosis [12],
and peroxisomes that are selectively cleared by autophagy in yeast cells [250]. In
the late 90’s Lemasters and colleagues demonstrated that changes in mitochon-
drial membrane potential stimulated autophagy [135]. In the following years more
evidence was provided on the selectivity of the autophagic system particularly in
yeast and later in higher eukaryotes.
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2.1.1.2 The era of molecular biology
Our understanding of the molecular control of autophagy vastly improved in the
late 90’s with the tools of the molecular biological era. These tools revolutionized
our ability to genetically manipulate the autophagic process in order to elucidate
the regulatory mechanisms that underlie the system, so uncovering the significance
of autophagy in human health and disease. Although autophagy was initially dis-
covered in rats, major breakthroughs in our understanding of autophagy regulation
came from analysis of a genetically altered yeast system. Ground breaking work
preformed by the Ohsumi laboratory demonstrated that the morphology of au-
tophagic vacuoles in yeast was similar to that reported in mammalian cells [236].
They were the first to genetically screen autophagy-defective yeast mutants and
showed that protein turnover was affected in non-specific macro-autophagy [248].
They later followed up with similar screens for mutants that affected selective
protein degradation through peroxisomes (pexophagy)[244] and vacuolar hydro-
lases (cytoplasm to vacuole targeting (Cvt) pathway) [79]. Two years later the
Ohsumi laboratory identified a novel protein kinase, Atg1, that was required for the
autophagic process; this was the first autophagy-related gene-product published
[156]. To this day novel proteins are being identified through genomic screening
of yeast mutants defective in selective degradation of mitochondria via selective
autophagy (mitophagy) [103, 190].
In 2000 distinct types of autophagy were discovered in the yeast system that
function as mechanisms for maintaining cellular integrity by controlled degrada-
tion. Although similar in terms of the formation of the autophagic vacuoles, these
types of autophagy show distinct differences. The Cvt pathway, pexophagy and
mitophagy show high selectivity in contrast to macroautophagy, which is generally
considered to be non-selective. Macroautophagy, pexophagy and mitophagy are
degradative in contrast to the Cvt pathway, which is biosynthetic by providing pep-
tidase enzymes for the degradative vacuoles [114]. Interestingly, all these various
types of autophagy share a subset of the Atg proteins that are essential for auto-
phagosome formation. These Atg proteins are referred to as the “core machinery”
and have been grouped into several functional classes: the Atg1–Atg13–Atg17
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kinase complex, the class III phosphatidylinositol 3-kinase (PtdIns3K) complex
consisting of Vps34, Vps15, Atg6 and Atg14, the ubiquitin-like Atg12 and Atg8
protein conjugation system and Atg9 with its cycling system. Furthermore it has
been shown that this core machinery is localized at the phagophore assembly site
[233]. An additional core set of components is required in the autophagy process
when the autophagic cargo is degraded and released into the cytosol through the
use of permeases for recycling [50]. Furthermore, these two subsets of core com-
ponents play a crucial part in negative feedback regulation of amino acids on the
autophagic system.
The identification of the Atg genes in yeast started the search for the Atg
homologues in the mammalian system. Mizushima described a novel protein con-
jugation system in humans in which the first mammalian autophagy genes, Atg5
and Atg12, were identified, and furthermore showed that the Atg12–Atg5 conju-
gation system is conserved in higher eukaryotes [164]. Two years later Yoshimori
and colleagues made a crucial finding in higher eukaryotes with the identification
of the mammalian Atg8 homologue, LC3 (also known as MAP1LC3) [98]. They
subsequently developed an LC3-based assay for monitoring autophagy capacity in
mammals. However, it already became clear that the increased synthesis or lipi-
dation of LC3 does not necessarily indicate the autophagy activity. It is crucial to
follow flux through the entire pathway and to assess the autophagic degradative
capacity [142].
Besides the conjugation systems, several other mammalian Atg homologues
have been identified. Of these, two Atg1 homologues, Unc-51-like kinase 1 (ULK1)
and ULK2 have been shown to be essential for autophagy induction. They form
part of a large complex that includes mAtg13 (mammalian homologue of Atg13)
and FIP200, which is a scaffold protein (an orthologue of yeast Atg17). These
will be discussed later in more detail. Mizushima and his colleagues followed
autophagosome formation using green fluorescent protein (GFP) linked to Atg5,
elucidating in a step-wise manner the sequestration of cytoplasm in a vesicle [165].
The complexity of autophagy regulation is becoming more apparent from recent
studies in higher eukaryotes. Recently, numerous additional components involved
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in autophagy have been identified in large scale screens with human cells, indicat-
ing their interaction with either the autophagy-related proteins or their partici-
pation in signal transduction [13]. The origin of the autophagosomal membrane
still remains unclear and under debate. Studies have suggested that the auto-
phagosomal membrane may originate from the endoplasmic reticulum [9, 272], the
plasma membrane [207] and the mitochondrial outer membrane [67]. This sug-
gests that various organelles can provide the required membrane components for
autophagosomal formation [245].
2.2 The molecular machinery of autophagy
In all living organisms, cells are in a constant state of dynamic shifting, which
ranges from organism development, metabolic perturbations and regeneration of
damaged cells/tissues. It ranges from changes in nuclear architecture (nuclear
remodelling) to the removing and replenishing of intracellular components to pro-
mote healthy growth and development as well as to adapt to both the micro- and
macro-environment. Autophagy is a generic term that is used for all pathways
that result in the degradation of intracellular components through lysosomal di-
gestion (Fig. 2.1). Autophagy has far-reaching implications; it degrades damaged
and old cellular components so that they can be replaced with new ones, or even
with alternative types that would change the characteristics of the cell, such as its
adaptive response to stress or a developmental cue during maturation of the organ-
ism. Furthermore autophagy acts as a survival strategy by degrading intracellular
components for fuel to synthesize ATP; the digested autophagic cargo can serve
as substrate for further anabolic reactions. Autophagy can be categorised into
three main groups: micro-autophagy, macro-autophagy and chaperone-mediated
autophagy (CMA) (see Fig. 2.1). Furthermore, macro-autophagy, although most
notably responsible for the degradation of long-lived proteins, is also involved in
selective degradation of organelles. We will be focussing on macro-autophagy
(generally referred to as autophagy), and highlight some of the selective forms of
autophagy throughout this literature review. In this section we will discuss the
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autophagy “core machinery” proteins and other autophagy-related proteins and
their involvement in the induction of the autophagic system, cargo recognition,
autophagosome formation and fusion between autophagosomes and lysosomes.
2.2.1 Autophagy-related (Atg) proteins: the core
machinery
Macro-autophagy, hereafter referred to as autophagy, is a dynamic process that
can be viewed as consisting of several distinct steps. It starts by the induction of
the autophagic system, which promotes the elongation of the double membrane
called the phagophore; this process is facilitated by the autophagic core machinery.
Subsequent completion of the vesicle forms the autophagosome, which fuses with
a lysosome resulting in the degradation of the autophagic cargo and consequently
the recycling of the digested goods (Fig. 2.1). Several key proteins are involved in
the regulation and formation of autophagosomes and the subsequent events (see
Fig. 2.2). The “core machinery” proteins that are intimately involved in autophagy
can be grouped into several functional units that are responsible for the different
steps that form part of the autophagy process. In this section we will consider the
mechanisms of the distinct steps involved in autophagy.
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2.2.1.1 Induction
The organism requires an efficient system to induce autophagy in order to adapt
to both intracellular and extracellular stress. mTOR, a central regulator of au-
tophagy is the mammalian target of rapamycin. In Drosophila and yeast, dTOR
and Tor respectively integrate a broad intracellular network of signal transduc-
tion pathways (see section 2.3) that negatively regulate a serine/threonine kinase,
Atg1 [24]. For instance, in yeast the inhibition of Tor by rapamycin intervention
or nutrient deprivation leads to the activation of Atg1, which increases the binding
affinity of Atg1 to Atg13 and Atg17 [101]. Furthermore, the activation of Atg1
stimulates the formation of Atg1-Atg13-Atg17 scaffold proteins and the subsequent
recruitment of other various autophagy related proteins to the phagophore assem-
bly site (PAS) to initiate autophagosome formation [29, 106]. Therefore, Atg1
plays a crucial role in the induction of autophagy. Additionally, Atg1 can inhibit
the activation of a downstream dTor effector, ribosomal protein S6 kinase (S6K) by
preventing the phosphorylation and subsequent activation of S6K during nutrient
deprivation in Drosophila [134]. However, how autophagy proteins or their activ-
ities are regulated by S6K still remains unclear. In the mammalian system two
homologues of Atg1 exist, namely Unc-51-like kinase (ULK1 and ULK2), and one
homologue of Atg17, namely focal adhesion kinase family-interacting protein of
200 kD (FIP200). FIP200 forms a complex with mammalian Atg13 (mAtg13) and
the ULKs, which localizes to the phagophore site upon starvation [76, 98]. Upon in-
duction of autophagy, by either chemical intervention or starvation, ULKs undergo
autophosphorylation that is facilitated by conformational change (see Fig. 2.3) [23],
which subsequently phosphorylates mammalian Atg13 and FIP200 (see Fig. 2.3)
[97]. Unlike in yeast, it appears that ULKs-Atg13-FIP200 forms a stable complex
despite the nutritional condition in mammalian cells. During periods of abun-
dant nutrients, mTOR associates with the ULKs-Atg13-FIP200 complex [87] and
thereby phosphorylates the conserved C-terminal domain (CTD) of ULKs and
Atg13, which subsequently inhibits autophagy. Once mTOR is inhibited, ULK1
and ULK2 are activated and subsequently phosphorylate and activate Atg13 and
FIP200, which is essential for the induction of autophagy [87, 97]. The phospho-
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rylation by either mTOR or ULKs of Atg13 exerts opposite effects on autophagy,
which is modulated by the nutrient status, likely as a result of the phosphorylation
on different Atg13 residues. Interestingly, in yeast the dephosphorylation of Atg13
during starvation induces autophagy [101], whereas in Drosophila phosphorylation
of Atg13 is amplified to induce autophagy [24]. It is therefore conceivable that the
phosphorylation of Atg13 in yeast requires TOR, whereas in Drosophila it requires
Atg1. Additionally, Atg101 is the most recent protein to be identified to form part
of the autophagic core machinery that binds to the ULKs-Atg13-FIP200 complex

















Figure 2.3: Conformational change in ULKs facilitates autophagy induction. A. ULK
in open configuration as a result of the phosphorylation of ULK by mTOR, therefore
inhibiting autophagy induction. B. Dephosphorylation of CTD domain of ULK results in
the conformational change that promotes autophosphorylation of ULK and subsequent
phosphorylation of mAtg13 and FIP200, which in turn stimulates autophagy.
2.2.1.2 Cargo recognition and selectivity
Although autophagy is generally responsible for the bulk degradation of cytoplas-
mic proteins, and so is the foremost means of degradation of long-lived proteins,
it can also selectively target specific organelles. Selective autophagy is mediated
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through specific receptor proteins that allow the autophagic machinery to recog-
nize specific cargo such as mitochondria for degradation. Since the C-terminal
motif of mammalian p62 (also known as sequestosome 1, SQSTM1) and yeast
Atg19 share structural and functional similarity, it suggests that p62 is an Atg19
analogue that acts as a receptor for ubiquitinated proteins or organelles in higher
eukaryotes. Autophagy plays an important role in the selective clearance of ubiq-
uitinated substrates and aggregate-prone proteins, in a process which is facilitated
by p62 [16]. p62 allows for the binding of both mono or poly-ubiquitinated pro-
teins to microtubule-associated protein 1 light chain 3 (LC3) which results in the
subsequent engulfment and degradation of the ubiquitinated cargo.
2.2.1.3 Autophagosome formation
Most vesicle formation in endomembrane trafficking systems is facilitated by ei-
ther budding from pre-existing organelles or by the formation of a continuous
membrane forming a single membrane layer vesicle. In contrast, autophagosomes
are formed from a double-membrane vesicle which is to be assembled at the pre-
autophagosomal structure site by the addition of new membranes. It is therefore
conceivable that formation of the sequestering vesicle is most likely the most com-
plicated step of autophagy. During the formation of autophagosomes, multiple
Atg proteins are recruited for the maturation process of autophagosomes in an
organized manner. The initiation of nucleation and assembly of the phagophore
requires the class III phosphatidylinositol 3-kinase (PtdIns3K) complex, which is
composed of PtdIns3K, vacuolar protein sorting-associated protein 34 (Vps34),
mAtg14 (also known as Barkor), p150 (also known as PIK3R4), UV radiation
resistance-associated protein (UVRAG) and Beclin1 (mammalian homologue of
Atg6/Vps30) [92, 108, 139, 232]. Beclin1, which is required for autophagy, is
negatively regulated by Bcl-2 (B-cell lymphoma/leukemia-2) and Bcl-XL (B-cell
lymphoma-extra large), an anti-apoptotic protein, that sequesters and binds to Be-
clin1 during periods of nutrient abundance. Therefore, the dissociation of Beclin1
from Bcl-2 is required for the induction of autophagy in mammals. The PtdIns3K
complex is responsible for the production of phosphatidylinositol-3-phosphate (Pt-
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dIns3P) as well as for the targeting and the recruitment of various other autophagy
proteins that bind to PtdIns3P, such as Atg18, Atg20, Atg21, and Atg24 in yeast
[82, 189, 231]. This indicates that in yeast Atg20 and Atg24 interact with the
regulatory complex. However, in the mammalian system, the mammalian ho-
mologue of Atg20 has not been identified, and the role of mAtg24 is not well
defined [82]. Additionally, the PtdIns3K complex further recruits ubiquitin-like
(Ubl) conjugation systems, LC3 (also known as mAtg8) and Atg12–Atg5-Atg16
to the phagophore construction site which is vital for elongation of the membrane
and subsequent expansion of the developing autophagosome [233, 234]. Similar to
ubiquitin, Atg12 is activated by Atg7, which has homology to the ATP-binding and
catalytic sites of the E1 ubiquitin activation enzyme, and is transferred to Atg10 (a
ubiquitin-like E2 conjugating enzyme) that attaches covalently to a lysine residue
of Atg5, the substrate protein [59] (see Fig. 2.2). Unlike ubiquitin, the conjugation
of Atg12 to Atg5 is irreversible and does not require substrate-specific E3 ligase.
The Atg12–Atg5 conjugate further complexes with Atg16 to form Atg12–Atg5-
Atg16 which tetramerises by self-oligomerisation and attaches to the developing
autophagosome [82, 163]. LC3 is first cleaved by Atg4, a cysteine protease, to
expose a C-terminal glycine residue, which then, similar to Atg12, is activated
by Atg7 and transferred to Atg3 (a ubiquitin-like E2 conjugating enzyme). Fur-
thermore, LC3 is conjugated to phosphatidylethanolamine (PE) via the E3-like
Atg12–Atg5 conjugate to form LC3-PE (also known as LC3-II) [74]. During basal
conditions, when nutrients are available, the majority of LC3 is cytosolic. How-
ever, upon induction of autophagy, these endogenous cytoplasmic LC3 reserves are
mobilized, lipidated and subsequently localized to both sides of the autophagosome
double membrane at the phagophore assembly site [98]. Since LC3 plays an impor-
tant role in determining membrane curvature it is conceivable that LC3 has some
control over the size of the autophagosome [266]. Additionally, LC3-II levels are
widely used to assess autophagy since these levels vary linearly with the number
of autophagosomes [167]. Recent studies have shown that mAtg9 may facilitate
membrane trafficking and/or fusion, since it is the only integral membrane pro-
tein identified that is required for autophagy [81]. Therefore the role of mAtg9
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may include the supply of the growing phagophore with membrane material and
furthermore assisting in the expansion of the phagophore [23, 275].
2.2.1.4 Vesicle fusion and autophagosome breakdown
Upon the completion of the autophagosome maturation process, LC3-PE is cleaved
by Atg4 from the outer membrane and released into the cytosol [112]. The fusion of
autophagosomes and lysosomes is mediated by the same machinery that is used in
homotypic vacuole fusion. The fusion process requires lysosome-associated mem-
brane protein 2 (LAMP2) and the small GTPase Rab7 [94, 238]. Upon completion
of the fusion process the inner compartment of the autophagosome is exposed to
the lysosomal acid hydrolases that include proteinases A and B as well as cathep-
sin B and L [239]. The exposure of the autophagic cargo to the hydrolases results
in its degradation and the subsequent transportation of digested goods back to
the cytoplasm, mostly in the form of amino acids, which can be used for protein
synthesis and nutrients during periods of starvation.
2.2.2 Non-Atg components required for autophagy
2.2.2.1 Cytoskeleton
In order for autophagy to proceed optimally, efficient protein trafficking is re-
quired during autophagosome formation, a process that is mediated by the cy-
toskeletal networks. For instance, in yeast the actin cytoskeleton and the actin-
related protein 2/3 complex (Arp2/3 complex), which serves as nucleation sites
for new actin filaments, is required for the anterograde transport of Atg9 to the
pre-autophagosomal assembly site [168, 209]. Similarly, in higher eukaryotes mi-
crotubules are involved in autophagy for transport of Atg proteins as well as auto-
phagosomes. The depolymerisation of microtubules by chemical intervention with
nocodazole in primary rat hepatocytes has been shown to inhibit autophagosome
formation [115]. Additionally, microtubules and tubulin deacetylase HDAC6 have
been shown to be essential for autophagic degradation of polyglutamine aggre-
gates [93, 194]. Furthermore, mutation in the dynein motor machinery impairs
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the autophagic clearance of aggregate-prone proteins, which leads to premature
aggregate formation [205]. In addition, there is an increase in the levels of the
autophagosome marker LC3-II, suggesting an impairment in autophagosome and
lysosome fusion. In mammalian cell lines it appears that autophagosomes are
formed in peripheral regions of the cell, and move bidirectionally along micro-
tubules. Their movement depends on the dynein motor protein that transports
them to the centre of the cell, leading to their accumulation at the microtubule
centre. This process is similar to other trafficking pathways [95]. The accumula-
tion of autophagosomes and lysosomes at the microtubule-organizing centre allows
for the fusion of autophagosomes and lysosomes driven by dynein motors that can
either result in the complete fusion, or the so called kiss-and-run event where there
is a partial transfer of vesicle content while still remaining as two separate vesicles
[95, 115].
2.3 Metabolic regulation of autophagy
Autophagy is a tightly orchestrated intracellular process that plays a key role in the
bulk degradation of cytoplasmic proteins and organelles. It serves multiple vital
biological roles such as maintaining cellular integrity and utilizing endogenous
energy reserves during periods of starvation. It is therefore not surprising that
autophagy is regulated by a broad intracellular nutrient and stress-sensing network
(Fig. 2.4). In this section we will discuss metabolic triggers and signalling pathways
that modulate autophagy activity.
2.3.1 Metabolic triggers of autophagy
Because autophagy plays an integral role in cellular metabolism and in maintaining
cellular integrity, it is essential that autophagy can either be up or down regulated
in response to a stimulus. Therefore, multiple signalling pathways are required,
each of which monitors defined cellular processes to assess the metabolic status
of the cell in order to adjust autophagy flux. Key metabolites involved in energy
production and protein synthesis, such as ATP or essential nutrients (for example
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glucose and amino acids), can induce autophagy. Besides the induction of au-
tophagy through changes in the cell’s energetic state, it can also be stimulated by
the accumulation of metabolic by-products such as ammonia. In this section we
will discuss the main key regulators of autophagy: reduced energy charge, amino
acid depletion, depletion of cytosolic acetyl-CoA, ammonia levels, lipids, reactive
oxygen species and hypoxia.
2.3.1.1 Reduced energy charge
The term “energy charge” refers to the metabolic status of the cell. It was coined
by Atkinson and Walton in the late 60’s, when they mathematically derived an
equation that describes the adenylate system of a cell as function of intracellular
ATP, ADP, and AMP concentrations [7]. The energy charge decreases when ATP is
not actively synthesized through oxidative phosphorylation or glycolysis, alongside
with the accumulation of AMP. These changes in ATP and AMP levels effectively
change the energy charge and stimulate autophagy through AMP-activated pro-
tein kinase (AMPK) [78]. AMPK plays an essential role as a cellular energy sensor
in multiple signalling cascades that regulate several intracellular metabolic path-
ways. Once activated, it is responsible for promoting ATP production by increas-
ing the activity and or expression of proteins involved in catabolic processes such
as fatty acid oxidation, glucose uptake and ketogenesis (see section 2.3.2). Con-
versely, AMPK inhibits energy expenditure of anabolic conditions by switching off
biosynthetic pathways in order to preserve energy for essential metabolic reactions
required for survival. AMPK is highly sensitive to fluctuations in the AMP and
ATP ratio and consequently regulates the cellular machinery that is responsible
for maintaining energy charge of the cell. It therefore acts as a metabolic master
switch. Interestingly, since autophagy also requires ATP in several steps in its
pathway, a rapid reduction in ATP levels and energy charge below a critical limit
is more likely to trigger cell death rather than an adaptive autophagic response
[56]. Cells that mainly depend on glycolysis for fuel are extremely sensitive to
glucose fluctuations, and therefore withdrawal from glucose will induce autophagy
as a result of a reduction in energy charge [78]. Interestingly, the inhibition of hex-
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okinase II, which catalyses the first step of glycolysis by phosphorylating glucose,
also promotes autophagy; however, the mode of action differs greatly. This is as
a result of hexokinase II directly interacting with mammalian target of rapamycin
complex1 (mTORC1) and thus inhibiting its activity, consequently inducing au-
tophagy [210]. It is worth noticing that toxins such as rotenone, that is used as
an inhibitor of the electron transport chain, inhibits mitochondrial ATP synthesis
and surprisingly also inhibits autophagy [148]. It is therefore possible that tox-
ins may not be considered as appropriate means to discern complex integration
linking metabolism and autophagy. In conclusion, glucose deprivation and the
consequent change in ATP and AMP affects the cell’s energy charge, which is a
potent activator of autophagy.
2.3.1.2 NADH/NAD+ ratio
Nicotinamide adenine dinucleotide (NAD) is a coenzyme found in all living cells
and exists in both a reduced (NADH) or oxidized (NAD+) state. In either of
its forms NAD is an essential substrate that is involved in redox reactions of
multiple metabolic pathways, including glycolysis and oxidative phosphorylation.
During periods of nutrient-poor conditions there is an accumulation of NAD+ at
the expense of NADH. The resulting shift in the NADH/NAD+ ratio stimulates
autophagy through the activation of histone deacetylases of the sirtuin family
[88]. Upon activation of NAD+-dependent enzymes such as poly-(ADP-ribose)-
polymerase-1 (PARP-1), which consumes NAD+, there is a depletion of intracel-
lular levels of both NAD+ and NADH [61]. The inhibition of NAD+-dependent
enzymes and metabolic pathways responsible for the supply of NAD precursors
are potent inducers of autophagy once sirtuins are activated [88]. Thus, the de-
pendence of sirtuins on NAD-reserves links the energy status of the cell via the
intracellular NADH/NAD+ ratio, as well as the total availability of NAD (includ-
ing precursors) directly to the enzymatic activity of sirtuins and, consequently,
autophagy.
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2.3.1.3 Depletion of amino acids
Amino acids play a crucial role in biological processes. The induction of au-
tophagy can be brought on by the availability of amino acids through four distinct
mechanisms. Firstly, a reduction in the availability of intracellular amino acids
results in the accumulation of uncharged tRNA species. This consequently acti-
vates eukaryotic translation initiation factor 2a kinase 4 (eIF2aK4) which in turn
inhibits protein synthesis and induces autophagy through the activation of tran-
scription factor 4 (ATF4) [271]. Secondly, the absence of various amino acids
(especially leucine, glutamate, and glutamine) diminishes intracellular acetyl-CoA
stores and therefore induces autophagy, since acetyl-CoA cannot be effectively gen-
erated [149]. Thirdly, the dwindling of the presence of amino acids in the lysosomal
lumen effectively turns off the ”inside-out mechanism” that promotes the associa-
tion of mTORC1 with the lysosomal surface membrane. Subsequent activation of
mTORC1 localised to lysosomes induces autophagy [281]. Fourthly, the reduction
in amino acid availability results in the depletion of α-ketoglutarate, which pro-
motes autophagy alongside the inhibition of prolyl hydroxylase [43]. These four
mechanisms constitute a broad intracellular amino acid-sensing network that inti-
mately links amino acid levels to autophagy. Additionally, proteasome inhibitors
can also reduce intracellular amino acid levels and therefore induce autophagy.
However the degree of control that each of these mechanisms has over the au-
tophagy pathway is not known. All these amino acid sensing mechanisms con-
tribute to the orchestration of autophagic responses to shortage of amino acids.
2.3.1.4 Depletion of cytosolic acetyl-CoA
Nutrient deprivation over several hours results in a significant reduction in cytosolic
acetyl-CoA levels alongside the induction of autophagy [149]. Similar trends have
been found in several pharmacological studies where the inhibition of acetyl-CoA
synthesis, either through direct inhibition or substrate limitations, accompanied
the induction of autophagy [47]. The dwindling reserve of cytosolic acetyl-CoA is
a potent stimulator of autophagy, which is thought to be facilitated by acetyl-CoA
acting as donor of acetyl groups for acetyl transferases. Some of the autophagic
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machinery components are regulated via acetyl transferases at the transcriptional
or the post-translational level by modulation through histone acetylation [133,
149]. In contrast, the replenishment of intracellular acetyl-CoA levels inhibits
starvation-induced autophagy in both cell culture and mouse models [149].
2.3.1.5 Ammonia levels
Ammonia is a stress-inducing and toxic byproduct of amino acid catabolism, and
acts as a potent activator of autophagy [48]. In contrast to amino acid deprivation-
induced autophagy, ammonia-induced autophagy does not rely on either mTORC1
inhibition [77] or ULK1/ULK2 activation [28]. Harder et al. [77] suggest that
ammonia triggers autophagy through the activation of AMPK and the unfolded
protein response (UPR). The role of the UPR in autophagy induction was sub-
stantiated by the finding of elevated ER stress markers DDIT3/CHOP and HSPA5
during ammonia treatment [77]. Interestingly, tumours generate high levels of
ammonia due to an increase in glutamine catabolism via glutaminolysis, which
up-regulates autophagy. This may be observed in established tumours and may
contribute to the resistance of tumours to treatments as a result of the protective
function of autophagy [65].
2.3.1.6 Reactive oxygen species and hypoxia
Reactive oxygen species (ROS) are reactive molecules containing oxygen and play
an important role in cell signalling and homeostasis [42]. It is well documented
that ROS is an effective inducer of autophagy [27]. The major contributors to ROS
generation are mitochondria, NADPH oxidase complexes (NOX), peroxisomes, and
the endoplasmic reticulum [27, 68, 176]. Acute ROS exposure can lead to extensive
cellular damage that may induce autophagy mediated cell death [27]. Cells main-
tain tolerable levels of ROS on a basal level and are able to protect themselves from
damage caused by rapid increases in mitochondrial ROS through anti-oxidative
strategies [27, 68]. Hypoxia is a condition where cells are exposed to oxygen levels
below 1% (hypoxic stress), in contrast to normoxia which is characterised by 2–9%
oxygen. However, hypoxic conditions play physiologically significant roles as in, for
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example, developing embryos, but are also created in pathological conditions such
as brain injuries, cardiovascular ischaemia, and solid tumours. There is an increas-
ing amount of data that shows that hypoxia induces autophagy. Interestingly, the
autophagy induction pathways of hypoxia and their cellular consequences appear
to be different between cell types. For instance, hypoxia enhances mitochondrial
autophagy (mitophagy) as an adaptive response in an attempt to reduce the levels
of reactive oxygen species to preserve the cell’s integrity. However, in several can-
cer cell lines prolonged exposure to hypoxic conditions can induce autophagic cell
death [10]. Oxygen deprivation induces hypoxia-inducible factor-1 (HIF-1) that
promotes transcription of various genes. This response subsequently decreases
mitochondrial biogenesis and respiration and promotes erythropoiesis and angio-
genesis. Therefore, the induction of HIF-1 is an adaptive response to counteract
deleterious effects caused by O2 deficiency. Interestingly, mouse embryonic fibrob-
lasts (MEFs) promote mitochondrial selective autophagy in response to hypoxic
conditions in order to remove damaged mitochondria. This process is dependent
on HIF-1 as well as the anti-apoptotic Bcl-2 adenovirus E1a nineteen kDa inter-
acting protein 3 (BNIP3) which is a HIF-1-induced target [280]. BNIP3 induces
autophagy by competing with Beclin1 to bind with Bcl-2, which subsequently
promotes the dissociation of Bcl-2 and Beclin1 and therefore promotes autophagy.
Although BNIP3 is regulated by HIF-1, it is also the target gene of the E2F fam-
ily transcription factors that are under the control of the retinoblastoma protein
(RB) family [246]. Thus hypoxia can induce autophagy by promoting the bind-
ing of HIF-1 and or E2F to the BNIP3 promoter with subsequent expression of
BNIP3, as well as through the RB-E2F-BNIP3 signalling pathway. Interestingly,
the increase in autophagic capacity observed in tumours appears to be indepen-
dent of the HIF-1pathway. Here, autophagy is alternatively induced through the
AMPK-mTOR [196] and protein kinase C δ(PKCδ)-JNK1 pathway [25].
Stellenbosch University  https://scholar.sun.ac.za
CHAPTER 2. LITERATURE REVIEW 25
2.3.2 Metabolic sensors that initiate autophagy
2.3.2.1 AMP-activated protein kinase
AMPK is a highly conserved energy sensor in eukaryotes which is activated when
there is decrease in intracellular ATP, hence a reduction in the energy status of the
cell. It is a heterotrimeric protein that is composed of a catalytic α-subunit, a regu-
latory γ-subunit and a scaffolding β-subunit. All subunits are expressed as multiple
isoforms, namely α1, α2, γ1, γ2, γ3, β1 and β2. The binding of AMP with an-
other AMP or ADP (AMP with a much higher affinity) to the γ-subunit prevents
the dephosphorylation of the α-subunit at T172 and the subsequent inhibition
of its catalytic activity [78]. Therefore a decrease in the energy charge, hence a
decrease in ATP levels and an increase AMP, will dramatically increase AMPK ac-
tivity. The phosphorylation of the α-subunit can be catalysed by serine/threonine
kinase 11 (STK11, also known as LKB1), calcium/calmodulin-dependent protein
kinase kinase 2 (CAMKK2) and by mitogen-activated protein kinase kinase kinase
7 (MAP3K7, also known as TAK1) [78]. MAP3K7 is required for the starvation-
induced phosphorylation of AMPK and subsequent activation of autophagy [36]
in cancer cells as well as in vivo in mouse hepatocytes [90]. It is also worth noting
that AMPK can be activated allosterically with pharmacological chemicals such as
salicylate (the active compound of aspirin). AMPK can stimulate autophagy via
the inhibition of mTORC1, or, more directly, phosphorylate and thereby activate
ULK1 [109] as well as the various subunits of the BECN1-VPS34 complex. Dur-
ing glucose deprivation AMPK phosphorylates BECN1 at serine residues 93 and
96, which induces autophagy. Since AMPK plays a major role in the regulation
of metabolism, it is not surprising that it can stimulate autophagy by multiple
mechanisms.
2.3.2.2 Mammalian target of rapamycin complex 1
The mammalian target of rapamycin complex 1 (mTORC1) is composed of mTOR
itself, two mTORC1-specific regulatory proteins and several other mTOR-associated
proteins that are shared with the mammalian target of rapamycin complex 2
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(mTORC2). These two mTORC1 specific regulatory proteins are regulatory-
associated protein of MTOR complex 1 (RPTOR, best known as raptor) and
AKT1 substrate 1 (AKT1S1, generally known as PRAS40). In addition, several
other shared mTOR-associated proteins include DEP-domain-containing MTOR-
interacting protein (DEPTOR) and mammalian LST8 homologue (mLST8, also
known as GβL). mTORC1 acts as an energy/nutrient/redox sensor whose activity
is regulated by amino acids, growth factors, energy reserves, nutrient availability
and oxidative stress. Its role is to control the translation of proteins in response to
growth factors in the presence of adequate nutrients. Growth factors can activate
mTORC1 by phosphorylation via the receptor tyrosine kinase (RTK)-Akt/PKB
signalling pathway, which leads to the phosphorylation of ribosomal protein S6 ki-
nase (RPS6K, also known as p70S6K) and eukaryotic translation initiation factor
4E binding protein 1 (EIF4EBP1). The active forms of RPS6K and EIF4EBP1
consequently promote protein synthesis [227]. Once phosphorylated, mTORC1
can suppress autophagy by phosphorylating and inhibiting of ULK1 [109], tran-
scription elongation factor b (TFEb) [223], Atg14 [277] and Autophagy/Beclin1
Regulator (AMBRA) [179]. AMPK can induce autophagy by indirectly phospho-
rylating, thereby activating, tuberous sclerosis complex 2 (TS2) which negatively
regulates mTORC1 [78]. Additionally AMPK can phosphorylate RPTOR, which
suppresses mTORC1 activity, hence promoting autophagy [78]. The availability of
amino acids, which are positive regulators of mTORC1, can suppress autophagy
through various pathways, many of which have not been fully elucidated. For in-
stance, lysosomes act as temporary stores of amino acids since they are the major
site of protein degradation and amino acid recycling. It is therefore not surpris-
ing that mTORC1 and its regulators Rheb (Ras homologue enriched in brain),
and Rag GTPases (RRAG, a Ras-related GTPase) reside on the lysosomal sur-
face (Fig. 2.5) [44]. The Rag GTPase complexes together with a trimeric p14,
p18, and MP1 protein complex form the regulator scaffolding. This implies that
an amino acid-sensing system exists on the surface of lysosomes, which assesses
amino acid availability within the lysosome lumen, and signals to the Ragulator-
Rag complex. However, the exact site of localisation still remains elusive. This
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reflects a currently unknown function of lysosomes to connect with intracellular
pools of amino acids [218]. Additionally, α-ketoglutarate, which is a glutaminol-
ysis intermediate, has been shown to be a potent activator of autophagy in the
absence of amino acids, a process which is thought to be facilitated by the lyso-
somal RHEB-dependent pathway [44]. Interestingly, a decrease in α-ketoglutarate
has been shown to extend life expectancy by inhibiting mTORC1 and by inducing
autophagy [30]. However, these attributes of α-ketoglutarate are credited to its
ability to inhibit mitochondrial ATP synthesis through the F1F0-ATPase. The
tuberous sclerosis complexes 1 and 2 (TSC1 and TSC2) regulate Rheb activity
by phosphorylation, thereby linking nutrient-sensing networks. Leucine depletion
strongly correlates with the activation of autophagy, therefore it is not surprising
that it can promote autophagy through multiple pathways. For instance, leucine
can allosterically activate glutamate dehydrogenase thereby promoting glutaminol-
ysis. It can also activate RRAG via leucyl-tRNA synthetase [69]. Not only do Rag
GTPases signal amino-acid concentrations to mTORC1, but also glucose levels
[45, 66]. This suggests that AMPK may not be the only glucose sensor. Impor-
tantly, mTORC1 not only regulates lysosomal biogenesis and represses autophagy,
but also functions as a general regulator of anabolic reactions [227]. Since both
mTORC1 and AMPK control broad intracellular metabolic networks, the use of
chemical inhibitors of mTORC1 such as rapamycin have wide-ranging metabolic
consequences other than inducing autophagy. In addition, when downstream au-
tophagy signalling pathways are affected, mTORC1 inhibitors lose their capacity
to induce autophagy.
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Figure 2.5: mTOR localisation to the lysosome.
2.3.2.3 eIF2a kinases
The activation of initiation factor 2a (eIF2A) forms part of the integrated stress
response that allows cells to limit protein synthesis alongside the activation of
autophagy in response to the accumulation of unfolded proteins. This is an attempt
to restore homeostasis [124]. There are four kinase variants that are expressed by
mammals that can phosphorylate eIF2a, which are eIF2ak1 (also known as HRI),
eIF2ak2 (also known as PKR), eIF2ak3 (also known as PERK) and eIF2ak4 (also
known as GCN2) [229]. Various stimuli, such as heme availability, can activate
these kinases. In summary, the regulation of autophagy is closely linked to the
integrated stress response network.
2.3.2.4 Sirtuins
Sirtuins are class III histone deacetylases, belonging to a protein family that con-
sists of several mammalian variants (SIRT1-7). Sirtuins catalyse the deacety-
lation of protein substrates. Unlike other deacetylases that hydrolyse acetyl-
lysine residues, sirtuin-mediated deacetylation requires NAD+ hydrolysis for ly-
sine deacetylation. The subsequent hydrolysis of NAD yields O-acetyl-ADP-ribose
and nicotinamide, which are inhibitors of sirtuins [88]. Of all the known sirtuin
deacetylases, sirtuin 1 (SIRT1) is the best studied. It is mainly localized within
the nucleus where it is responsible for the deacetylation of histones such as H1
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and H2, as well as various other proteins. These include transcription factors
such as forkhead box O1 (FOXO1) and NF-kB [88]. Resveratrol, a plant-derived
polyphenolic compound with wide-ranging health benefits, can activate SIRT1 and
promote autophagy [128]. Interestingly, the expression of the cytoplasm-restricted
mutant of SIRT1 could induce autophagy, which suggests that SIRT1 could in-
duce autophagy without assistance of its transcriptional cascade [170]. Although
Atg5, Atg7, Atg12 and LC3 have been implicated in the SIRT1-induced autophagy
cascade, the precise mechanism through which autophagy is induced via SIRT1
activation still remains elusive [130]. Since sirtuins form part of broad intracellular
networks, similar to that of mitochondrial biogenesis and inflammation [201], it is
not surprising that SIRT1 can be activated by other factors than NAD+ [22]. For
instance, a low caloric diet can stimulate SIRT1 activity, whereas a high-fat diet
can reduce SIRT1 activity [22]. To conclude, SIRT1 can promote autophagy under
defined circumstances and contributes to the pro-autophagic activity of AMPK.
2.3.2.5 Acetyltransferases
Transfer of acetyl groups plays a major role in signalling cascades, post-translational
modification of proteins as well as histone modification. Histone modification leads
to nuclear remodelling of chromatin architecture that can either result in chromatin
condensation or expansion. Reductions in the intracellular pool of acetyl-CoA re-
sults in overall reduction of protein acetylation in the cytoplasm, as well as in the
nucleus [47, 149]. Accordingly, the availability of acetyl-CoA, which is the sole
donor of acetyl groups, determines the catalytic activity of several acetyltrans-
ferases. Reduction in the availability of acetyl-CoA has been linked to autophagy
activity and the E1A-binding protein p300 (EP300) has been found to play a crit-
ical role in the regulation of autophagy [149]. The physiological role of EP300 is
to monitor intracellular acetyl-CoA availability and to respond to the transition
between a fed and unfed state and the accompanying shifting between intracellu-
lar endogenous energy reserves. Furthermore, the inhibition of EP300 stimulates
autophagy even during conditions of high abundance of acetyl-CoA [149]. EP300
inhibits several proteins involved in autophagy induction by acetylating proteins
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of the core autophagic machinery such as Atg5, Atg7, Atg12, and LC3 [131]. Al-
though EP300 is implicated in autophagy regulation, it is likely that other acetyl-
transferases, such as the inhibitor of growth (ING) family, may play a part in
regulating autophagy [149]. Interestingly, several histone acetyltransferases have
been connected to autophagy regulation in yeast, which lacks an EP300 ortho-
logue [46]. Furthermore, in yeast models, mutated histone-coding genes can cause
an increase in autophagy as a result of over-expression of components of the core
autophagic machinery [47]. Acetyltransferases form part of a broad intracellular
acetylation network where activation of one can inhibit another. For instance,
tubulin acetyltransferase 1 (ATAT1, best known as MEC17) is negatively regu-
lated by EP300. ATAT1 can be activated by AMPK, and conversely AMPK can
inhibit EP300 activity by phosphorylation on the serine residue 89 [269]. Therefore
the activation of AMPK causes the inhibition of EP300 as well as the activation
of MEC17, which subsequently results in the hyperacetylation of α-tubulin. This
scenario seems to bring about pro-autophagy effects [147]. To conclude, both hy-
peracetylation and deacetylation have inhibiting or inducing effects on autophagy,
linking energy sensing networks to the control of autophagy.
2.3.2.6 Cell-surface nutrient receptors
Cell-surface nutrient receptors have import biological roles, acting as a means for
the cell to respond to extracellular metabolite changes as well as to physiologi-
cal cues from the brain and pivotal organs. Autophagy, an adaptive response to
stress, is therefore associated with a cell-surface receptor signalling cascade. Sev-
eral cell-surface receptors have been linked to autophagy, but the precise signalling
cascade involved still remains unclear. It is thought that increases in intracellular
levels of inositol-1,4,5,-triphosphate, diacylglycerol and cyclic AMP play a role in
autophagy regulation as a result of cell-surface receptor signal transduction [258].
Several G protein-coupled receptors (GPCRs) found on the cell surface assess nu-
trient availability in the extracellular microenvironment and communicate with
the autophagic machinery. Several identified cell-surface receptors include, but
are not limited too, amino acid sensing receptors, γ-aminobutyric acid B recep-
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tor 1 (GABBR1), the G protein-coupled receptor GPRC6A, heterodimeric taste
receptors, metabotropic glutamate receptors (mGluRs), calcium-sensing receptors
(CASR), as well as free fatty acid receptors. In conclusion, several nutrient-sensing
networks detect extracellular and/or intracellular nutrient fluctuations and initiate
an autophagic response. However, it must still be investigated whether systemic
nutrient limitation preferentially stimulates autophagy compared to limitation of
a single molecule. Furthermore, it is not known what degree of control each sensor
exerts over autophagy, systemically as well as tissue specific. This chapter has
shown that different isoforms of key proteins involved in the autophagy induc-
tion cascade, such a AMPK, the mTORC1 complex, and acetyltransferases, all
contribute to the fine regulation of autophagy.
2.4 The biological role of autophagy
Autophagy, an evolutionary conserved process found in all eukaryotes, is presumed
to be the primary means of maintaining cellular homeostasis during conditions of
diminishing nutrient reserves as well as metabolic perturbations. This is achieved
through targeting endogenous reserves, such as cytoplasmic proteins, for degrada-
tion to supply the building blocks for essential anabolic reactions as well as ATP
synthesis [230]. Cells with defective autophagic machinery are more susceptible
to nutrient perturbation than their wild type counterparts [124]. For instance,
genetically altered mice that express defective components of the autophagic ma-
chinery die shortly after birth, which is thought to be as a result of the inability
to mobilize energy reserves through autophagy. These mice do not survive the pe-
riod of starvation between placental metabolism and suckling [126]. A reduction
in autophagic capacity has been associated with numerous diseases such as neu-
rodegeneration, cardiovascular disorders, cancer and ageing-associated pathologies
[31]. In contrast, the autophagic system is exploited by tumours as a means to
cope with adverse conditions [65]. On a systemic level, the induction of autophagy
extends the lifespan of mice and various other animal models [215]. Here, we will
discuss autophagy at the single cell and whole body level and ask how the regula-
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tion of autophagy influences the health of an organism as well as susceptibility to
disease.
2.4.1 Basal autophagy in intracellular quality control
2.4.1.1 Protein quality control
Basal autophagy plays an essential role in maintaining cellular homeostasis. In-
tracellular proteins can be categorized into short-lived and long-lived proteins
[89, 105]. Short-lived proteins constitute less than 1% of protein content in hep-
atocytes, but they represent nearly one-third of protein degradation as a result
of their rapid turn-over [105, 173]. It is widely accepted that the majority of
short-lived proteins are degraded by the ubiquitin-proteasome system, while long-
lived proteins are degraded via autophagy. In contrast, long-lived proteins are
not selectively degraded, but rather randomly sequestrated by autophagosomes
and degraded. Long-lived proteins constitute 99% of intracellular proteins [105].
Short-lived proteins can also be degraded via the autophagic machinery [2]. Only
recently, the importance of basal autophagy has come to light, implicating its role
as a quality-control system, particularly in neuronal cells and hepatocytes.
Liver-specific Atg7 knock-out mice. The importance of basal autophagy
was first revealed in liver-specific Atg7 knock-out mice. Not only did the mice
exhibit defective starvation-induced autophagy, but they also developed various
abnormalities such as hepatomegaly, even when they were maintained in nutri-
ent rich conditions [119]. Intriguingly, a considerable amount of ubiquitin-positive
aggregates was observed in these hepatocytes [119], and both serum alanine amino-
transferase and aspartate aminotransferase levels were considerably elevated.
Atg5 and Atg7 mice knock-out embryos. Neonates from Atg5 and Atg7
knockout mice showed minimal defects at birth. However, they had a reduced
body size in comparison to their wild type counterparts, and exhibited suckling
defects [119, 126]. Systematic analysis of Atg5-/- neonates showed accumulation of
ubiquitin-positive aggregates in hepatocytes and some parts of the brain [75], which
reflects the significance of basal autophagy that varies among cell and tissue types.
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The dorsal root ganglion exhibited the largest amount of protein aggregates, in
contrast to other cell/tissue types, such as skeletal muscle and kidney, that showed
very few aggregates.
Neuronal cell specific Atg5 and Atg7 knock-outs. The role of basal au-
tophagy in the central nervous system was further investigated in Atg5 and Atg7
knock-out mice. Although these mice were born normally, they showed growth
retardation and developed progressive motor and behavioural defects after three
weeks [75, 117]. Closer examination of the brain revealed partial loss of cerebel-
lar Purkinje cells, pyramidal cells, as well as axonal swelling in various regions
of the brain. Intriguingly, there was a difference between the survival rates of
Atg5 and Atg7 knock-out mice. Atg5 knock-out mice exhibited sporadic death,
whereas most Atg7 knock-out mice died within three weeks. This suggests that
Atg7 may serve functions in neuronal cells other than autophagy, especially since
it is implicated in the activation of Atg8 homologues such as GATE-16 [216] and γ-
aminobutyric acid (GABA)A-receptor-associated protein (GABARAP) [254]. The
mechanism responsible for the observed ubiquitin-positive aggregates is still un-
clear. However, these aggregates are not found in glial cells. Autophagy arrest
leads to the accumulation of ubiquitinated proteins and subsequent protein aggre-
gate formation in the cytoplasm [75]. Therefore, it seems that protein aggregation
formation results from impaired protein turnover. Accordingly, basal autophagy
facilitates continuous clearance of diffuse cytosolic proteins, and not of aggregate
itself, thereby preventing the accumulation of abnormal proteins as well as protein
aggregation.
It is essential for cell growth and whole organism development to maintain a
fine balance between protein and organelle synthesis and degradation in order to
maintain vital cellular functions. By preventing further damage to cellular com-
ponents by rapidly degrading proteins with potentially deleterious effects, basal
autophagy acts as a protein quality control system. Cell-specific differences in
autophagy could possibly be attributed to the importance of quality control in
non-dividing and post-mitotic cells, in comparison to rapidly dividing cells where
abnormal constituents can be rapidly diluted out if they are not degraded.
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2.4.2 Adaptive responses to stress
2.4.2.1 Starvation response
Autophagy is characteristically induced upon starvation. In mammals, autophagy
can be induced by the absence of nutrients, most notably through caloric and amino
acid deprivation. Metabolic perturbations induce autophagy via energy-sensors
(see Section 2.3.2) [124]. Therefore decreases in intracellular ATP, amino acids,
NADH/NAD+ ratio, AMPK, sirtuins, and inhibition of mTORC1 result in the in-
duction of autophagy via energy-sensing networks. Furthermore autophagy can be
induced in a biphasic manner, a rapid response that occurs in a matter of minutes
to hours [170, 241], and a protracted response that relies on the transcriptional
programs [223, 257]. The rapid response does not require de novo synthesis of
macromolecules, but rather relies on the mobilization of endogenous reserves upon
autophagy activation through post-translational regulatory mechanisms such as
phosphorylation and acetylation. The protracted autophagic response modulates
autophagy by regulating multiple kinases that form part of the autophagic “core
machinery” such as Atg1 as well as key kinases, such as mTORC1 and Vps34,
involved in signalling pathways [13].
2.4.2.2 Systemic autophagy response
Although the majority of studies focus on autophagy in the liver and neuronal
cells, autophagy does occur throughout the whole body [161]. In GFP-LC3 trans-
genic mice it was observed that autophagy is activated after 24 hr food withdrawal
in liver, heart, skeletal muscle, exocrine glands, podocytes in kidney and seminal
gland cells [161]. Furthermore, autophagy is differentially induced by nutrient de-
privation in a tissue-dependent manner. The maximal rate is reached after 24 hr,
followed by a decrease in most tissues. In contrast, in some tissues, such as the
heart and slow-twitching muscle, the rate of autophagy continues to accelerate after
24 hr. Interestingly, thymic epithelial cells are constitutively active in autophagy
even under nutrient-rich conditions. Therefore the regulation of autophagy is or-
gan dependent and also not only limited to an adaptive response to starvation.
Stellenbosch University  https://scholar.sun.ac.za
CHAPTER 2. LITERATURE REVIEW 35
Minimal autophagy activity was reported in brain in starvation, because presum-
ably the brain is nutritionally protected under physiological stress conditions. For
instance, depending on the nutritional state, the brain can utilize either glucose
or ketone bodies, which are supplied by the liver. However, it is crucial to note
that assessing autophagic capacity solely on GFP-LC3 vesicles can be misleading
(see Section 2.6). For instance, as revealed through this thesis, high flux may ob-
tain at low levels of intermediates such as autophagosomes, which may be true for
cells where autophagy plays a major role in cytoprotection and protein degrada-
tion. Basal autophagy has been shown to play a vital role in maintaining cellular
integrity, and aberrations in autophagy are intimately linked to several neurode-
generative diseases. Therefore, it is possible that a low vesicle count in neuronal
cells does not reflect low autophagic flux, but is rather suggestive of high flux; this
still needs to be investigated. Thus, a robust and accurate method needs to be de-
veloped to assess autophagic flux. Furthermore, the liver characteristically has an
abundance of autophagosomes, especially during nutrient deprivation, which may
indicate relatively low autophagic flux. It is not unreasonable to expect different
rates of autophagic flux in different tissue/cell types, since they differ in protein
turnover and amino acid demand.
2.4.3 Autophagy and human disease
2.4.3.1 Neurodegeneration
There is an increasing number of papers in the literature that supports the notion
that aberration in autophagy is intimately linked to several human diseases. The
basal autophagic flux varies among cell types, and may be particularly heightened
in cells, such as neurons, that do not divide after differentiation [75, 117, 119, 120].
Neuronal-specific Atg5 and Beclin1 knock-out mice that survive the postnatal
starvation period develop cumulative motor deficits and exhibit abnormal reflexes
as well as present excessive ubiquitin-positive inclusion bodies in their neurons
[75, 117]. Although the autophagosomal pool size seems remarkably lower than
that of other tissue types [161], this may provide indirect evidence of high au-
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tophagic flux in these tissues and may reflect the indispensable role of autophagy
in maintaining protein quality control. The importance of autophagy becomes
more apparent under disease conditions. Recent studies indicate the importance
of autophagy, in addition to the ubiquitin/proteasome degradation system, in the
clearance of disease-related mutant proteins. For instance, the accumulation of ex-
tended polyglutamine-containing proteins is the root of various neurodegeneration
diseases such as Huntington’s disease and spinocerebellar ataxia, as well as mu-
tated forms of α-synuclein contributing to the origin of familial Parkinson’s disease
[151, 212, 214]. Chaperone-mediated autophagy is also involved in the degradation
of α-synuclein, but the mutant α-synuclein blocks the lysosomal receptor which
subsequently inhibits CMA [38]. Affected cells up-regulate macroautophagy in
an attempt to compensate for the CMA congestion, which ensures cell survival.
However this renders them more susceptible to stress [152].
Alzheimer’s disease (AD) is a chronic neurodegenerative disease that is com-
monly associated with memory loss. It is characterized by the presence of senile
plaques in the extracellular space in especially the cerebral cortex, as a result of
extensive amyloid beta (Aβ) deposits [91]. These plaques result from dysfunctional
proteolytic cleavage of the amyloid precursor protein (APP) that is localized in
endocytic and secretory compartments. Autophagosomes are actively formed in
synapses and along neuritic processes and require retrograde transport towards the
neuronal cell body for degradation. Lysosomes are highly concentrated in these lo-
cations for efficient clearance of autophagosomes and its cargo. In Alzheimer’s dis-
ease, both the maturation process of autophagosomes and their retrograde trans-
port is impaired and leads to extensive accumulation of autophagic vacuoles along
dystrophic and degenerating neurites [185]. Furthermore, since both APP and
its processing enzymes are found in these impaired autophagosomes, it increases
substrate and enzyme interaction time and may lead to further generation of Aβ
plaques [276]. Recently, the expression levels of Beclin1 have been shown to be
reduced in the brain of patients with late stage Alzheimer’s disease [199]. More-
over, the heterozygous deletion of Beclin1 in transgenic mice has been shown to
increase intracellular Aβ accumulation and extracellular Aβ deposits in old mice
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with subsequent promotion of neurodegeneration [132, 199]. Increased expression
of Beclin1 in mice seems to have the reverse effect. In summary, Aβ levels are
influenced by both autophagosome production and clearance [222]. Thus, an im-
pediment in the autophagosome maturation process increases Aβ which promotes
neurodegeneration.
Parkinson’s disease (PD), also known as paralysis agitans, is a neurodegen-
erative disorder of the central nervous system. It is characterized by the continued
loss of dopamine-generating neurons in the substantia nigra. The most notable
symptoms of PD, such as tremors and rigidity, are movement-related. PD is an
idiopathic disease with no known cause, but several factors have been shown to
be involved in the progression of the disease, such as the accumulation in the neu-
rons of α-synuclein (α-syn) into inclusion bodies termed Lewy bodies. Healthy
neurons degrade α-syn via chaperone-mediate autophagy (CMA), but in PD mu-
tant variants (A53T and A30P) of α-syn bind to the lysosomal membrane recep-
tor and prevent their own degradation as well as that of other substrates [38].
Therefore pathogenic mutant variants of α-syn are found in cytosolic inclusion
bodies. Moreover, α-syn aggregates can only be degraded through the autophagic
pathway [259]. Intriguingly, a fraction of α-syn present in Lewy bodies is mono-
ubiquitinated, which promotes the transition of aggregation of α-syn to amorphous
aggregates as well as stimulates the formation of α-syn aggregate inclusion bod-
ies within dopaminergic cells [49]. It is worth noting that ubiquitination and the
majority of other post-translational modifications of α-syn seems to impede its
degradation by CMA. Moreover, dopamine-modified α-syn is poorly degraded by
CMA and prevents the degradation of other CMA substrates, all of which renders
the cells more susceptible to stress.
Huntington’s disease (HD) is a neurodegenerative genetic disorder caused
by a polyglutamine expansion mutation in the huntingtin protein. Affected in-
dividuals have impaired muscle coordination and cognitive as well as behavioural
symptoms. Mutated huntingtin proteins have cytotoxic qualities and are also more
aggregate-prone, leading to the formation of neuronal intra-nuclear inclusion bod-
ies and neuronal death. Several factors have been implicated in the progression of
Stellenbosch University  https://scholar.sun.ac.za
CHAPTER 2. LITERATURE REVIEW 38
HD, including excitotoxicity, metabolic impairment, autophagy, dopamine toxicity
and oxidative stress [62]. Several studies have implicated autophagy in the pro-
gression of the disease. HD patients’ brains are characterised by an increased endo-
somal and/or lysosomal content, accompanied by lipofuscin accumulation which
is suggestive of autophagy [242]. In addition, endosomal and/or lysosomal ac-
tivity is increased by the expression of mutant huntingtin [107]. The wild type
huntingtin protein naturally associates with the ER, and is released from the ER
membrane during periods of stress, after which it translocates to the nucleus. Once
the stress dissipates, huntingtin translocates back and re-associates with the ER.
Cells affected by mutated huntingtin show a disrupted ER as well as an increase in
autophagic vesicles [8]. Interestingly, both polyglutamine and polyalanine expan-
sions of proteins make them aggregate-prone and therefore targets for degradation
by autophagy [206]. Inhibition of autophagy by either chemical or physiological
intervention leads to the accumulation of mutant huntingtin protein aggregate and
increased cell susceptibility to stress, whereas the induction of autophagy promotes
huntingtin degradation and increases cell viability [202]. In addition, mTOR ac-
tivity is inhibited as a result of being embroiled within mutant huntingtin protein
aggregates, which induces autophagy [208]. This may directly promote huntingtin
protein aggregate degradation via autophagy [202, 206, 208]. The accumulation of
mutant huntingtin can also induce autophagy through mTOR-independent path-
ways, which include the insulin signalling pathway that requires Beclin1 and Vps34
[267]. The increase in insulin receptor substrate 2 (IRS2) activity stimulates the
clearance of huntingtin regardless of Akt and mTOR activation. The entanglement
of Beclin1 in affected neuronal intra-nuclear inclusion bodies seems to reduce the
autophagic clearance capacity [226]. Furthermore, in human brains the expression
of Beclin1 decreases in an age-dependent manner, which leads to a reduction in
the autophagy capacity during ageing and in turn promotes the accumulation of
mutant huntingtin and the progression of the disease.
There is no doubt that autophagy has protective effects against neurodegen-
eration. However, the mechanisms by which autophagy protects against neurode-
generation are still poorly understood. The leading hypothesis indicates that au-
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tophagy either directly eliminates inclusion bodies or protein aggregates, or indi-
rectly suppresses aggregate formation by rapidly degrading aggregate prone pro-
teins [16, 93]. Furthermore, p62/sequestosome-1 (SQSTM1) plays a crucial role
in preventing spontaneous protein aggregate formation [118]. It has both LC3-
binding and ubiquitin-binding domains that mediate recognition and binding of
aggregate prone proteins to LC3, a key membrane component of the autophagic
sequestering vesicle, thereby facilitating degradation [16, 195]. A recent hypothesis
has been proposed that contradicts the degradation of aggregates by autophagy;
it rather suggests that the creation of protein aggregates is a cytoprotective mech-
anism [5, 237]. Therefore, it could be that the role of autophagy is rather to
maintain cytosolic protein quality, implying that protein aggregate and inclusion
body formation result from impaired protein turnover in autophagy-compromised
cells [75]. These data suggest that an exact measurement of autophagic flux is
instrumental to understanding the role of autophagy and elucidating its role in
the pathogenesis of neurodegeneration.
2.4.3.2 Cancer
Autophagy has long been known to be associated with cancers [18]. It is likely
that the role of autophagy varies in the different stages of cancer development. For
instance, during normal cell development autophagy acts as a preventive strategy
against cancer, in contrast to established tumours that exploit autophagy for their
own cytoprotection [96, 153, 260]. Additionally, cancer is one of the first dis-
eases to be genetically linked to autophagy impairment [153]. An example is the
mono allelic deletion of BECN1, which encodes the Beclin1 protein. The deletion
of BECN1 is present in 40–75% of cases of human breast, ovarian, and prostate
cancer [3, 58, 139, 217]. Additionally, unusual expression levels of Beclin1 in
various tumours have been linked to poor prognosis [60, 123, 225, 253, 264]. It
therefore seems that Beclin1 is mechanistically important in tumorigenesis, a pos-
sibility which is supported by the heterozygous disruption of Beclin1 in mice that
show decreased autophagy and are more susceptible to spontaneous tumour de-
velopment [203, 278]. Beclin1 is the mammalian orthologue of yeast Atg6/Vps30
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protein, which plays a vital role in the regulation of autophagy. Beclin1 forms part
of the class III phosphatidylinositol 3-kinase (PtdIns3K) complex, which consists
of PtdIns3K Vps34, mAtg14 and p150 [92, 108, 139, 232]. Beclin1 is the regulator
of the PtdIns3K complex, which is required for initiation of the nucleation and
assembly of the phagophore. In addition to its regulatory role in autophagy in-
duction, it also has biological roles in anti-apoptosis [33] and endocytic trafficking
[243].
Several other proteins involved in the autophagic cascade that exhibit altered
expression levels, such as Atg5 [110, 141] and the protein encoded by the ultra-
violet irradiation resistance-associated gene (UVRAG), [138] have been reported
to be linked with cancers. In fact, several other autophagy-related proteins, such
as Atg4c, exhibit tumour suppressor properties, which suggests that this may be
an inherent property of autophagy proteins involved in vital signalling cascades
[150]. Moreover, the regulation of autophagy signalling is closely associated with
oncogenic signalling. Several generally activated oncogenes such as PKB, mTOR
and Bcl-2 inhibit autophagy, whereas frequently mutated or epigenetically silenced
tumour suppressor genes involved in the mTOR signalling network, such as p53,
PTEN and TSC2, stimulate autophagy [18, 162]. These genetic links between
molecular dis-regulation and cancer suggest that autophagy may operate as a tu-
mour suppressor pathway, but the exact mechanisms are unclear. Furthermore,
studies in autophagy-deficient yeast show an increase in the frequency of mito-
chondrial DNA mutations, which implies that basal autophagy plays a role in
preventing genotoxic stress and DNA damage [137, 153]. A recent study that used
immortalized epithelial cells with either Beclin1 or atg5 knockdown mice showed
increased DNA damage as well as increased tumorigenicity, indicating that both
Atg5 and Beclin1 preserve genomic integrity [153]. Hence, while the primary role
of autophagy is to promote cell survival, it can also function as a tumour suppres-
sor. Autophagy can promote tumour survival when exposed to metabolic stress,
thereby preventing tumour necrosis. However, the activation of autophagy dur-
ing metabolic stress conditions has also been shown to prevent cell growth [137].
Therefore it is likely that the pro-survival effects of autophagy are counterbalanced
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by its tumour suppressor effects. The pro-survival effects are of great interest in
anti-cancer treatment, because of their potential contribution to chemotherapy
resistance in tumours. Recent studies have shown that inhibition of autophagy
increases cytotoxicity of cancer chemotherapeutic agents [1, 21]. Consequently,
the disruption of autophagy could maximize the effects of cancer cytotoxic drugs.
A sensitive and quantifiable tool would be required to assess and standardize au-
tophagy flux, and could be used to develop effective autophagy inhibition inter-
ventions.
2.4.3.3 Ageing
A hallmark of ageing cells is a build-up of damaged proteins and organelles in
parallel with an increase in cellular susceptibility, even in the absence of diseases.
Accumulation of damaged proteins and organelles and the resulting inclusion of
deposits have particularly deleterious effects in non-dividing, differentiated cells
such as neurons and cardiomyocytes. It is evident that non-dividing cells are char-
acterized by an earlier functional decline with age than other cell types. The activ-
ity of both macro-autophagy and chaperone-mediated autophagy decreases with
ageing [37, 40]. Taking into consideration the recently-obtained data from genetic
mouse models with impaired autophagy and which exhibit detrimental phenotypes
[75, 117, 119, 177], it could transpire that the progressive loss in autophagic ac-
tivity with age plays a crucial role in cell and whole organism deterioration. It
is interesting that caloric restriction, which is known to induce autophagy, has
been shown to delay the effects of ageing [83]. Bergamini [15] suggested the use
of anti-lipolytic drugs to simulate caloric restriction in order to induce autophagy
and slow the progression of ageing.
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2.5 Therapeutic modulation of autophagy in
diseases
Autophagy has been identified as a therapeutic target for the treatment of neu-
rodegeneration because of its cytoprotective function in neurons. For instance, the
up-regulation of autophagy by targeting the autophagy regulatory protein mTOR
with inhibitors such as rapamycin and its analogue CCI-779 protects against neu-
rodegeneration in mouse models [208]. Autophagy inducers improve the clearance
of the aggregate-prone mutant huntingtin and α-synuclein, thereby protecting the
cellular integrity and promoting health. Furthermore, other small molecules that
induce autophagy independent of mTOR have been identified. Since mTOR is an
essential protein involved in multiple pathways such as energy sensing pathways,
targeting mTOR might lead to unwanted downstream effects. Thus, using mTOR-
independent autophagy inducers in combination with rapamycin for therapeutic
purposes would allow for the fine manipulation of autophagy without severe side
effects.
Autophagy has become an attractive target for therapies that aim to treat var-
ious diseases. A practical means of exploiting autophagy in cancer treatment is
autophagy-mediated cell death. Induced autophagy-mediated cell death has been
reported in tamoxifen-treated MCF-7 cells [220] and soya bean saponin-treated
colon cancer [247]. Alternatively, cancer cells can be sensitised by initially up-
regulating autophagy followed by its inhibition. Inhibition of autophagy via phar-
macological agents can be used to increase the cytotoxicity of cancer chemothera-
peutic drugs [4, 21]. Clinical trials are in progress to increase the cytotoxic effect of
cancer chemotherapeutic drugs by impairing the autophagic degradative capacity.
The dosages required to induce/inhibit autophagy are based on animal model
trials. Too much or too little autophagy can have deleterious effects that can lead
to necrosis [82]. It would be wise to differentially target autophagy in a disease-
stage and context-specific manner to determine what would be most beneficial.
In manipulating autophagy for therapeutic purposes it is important to note the
dynamic behaviour of autophagy during the pathogenic course of a disease and
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to determine if the autophagic flux is too high or too low and to adjust it ac-
cordingly. Furthermore, the numerical quantification of autophagic flux and the
kinetic modelling of the mammalian autophagic system are critical for understand-
ing the control of the autophagic process, which would allow for the exploitation
of autophagy as adjunct to existing therapies or even as standalone therapeutic
treatment.
2.6 Current methodologies for measuring
autophagy activity
In the past decade there have been rapid advances in the autophagy research field,
with the advent of the discovery of evolutionarily conserved autophagic related
genes. The dawn of the molecular era ushered in novel techniques such as genetic
manipulation, which uncovered the importance of autophagy in processes ranging
from cellular homoeostasis to foetus development. In contrast, accumulating ev-
idence suggests that dysfunctional autophagy contributes to a wide spectrum of
human diseases [137, 162]. Therefore, there is a growing demand for accurate as-
sessment of autophagy and an understanding of its role in biological processes. One
of the major challenges faced in the autophagy research field is that of monitoring
a dynamic process with predominately “static measurements” such as Western
blotting and electron microscopy. This is accompanied by inherent shortcomings
in conclusions reached from the use of these methods. Furthermore, it remains
a challenge not to conflate autophagosomal pool size with autophagic flux. For
instance, neurodegeneration was initially thought to be characterized, to some de-
gree, by an increase in autophagy, a conclusion which was based on microscopy
techniques that showed an increased presence of autophagosomes. However, an
accumulation of autophagosomes may be a result of an obstruction in the later,
downstream stages of autophagy [137, 162] (see Section 2.2, Fig. 2.2). These chal-
lenges have been only partially overcome by the development of new methods in
autophagy research to elucidate autophagy’s dynamic nature and to shed light on
the functionality of autophagy in cellular processes. In the next sections current
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methods used in autophagy research will be discussed with the aim of indicating
their shortcomings in the above highlighted challenges.
2.6.1 Methods in monitoring autophagic intermediates
Presently three methods are used to monitor the number of autophagosomes in a
cell: electron microscopy, light microscopy and the biochemical detection of LC3-
II, which is associated with the autophagosomal membrane.
2.6.1.1 Electron microscopy
Electron microscopy (EM) is the longest-used and most established method for
monitoring autophagic vesicles, and is still considered the gold standard in au-
tophagy research. Mammalian autophagy was first discovered in the 1950s whilst
studying lysosomes with electron microscopy. Autophagosomes were described as
double-membraned structures that contain undigested or partially digested cyto-
plasmic content, indicating mitochondria or endoplasmic reticulum. Therefore it
is rather easy to identify autophagosomes in electron micrographs because their
unique morphological characteristics make them distinct from other cellular mem-
branous vesicles. In comparison to autophagosomes, which contain cellular cargo,
autophagolysosomes are somewhat more difficult to identify since the cargo is being
degraded and there is no other obvious characteristic material to recognize in auto-
phagolysosomes. Electron microscopy allows for ultra-structural characterization
and morphometrical analysis of autophagosomes, such as dimensions, autophago-
somal count and area occupied. Although electron microscopy is a well-established
method in autophagy research and although it provides invaluable data, there are
a number of disadvantages which are often overlooked. For instance, EM does
not reflect the dynamic nature of the autophagic process, but rather provides a
snapshot of the intracellular composition in time on a single z-axis plane. Since
EM requires the fixation of cells, the autophagic behaviour cannot be monitored
in a time dependent manner on a single cell level. Furthermore, studies that re-
port autophagosomal numbers based on electron micrographs can only reflect the
autophagosomal pool size that was visible in a single plane, which provides no
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indication of the complete pool size. Hence, EM may lead to the reporting of
underestimated pool sizes.
Figure 2.6: Electron microscopy. Typical electron micrograph of mouse embryonic
fibroblasts. Single arrows show autophagosomes with a double membrane, double arrows
indicate autophagolysosomes, and arrow heads point towards endoplasmic reticulum
partially digested inside an autophagosome [167].
2.6.1.2 Fluorescence microscopy
Fluorescence microscopy (FM) makes use of fluorescent proteins or probes that
are tagged to the protein of interest. These probes are excited and in turn gen-
erate a fluorescence emission signal which is used to produce an image. FM re-
quires considerable less expertise than EM to identify autophagy related structures
and therefore has recently become very popular amongst scientists. In autophagy
research the most common probe used is the green fluorescence protein (GFP)
tagged to microtubule-associated protein light chain 3 (LC3). The formation of a
sequestering vesicle requires LC3 for the elongation of its membrane. This protein
continues to associate with the outer and inner autophagosomal membrane after
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its formation. Moreover, after fusion with the lysosome, LC3 is cleaved from the
autophagosome outer membrane, whereas the inner membranous LC3 is degraded
by lysosome hydrolases. Therefore endogenous LC3 or LC3-GFP is visualized ei-
ther as a diffuse cytoplasmic pool or as fluorescing puncta which represent mainly
autophagosomes. In contrast to EM, micrographs based on FM can be taken
through the z-plane, which allows for the acquisition of the total autophagosomal
pool size of a whole cell (see Fig. 2.7). In addition to the ease of identifying
autophagosomal structures, FM allows the live imaging of cells, which enables the
monitoring of autophagy in real time, thereby assessing the dynamic behaviour
of autophagy. Although the number of GFP-LC3 puncta accurately reflects the
autophagosomal pool size when acquired in the z-plane, this technique still has
some potential experimental pitfalls. Foremost is subjectivity in the selection of
GFP-LC3 puncta. A uniform approach needs to be developed that can detect
a punctum and automatically quantify the total number of puncta. There are
automated puncta-counting software package available, such as WatershedCount-
ing3D, which is a plug-in for ImageJ. Furthermore, common practice is to report
the average number of GFP-LC3 puncta as well as the total area of GFP-LC3
puncta per cell, but it is important to exclude experimental artefacts which arise
from the formation of large GFP-LC3 aggregates. In addition, autophagy activity
is also often expressed as a percentage change in GFP-LC3 puncta. However, in
itself this approach could be misleading, since an increase in autophagosomes can
be a result of either the induction of autophagy, or of an impairment in lysosome
and autophagosome fusion. This is the most crucial aspect, which is currently
not well addressed. Another potential pitfall of GFP-LC3 puncta screenings for
assessing autophagic activity lies in the fact that GFP-LC3 and LC3 can easily ag-
gregate when over-expressed or co-expressed with aggregate-prone proteins [127].
These GFP-LC3 aggregates can then be mistaken for autophagosomes. However,
precautionary steps can be taken to reduce GFP-LC3 aggregate formation, for ex-
ample by first using stable GFP-LC3 cell lines [167] and second using a C-terminal
glycine mutant GFP-LC3 [240]. Stable GFP-LC3 cell lines are selected based on
the expression of appropriate levels of GFP-LC3 without artificial aggregation.
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Figure 2.7: Fluorescence microscopy, series of z-stack micro-graphs of a single cell (see
Section 3.7.1 for the experimental protocol by which these images were obtained).
2.6.1.3 Biochemical assays
Traditionally, together with EM, biochemical assays are used to assess autophagic
activity. The role of LC3 in autophagy (see Section 2.2) has made it a particularly
attractive means for assessing autophagic activity. LC3 has several homologues,
among which LC3B is most commonly used as a probe in Western blotting. West-
ern blot analysis of endogenous LC3 presents two distinct bands after sodium do-
decyl sulphate–polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblot-
ting: one represents LC3-I, which is cytosolic, and the other represents LC3-II that
is conjugated with phosphatidylethanolamine (PE). LC3-II is associated with the
sequestering vesicle and the autophagosome. Although the true molecular mass
of LC3-II is larger than that of LC3-I, conjugation with PE causes it to migrate
faster than LC3-II in SDS-PAGE, presumably due to its extreme hydrophobicity.
LC3-I and LC3-II are detected on the gel at a molecular mass of approximately
16 kDa and 14 kDa respectively. The amount of LC3-II generally corresponds to
the number of autophagosomes, or, more accurately, the overall abundance of the
autophagic membrane which is labelled with LC3-II [98]. However, not all LC3-
II protein in the cells is localised in autophagosomal membranes, but also seems
to be generated independently of autophagy. For instance, in Atg14 and FIP200
deficient mouse embryonic fibroblasts and Beclin1-deficient embryonic stem cells
there was a significant amount of LC3-II detectable in Western blots, even though
autophagosomal synthesis was completely inhibited [76, 154, 155]. The same was
also seen in RNA interference (RNAi)-mediated suppression of various autophagic
key proteins [87, 92, 154, 279]. Thus, the suppression of autophagy either genet-
ically or pharmacologically may still result in LC3 being detected by biochemical
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assays. Therefore alternative methods should be used in conjunction with LC3
assays to accurately report autophagy activity.
2.6.2 Current methods for monitoring autophagic flux
Electron and fluorescence microscopy as well as biochemical assays are useful to
assess autophagic intermediates such as autophagosomes. However, these methods
cannot be used to determine autophagic activity, since the accumulation of auto-
phagosomes does not necessarily correlate with high autophagic activity. Similarly,
LC3-II levels on their own may not truly reflect the autophagic activity. Culturing
cells with lysosomotropic compounds that de-acidify lysosomes, such as bafilomy-
cin A1, and subsequently impair the lysosomal and autophagosomal fusion process,
is required as it will result in the accumulation of autophagosomes and therefore
LC3-II. Therefore, hence an enhanced autophagic flux, induced, for example, with
rapamycin, will result in a greater increase in the number of autophagosomes after
lysosomal and autophagosomal fusion impairment, with a concomitant increase in
LC3-II. Currently the assays purporting to measure “autophagic flux” can only
distinguish between autophagic induction and inhibition. For example, because
electron microscopy is used to quantify the relative numbers of autophagosomes in
electron micrographs it cannot reflect the degradation capacity of the autophagic
system or the rate of autophagosomal degradation or synthesis.
2.6.2.1 LC3 turnover
The most widely used method to assess autophagic flux is by monitoring LC3
turnover. The method is based on the principle that LC3-II is degraded dur-
ing the maturation process of autophagolysosomes. Thus, when cells are treated
with lysosomotropic agents such bafilomycin A1 or chloroquine, it results in the
accumulation of LC3-II since the de-acidification of lysosomes prevents autophago-
some and lysosome fusion [239]. Therefore, currently, the difference in the LC3-II
levels between samples in the presence and absence of lysosomal inhibitors re-
flects the amount of LC3-II that would be delivered to lysosomes for degradation
[113, 166, 213]. For instance, under normal conditions there will be an increase in
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LC3-II levels when treated with bafilomycin A1 (Fig. 2.8). However, during the in-
duction of autophagy through rapamycin treatment the difference in LC3-II levels
in the presence and absence of bafilomycin A1 is larger (Fig. 2.8). Therefore, au-
tophagic flux would have increased during rapamycin treatment since more LC3-II
is being degraded. Even though the LC3 turnover assay is a relatively simple assay
























Figure 2.8: Western blot of LC3, lane 1: control condition, lane 2: control condition
treated with bafilomycin A1, lane 3: cells treated with rapamycin, lane 4: cells treated
with rapamycin and followed by treating with bafilomycin A1.
2.6.2.2 Degradation of selective markers
The degradation of LC3 through autophagy results in the reduction of total LC3
levels which could be used to assess autophagic flux, as mentioned above. Whereas
induction of autophagy increases the number of GFP-LC3 puncta, the free cyto-
plasmic and nuclear GFP-LC3 signals are however reduced. The loss in cytoplas-
mic and nuclear GFP-LC3 signal can sensitively and quantitatively be monitored
by flow cytometry [228]. Therefore the total free cellular LC3-GFP, which re-
lates inversely to autophagic activity, can be measured by immunoblot analysis
or flow cytometry. In addition, autophagy substrates can be used to assess au-
tophagic flux. Historically autophagy was believed to be the random degradation
of cytoplasm, but recent studies showed that several specific substrates are se-
lectively degraded by autophagy. Of these selective substrates, p62 (also known
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as SQSTM1/sequestome 1) is the best studied. It is selectively incorporated into
the autophagosome by binding directly to LC3 followed by its degradation through
autophagy [16]. Therefore the total intracellular p62 levels correlate inversely with
autophagic activity. For instance, a reduction in p62 levels compared to control
conditions would indicate an increase in autophagic flux. Since the cellular p62
level correlates well with autophagic flux, it provides a promising method to assess
it. It is, however, still not clear whether p62 is only degraded through autophagy
or partly through the ubiquitin-proteasome pathway. Furthermore, both LC3 and
p62 are transcriptionally regulated during autophagy which may result in the in-
accurate interpretation of autophagic flux when assessing LC3 and p62 [82, 178].
Besides monitoring LC3 and p62, autophagic flux can also be monitored by
measuring the bulk degradation of long lived proteins. One of the now more
historical methods, developed in the 1970s, monitors radiolabeled long-lived pro-
teins [167]. This technique involves the culturing of cells with isotope-labelled
amino acids (commonly [14C] or [3H]-labelled leucine or valine) for several days.
Thereafter cells are cultured with normal media in order to wash out radiolabeled
short-lived proteins. The release of the degraded proteins into the cytoplasm is
then quantified and gives an indication of autophagic flux. This method provides
precise numerical data that reflect the half life of long-lived cellular proteins, and
circumvents the pitfalls associated with monitoring a single autophagic substrate.
A more recent technique expresses photo-switchable proteins in the cytoplasm;
upon activation the change in fluorescence is measured and used to determine the
half-life of the fluorescently-labelled protein.
2.6.3 Conclusion
The above sections reviewed the currently available techniques used in autophagy
research. Since these methods have potential limitations, it is currently recom-
mended that several of these methods are used in combination to assess autophagic
activity. Nevertheless, there is currently no method that can accurately quantify
autophagic flux numerically as a rate, which is crucial for determining the dynamic
behaviour and the degree of control a given pathway step has over autophagy.
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Clearly, better assays are required to accurately assess autophagic flux and its
control. Such novel techniques would improve our understanding of the dynamics
of autophagy and may allow us to exploit autophagy in new clinical therapies.
2.7 Measuring autophagic flux
Autophagic flux is commonly defined as a measure of autophagic degradation ac-
tivity. Currently there are a number of proposed methods to assess autophagic
flux, many of which reflect whether or not autophagic flux is occurring or chang-
ing with a given treatment [113]. However, they remain to a lesser extent able to
express autophagic flux and its change in a robust, sensitive and quantifiable man-
ner. We have proposed a novel fluorescent-based microscopy method that fulfils
the requirements for quantitative flux analysis as it allows for the measurement of
autophagosome flux as a rate at the single cell level in a sensitive and quantifiable
manner [142]. The refinement and application of this method is described in this
thesis.
2.7.1 Defining autophagic flux
The autophagic pathway is defined as the pathway along which there is a flow of
material, and the autophagic flux is the quantitative measurement of the rate of
flow through the pathway at a steady state (Fig. 2.9). This definition of autophagic
flux is similar to that of flux in metabolic control studies, where metabolic flux
refers to the steady-state rate of flow of metabolites along a metabolic pathway
[99]. The autophagic system can be regarded as a multi-step pathway with each
step characterized by a particular rate, v.
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Figure 2.9: (A) Schematic representation of the autophagic process, and (B) reaction
network representation of the autophagic process. P, phagophore, A, autophagosome,
L, lysosome, AL, autophagolysosome, AA, amino acids.
Each individual step in the pathway proceeds at a particular rate, which is
defined by the number of entities processed per time unit per cell. For example,
step 2 proceeds at a particular rate, v2, in which an autophagosome fuses with
a lysosome. This rate can be described as either a decrease in the number of
autophagosomes per time unit, or, equivalently, as a decrease in the number of
lysosomes per time unit (assuming a one-to-one fusion of autophagosome with











where nA, nL, and nAL denote the number of entities per cell. As defined here the
rate v2 is a positive quantity.
The following set of ordinary differential equations define the rate at which the






= v1 − v2,
−dnAL
dt




In order to achieve a steady state, the entities that are only being produced or
consumed (P, L and AA) must be regarded as buffered during the experiments,
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and are therefore constants. In steady state the rate of change in the numbers of









v1 = v2 = v3
Therefore the steady-state flux, J , is numerically equal to the steady-state rate
of any of the individual reaction steps in the pathway. This allows us to experi-
mentally quantify the autophagic flux by completely blocking one of the reaction
steps in the autophagic pathway, such as step 2, and measuring the initial rate of
accumulation of the substrate of the inhibited step, in this case autophagosomes.
The transition time, τ , of any variable intermediates in the pathway (A and AL) is
defined as n/J , which can be interpreted as the turnover time of the intermediate’s
pool size in steady state, which in turn is equal to the time required to fill the pool
size from zero to its steady-state value.
2.7.2 Quantifying autophagic flux
Based on the methods discussed in the current methodologies section, fluorescence
microscopy has the enormous potential for determining autophagic flux by mea-
suring the autophagosome pool size per cell and the change thereof over time.
Furthermore, monitoring the decay of the fluorescence signal of reporter proteins
using photo-switchable proteins has been thus far the most direct way measuring
autophagic flux. This technique has been successfully employed in elucidating the
kinetic properties of macroautophagy [249], chaperone-mediated autophagy [116],
and the proteasome [251]. What sets this method apart from the conventional
methods is that it assesses the loss of fluorescence intensity over time, therefore al-
lowing the determination of half-lives of the specific protein within the autophagy
context [116, 249].
The proposed method of Loos et al. [142] allows for the calculation of auto-
phagosome flux, J . The protocol is based on the time-dependent change in the
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total autophagosomal pool size after the complete inhibition of the autophago-
somal and lysosomal fusion process. Furthermore, the transition time, τ , can be
derived from the ratio of the total autophagosomal pool size and the flux. The
transition time differs from the intensity-based half-life as it indicates the time
required to turn over the autophagosome pool in the system, which can be used
as additional means of quantification, and could be employed to compare systems.
Such a protocol requires a reliable means of counting the total number of auto-
phagosomes per cell at several time points under control/treatment conditions and
then the complete inhibition of the autophagosomal and lysosomal fusion process
(Fig. 2.9). The autophagosomal number (nA) is plotted over time, as well as the
change thereof after the complete inhibition of the fusion process (see Fig. 2.10).
The initial change in nA per time unit per hour per cell can be considered as the
autophagic flux per cell.
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Figure 2.10: Quantifying autophagic flux. The graph depicts three autophagic states.
Although the state with nA = 50 has the largest autophagosomal pool size, it does not
imply that it also has the highest flux; compare, for example, the state with nA = 10,
which has double the flux. Since autophagosomal pool size is monitored over time, the
accumulation of autophagosomes after the complete inhibition of the fusion process can
be used to calculate autophagic flux: dnA/dt = J . Furthermore, the transition time,
τ = nA/J , quantifies the time taken for the system to turn over its autophagosomal
pool.
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Materials and methods
3.1 Consumables and materials
Sterile disposable 5mL (SPL, # 91005), 10mL (SPL, # 91010) and 25mL (SPL, #
91025) serological pipettes, as well as Pipetman P20, P200, and P1000 (Pipetman
Starter Kit) were used for cell culturing. Disposable pipette tips, 10µL (Pipet-
man, # D10), 200µL (Pipetman, # D200) and 1000µL (Pipetman, # D1000),
and 2mL Eppendorf tubes (Gilson, #04-230-1150) were used for cell culturing
and protein extraction. Chemical solvents and solutions: ethanol, Illovo (#500),
methanol, Merck (# 106009) and PBS, Life Technologies (# 10010-023). Cells were
maintained in a Shel Lab incubator supplied with 100% carbon dioxide (Afrox,
#201-RC). Proteinase inhibitors were purchased from Sigma: pepstatin (# P-
4265), benzamidine (# B 6506), aprotonin (# A-6279), leupeptin (# L-9783),
PMSF(#P-7626), and phosphatases inhibitors NaF (# S 7920) and Na3VO4 (#
S 6508). Salts EDTA (Sigma, # T-9285) and Tris (Sigma, # D-6750) were used
as components of buffer solutions. Na-deoxycholate (Sigma, # 30970) was used as
an ionic detergent.
56
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3.2 Mammalian cell culture protocol
Mouse Embryonic Fibroblast (MEF) cells with stable expression of GFP light
chain 3 (LC3) protein (a kind gift from Prof. Noboru Mizushima, Tokyo Univer-
sity, Japan) and wild type MEF cells (a kind gift from Dr. Robea Ballo, Univer-
sity of Cape Town, South Africa) were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) (Life Technologies, #41965-039) supplemented with 10% fetal
bovine serum (Biochrom, #S-0615), 1% Antibiotic-Antimycotic (Life Technolo-
gies, #15240-062); 100 U/mL of penicillin, 100 µg/mL of streptomycin and 250
ng/mL of Fungizone R© antimycotic, and maintained in a humidified atmosphere in
the presence of 5% CO2 at 37
◦C. The sub-culturing of MEF cells involved trypsin-
isation (Life Technologies, #25200-072) to dissociate adherent cells from the flask.
Culturing medium was removed and washed with phosphate-buffered saline (PBS)
(NaCl 137 mmol/L, KCl 2.7 mmol/L, Na2HPO4 10 mmol/L, KH2PO4 1.8 mmol/L,
pH 7.4) and trypsinised using either a T25 (Porvair, # 500030), T75 (Porvair, #
500029) or T75 (Porvair, # 500028) depending cell culturing needs. Following
trypsinisation, cells were collected in a 50 mL falcon tube (Biocom Biotech, #
50050) and DMEM was added in a 2:1 ratio. Cells were centrifuged (Eppendorf
Centrifuge 5804R) at 1500 rpm for three minutes at room temperature. The su-
pernatant was discarded and cells re-suspended in DMEM. Cells were reseeded
in culturing flasks, petri-dishes (Sterlin # 90032), an 8-chamber cover slip-based
dish (Nunc, Lab-Tek, #155411) or a CYTOO chamber single well plate (CYTOO,
#30-010) for experimental purposes.
3.3 Protein extraction
For protein extraction, the medium was quickly removed and cells were rinsed
twice with cold PBS. 300 µL of RIPA buffer (Tris-HCl: 50 mM, pH 7.4, NP-40
(1%), Na-deoxycholate (0.25%), 150 mM NaCl, 1 mM EDTA, 1 mM PMSF, 1 mM
Na3VO4, 1 mM NaF, leupeptin, aprotonin and benzamidine (1 µg/mL), pepstatin
(10ug/mL)) were added per petri-dish and cells scraped off using a cell scraper
(Porvair, #500034). Lysates were collected, samples sonicated using a Mixsonic
Stellenbosch University  https://scholar.sun.ac.za
CHAPTER 3. MATERIALS AND METHODS 58
(S-4000), and centrifuged at 8 000 rpm at 4◦C for 10 min (Spectrafuge 16M).
Supernatant was collected and stored at -80◦C.
3.4 Protein concentration determination
The Bradford protein assay was used to determine the protein concentration of
the lysates. First a protein standard was generated using bovine serum albumin
(BSA) (Roche #10 735 078 001). BSA concentrations ranged from 0 to 2 µg/ul.
The protein standard was treated with Bradford reagent (Coomassie Brilliant blue
50 mg/L, methanol 50 mL/L, phosphoric acid (85% stock solution) 100 mL/L, and
dH2O 850 mL/L) for five minutes in the dark and absorbance was measured at
595nm with a universal microplate reader (EL800). Absorbance value for 0 µg/µL
was subtracted from the respective standard range concentrations absorbance val-
ues. A standard curve was generated by plotting absorbance values against protein
concentration. Protein samples were assayed as described above and absorbance
measured at 595nm was used to determine the protein concentration of the sam-
ples.
3.5 Western blotting
For Western blotting 40 µg of protein mixed with LaemmLi buffer (6.5 mM Tris-
HCl pH 6.8, 2% sodium dodecyl sulphate (SDS), 5% -
¯
mercaptoethanol, 10% glyc-
erol, 0.01% Bromophenol blue) in a 2:1 ratio was boiled at 95◦C for 5 min. Proteins
were separated on a 4–15% Mini-PROTEAN R© TGX Stain-FreeTMPrecast gel (Bio-
rad, #456-8084) and transferred onto a Transfer PackTMPVDF membrane (bio-
rad, #170-84156) using Trans-Blot R© TurboTM(Bio-rad, # 170-4155). Membranes
were blocked with 5% milk in TBS-T (137 mM sodium chloride, 20 mM Tris, 0.1%
Tween-20 at pH 7.6) for 1 hour. Thereafter membranes were washed with TBST
three times for five minutes and incubated with primary antibodies overnight at
4◦C. The primary antibodies used include mouse monoclonal anti-GFP (Sigma,
#G-1546), rabbit anti-LC3 (Sigma, # L-8918), anti-mTOR (Sigma, # T-2949),
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anti-phospho-mTOR Ser2448 (Sigma, # SAB-4504476), anti-p62 (Abcam, # ab-
56416), anti-β-actin (Cell Signalling, # 4970) and anti-GAPDH (Sigma, # G-
9545). Membranes were rinsed with TBST three times for five minutes and then
incubated with either peroxidase linked anti-mouse IgG (Sigma, # A-9044) or anti-
rabbit IgG (Sigma, # A-0545) for one hour at room temperature and visualized
using ClarityTMWestern ECL substrate and the ChemiDocTMMP System.
3.6 Mass spectrometry
Total amino acid content of free amino acids was determined by mass spectrometry.
Protein extract was treated with the Waters AccQ TagTMUltra Derivatization Kit,
placed in a heating block at 55◦C, for ten minutes. Waters API Quattro Micro
Waters mass spectrometry was used in the positive electrospray ionization mode.
Nitrogen was used as a drying agent. Desolvation gas flow was 350 L/h, and the
cone gas flow was maintained at 50 L/h. Desolvation temperature was 350◦C and





Initial protocol MEF cells were seeded onto an sterile 8-chamber cover slip-
based dish at a density of 2x104 cells per well containing DMEM. Cells were
incubated over night in a humidified atmosphere in the presence of 5% CO2 at
37◦C. The 8-chamber cover slip-based dish was then enclosed in IX-81 stage of
the fluorescent microscope in the presence of 5% CO2 for the duration of the
experiment.
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Modified protocol MEF cells were seeded onto a sterile cover-slip patterned
with large Fibronectin discs (CYTOO, #10-003-10) in a CYTOO chamber single
well plate. Cells were seeded at a density of 2x104 cells and incubated for 30
minutes. Thereafter the chamber was rinsed several times using DMEM until
all adherent cells in the non-patterned regions were washed off. The cells were
maintained for 2 hours prior to the experiment in DMEM, containing 75 nM
LysoTracker R© (Life Technologies, #L-7528), in a humidified atmosphere in the
presence of 5% CO2 at 37
◦C. The chamber plate was then enclosed in IX-81 stage
of the fluorescent microscope in the presence of 5% CO2 for the duration of the
experiment.
Experimental hardware and software set-up An Olympus IX81 inverted
fluorescent microscope (Olympus Biosystems GMBH) was used with automated
z-stack control to determine the total autophagosomal and lysosomal pool size in a
single cell. The raw image stacks were acquired using a high NA objective (Olym-
pus Plan APO N 60x/1.42 Oil/0.17/FN26.5) and a 500 nm step width between
the image frames.The slides containing MEF cells were placed in a heated cham-
ber at 37◦C that encases the IX-81 stage of the microscope. Exposure time and
illumination excitation outputs were chosen using a 492 nm GFP excitation filter
and 572 nm TxRed excitation filter with a UBG triple-bandpass emission filter
cube (Chroma) to ensure an optimal signal/noise ratio with minimal saturation,
using a Xenon-Arc burner (Olympus Biosystems GMBH) as a light source. Images
were processed using Cell R© imaging software and exported to automated counting
software, ImageJ with WatershedCounting3D plug in [63], to count the green and
red puncta using voxel dimension 0.08 for both x and y as the search parameters.
3.7.1.2 Puncta analysis
Puncta count and morphometric analysis was performed using the Watershed-
Counting3D plugin of ImageJ. Images were converted to RGB colour format and
processed WatershedCounting3D. Puncta count and surface area was determined
for each respective colour puncta from the output file generated. Surface area, Ac,
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Using the calculated volume data the total surface area of spheres was deter-
mined by multiplying the surface area of the sphere, As, which is calculated using
eqn. 3.3, with the total puncta count.
As = 4πr
2 (3.3)
3.7.2 Transmission electron microscopy (TEM)
3.7.2.1 Sample preparation
Cell harvesting. MEF cells were seeded into a T-25 flasks at a density of 5x105
cells and grown to approximately 90% confluency. Groups were divided and treated
as described in treatment protocol. After incubation, cells were harvested by
trypsinisation. After centrifugation at 1500 rpm for three minutes at 37◦C, the
trypsin and media was decanted and cells were re-suspended in PBS to remove
trypsin and media. Cells were then centrifuged at 1500 rpm for three minutes and
PBS was decanted. Cells were re-suspended in 2.5% glutaraldehyde (Sigma, #
G5882) fixative, centrifuged, and transferred to Tygerberg Hospital where TEM
analysis was performed by the National Health Laboratory Service.
Preparation, sectioning and image capturing. A dissecting microscope was
used to cut the pellets into 1 mm sections. Samples were rinsed in phosphate buffer
and incubated in 3% osmium tetroxide for 1 hour. Thereafter samples were stored
in a 10% formalin solution in order to reduce the osmium tetroxide. Samples were
then transferred to an automated tissue processor, and immersed in the following
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solution: 10% uranyl acetate for 15 minutes, 70% ethanol twice for 10 minutes.
Thereafter samples were subjected for 20 minutes to 10% uranyl nitrate, and for 15,
20 and 30 minutes to 100% ethanol. Samples were immersed for 90 minutes in a 1:1
ratio of 100% ethanol and Spurr’s resin solution, followed by an incubation for 60
minutes in Spurr’s resin. Samples were embedded in gelatin capsules overnight at
60◦C and cut into 20 nm sections using a Leica EM UC7. Sections were stretched
with chloroform and placed onto copper grids. Images were captured with a JEOL
JEM 1011 transmission electron microscope, using an ITEM soft imaging analysis
program.
3.7.2.2 Morphometric analyses
Morphometric analyses were performed using ImageJ. Images were imported into
ImageJ and the brightness and contrast was adjusted. Vacuolar structures were de-
marcated and thereafter, using the brightness and contrast panel, the background
was set to white so that the demarcated areas became visible. The ‘analyse parti-
cles’ function of ImageJ was used to count and measured the surface areas of the
vacuolar structures. Furthermore, vacuolar structures volume and surface area
was determined as described in section 3.7.1.2.
3.8 Treatment protocol
Cells were divided into seven groups: a control group (Con), a 30 minute bafilomy-
cin A1-treated group (Baf 30min), a two hour bafilomycin A1-treated group (Baf
2hrs), a 30 minute rapamycin-treated group (Rapa 30min), a four hour rapamycin-
treated group (Rapa 4hrs), a four hour rapamycin-pretreated group followed by a
30 minute bafilomycin A1-treated group (Rapa Baf 30min), a four hour rapamycin-
pretreated followed by a two hour bafilomycin A1-treated group (Rapa Baf 2hrs).
The control group represented basal steady state conditions, whereas the four hour
rapamycin-treated group represented the rapamycin induced steady state. The 30
minutes rapamycin-treated group represented and early transition time point be-
Stellenbosch University  https://scholar.sun.ac.za
CHAPTER 3. MATERIALS AND METHODS 63
tween the two steady states. The bafilomycin A1 and rapamycin concentration
used was 400 nM and 25 nM respectively.
3.9 Determining flux dynamics: Experimental
procedure
A fundamental part of the protocol was the initial counting of autophagosomes
over time without the use of any fusion inhibitors in order to determine whether
the system was in a steady state. A steady state was verified over several time
points when the rate of change of the number of autophagosomes/cell (nA), did
not change over time (see Fig. 2.9). Cell images were acquired at predetermined
time points, the first experimental time points were 0, 1, 2, 2.5, 3, 4, 5, 6, 7, 8,
8.5, 9 and 10 hours, whereas the modified experiment time points were 0, 1, 2,
2.5, 3, 4, 5, 6.5, 6, and 8 hours. Cells were treated with 100 nM, 200 nM, 400 nM
and 800 nM bafilomycin A1. The autophagosomal pool size was monitored for two
hours post-inhibition and images acquired at 30 minutes intervals.
The basal flux, Jbasal, was determined by allowing the autophagic system to
reach a steady state under basal conditions; basal flux was the initial slope of the
progress curve at the point of inhibition of fusion. Multiple cells were assessed (n =
10) simultaneously using a stage control. Furthermore, the transition time, τ , was
calculated from the ratio nA/J of the autophagosome pool size and autophagosome
flux, and indicated the turnover time of the autophagosome pool at steady state.
Therefore, the smaller τ becomes the less time is required to completely replenish
the autophagosome pool at steady state.
3.10 Statistical analysis
Statistical analysis was performed with Prism 5 software using a one way ANOVA
with the Bonferroni post-test. Significance was indicated at p < 0.05. All results
were presented as means ± SEM’s.
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Results and Discussion
As discussed in Section 2.7, we define autophagic flux as a rate of flow of material
through the autophagic pathway (Fig. 2.9). This chapter describes a fluorescence
microscopy technique for measuring this flux in terms of the initial rate of accumu-
lation of autophagosomes after the fusion between autophagosomes and lysosomes
is completely inhibited. This method was used to compare the autophagic flux
under basal conditions with that which obtains after induction of autophagy by
rapamycin. Preliminary experiments were done to prove the concept, after which
the method was further refined to yield more reliable and accurate measurements
of autophagic flux.
At selected time points during the progress of these experiments autophagic
flux was also assessed with traditional methods used in autophagic research such as
Western blot analysis and electron microscopy. The data generated by these meth-
ods could be used as a context for assessing the usefulness of the data generated
by our novel approach. Since amino acids are the end-products of the autophagic
process, their concentrations were also measured at these selected time points.
Furthermore, a mathematical model that describes the autophagic system was
parameterised with the experimental data obtained by the fluorescence microscopy
experiments. With this parameterised model we could study the dynamic be-
haviour of the autophagic system and the degree to which the different steps
control the autophagic flux. Our model of autophagy is described in Chapter 5.
64
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4.1 Preliminary measurement of autophagic
flux (proof of concept)
In the preliminary experiments described here we tested the approach of quan-
tifying autophagic flux in terms of the initial rate of increase in the number of
autophagosomes in a single cell after complete inhibition of fusion of autophago-
somes with lysosomes.
4.1.1 Quantifying autophagic flux by inhibiting
autophagosomal and lysosomal fusion with
bafilomycin A1
Fluorescence microscopy was performed to measure the initial rate of increase in
autophagosome count after inhibition of fusion by bafilomycin A1, and to confirm
that inhibition of fusion was complete at 400 nM bafilomycin A1, as suggested by
our Western blot experiments (which are described in section 4.2.1 with results
in Fig. 4.7) described above. Fig. 4.1 shows a representative time lapse image
sequence of MEF GFP-LC3 cells treated with bafilomycin A1. Each image is a
superposition of z-stack image frames, while the total count of puncta in the cell
is the sum of puncta counts in each such a layer (co-localised puncta shared be-
tween two layers are counted as one). Fig. 4.2 shows the effect of incremental
increases in bafilomycin A1 concentration on the rate of green puncta accumula-
tion. Conventionally, green puncta are equated to autophagosomes, but it is more
correct to equate green puncta to vacuolar structures that contain GFP-LC3, i.e.,
autophagosomes and autophagolysosomes. Here we adhered to this convention, so
that the total number of puncta per cell was regarded as equivalent to the total
number of autophagosomes per cell (nA). After 2 hr with 800 nM bafilomycin A1
treatment the majority of cell population exhibited cell death.
What is also clear from Fig. 4.1 is that under basal conditions the background
noise is very high, especially in the perinuclear region where autophagosomes are
known to congregate; this complicates the counting of green puncta, probably
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underestimating their number considerably.
At all four bafilomycin A1 concentrations (100, 200, 400 and 800 nM) there was
a significant increase in nA 60 min after treatment with bafilomycin A1, while the
initial rate of increase in nA after bafilomycin A1 treatment reached a maximum
at 400 nM (46 autophagosomes/hr/cell at 100 nM, 52 autophagosomes/hr/cell
at 200 nM, 54 autophagosomes/hr/cell at 400 nM, 54 autophagosomes/hr/cell at
800 nM). We therefore regard the initial rate of increase in nA per cell after treat-
ment with 400 nM bafilomycin A1 as our measure of the autophagic flux. What
we measure here is the basal autophagic flux, Jbasal, which in this experiment is
54 autophagosomes/hr/cell. However, since autophagolysosomes also in principle
show up as green puncta, these values may not be a true reflection of autophagic
flux.
In Fig. 4.1, nA at 0 hr is considerably lower than nA in the steady state be-
tween 1–2 hr. A possible explanation could be that the change from 5% CO2
in the culture atmosphere to the virtual absence of CO2 (0.04%) in the ambient
atmosphere that prevails under the experimental conditions causes induction of
autophagy through stress caused by an increase in pH (as indicated by the pH
indicator phenol red in the culture medium). Section 4.2 describes modifications
to the experimental protocol that overcame this problem. However, the fact that
in all cases a steady state was reached after 1 hr (within experimental error) still
allowed for a reliable assessment of the bafilomycin A1 concentration required for
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the complete inhibition of autophagosome and lysosome fusion.
Figure 4.1: Representative time lapse images of basal autophagy. At 2 hr cells were
treated with 400 nM bafilomycin A1. Each image is a superposition of z-stack image
frames obtained by scanning vertically through the cell. Scale bar: 20 µm.
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Figure 4.2: Time series of autophagosomal pool size (nA) at the basal state of the
autophagic system and after treatment at 2 hr with 100 nM, 200 nM, 400 nM or 800 nM
bafilomycin A1. ∗ vs. 2 hr, p < 0.05; (n = 3).
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4.1.2 Induction of the synthesis of autophagosomes with
rapamycin
This section describes preliminary experiments to study the effect of induction of
autophagy by rapamycin on both the autophagosomal pool size and the autophagic
flux.
Figure 4.3 shows a representative time-lapse image sequence from which the
change in autophagosomal pool size before and after induction by rapamycin could
be measured by counting the green puncta. Figure 4.4 combines the results of a
series of six such experiments. As before, the autophagic flux was calculated from
the initial rate of increase in nA after the complete inhibition of lysosomal and
autophagosomal fusion by 400 nM bafilomycin A1.
Before rapamycin treatment the basal autophagosomal pool size (nA-basal) was
in steady state (that this experiment does not show the initial increase in nA
observed in Fig. 4.2 is due to equilibration to ambient atmosphere prior to the first
measurement). After treatment with 50 nM rapamycin (2–8 hr) nA increased from
its average basal value of 33 autophagosomes/cell until it approached a new steady
state at 4 hr with an average value of 142 autophagosomes/cell during the 4–8 hr
period (a 4.3-fold increase in nA). However, during the 2–8 hr period the control
nA varied significantly, casting doubt on the accuracy of this calculation of the
fold-increase in nA. In the next section we discuss refinements in the experimental
conditions that yielded more accurate results.
Following treatment with bafilomycin A1, nA increased rapidly and significantly
relative to the induced steady-state nA. The induced autophagic flux (Jinduced)
was calculated as before as the initial rate of increase in nA after bafilomycin A1
treatment (using the first time point after bafilomycin A1 treatment, here at 1 hr,
for the calculation) and had a value of 143 autophagosomes/hr/cell, but as with
the calculation of the fold-increase in nA after induction, variation in the control
casts doubt on the accuracy of this value of Jinduced. The next section describes a
more accurate measurement of Jinduced.
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Figure 4.3: Time lapse image sequence that shows changes in the autophagosomal pool
size (nA) after induction of autophagy with 50 nM rapamycin at 2 hr. At 8 hr cells were
treated with 400 nM bafilomycin A1. Each image is a superposition of z-stack image
frames. Scale bar: 20 µm.
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Figure 4.4: Monitoring autophagosome pool size before and after induction of the
autophagic system with 50 nM rapamycin at 2 hr. Fusion was inhibited at 8 hr with
400 nM bafilomycin A1. ∗ vs. 8 hr, p < 0.05 (n = 6).
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4.2 Refined measurement of autophagic flux
In the preliminary experiments described above, changes in gas composition and
changes in cell volume and shape not only made it challenging to track the cells, but
also increased the variability in puncta counts as time progressed since variation
in cell volume affected the number of autophagic vesicles a cell can accommodate.
The experimental conditions under which basal and rapamycin-induced autophagy
was studied were modified as follows in an effort to counteract these problems and
produce consistent and reliable results.
The possible effects caused by changes in the gas composition between culture
and experiment discussed in Section 4.1.1 were eliminated by keeping the cells
inside the XI81 microscope case at 37 ◦C in a humidified atmosphere with the CO2
maintained at 5% while measuring autophagic progress. Humidification prevented
a possible stress-inducing increase in osmotic potential caused by evaporation and
the concomitant decrease in the volume of culture medium during the experiment.
Furthermore,the problem of changes in cell shape (see Fig. 4.3) as the cells migrated
over the surface of the slide chamber was overcome by using micro-patterning
(CYTOO, see section 3.7.1), which anchored the cells to the chamber using micro-
patterned fibronectin discs and so prevented variations in cell shape.
Another refinement was the use of Lysotracker dye that allowed us to visu-
alise the intermediates of the autophagic pathway, namely, autophagosomes (green
puncta), lysosomes (red puncta), and autophagolysosomes (yellow puncta). The
Lysotracker dye diffuses into both autophagosomes and lysosomes, but only flu-
oresces red in the acidic environment of the lysosomal lumen, so that lysosomes
show up as red puncta, while autophagosomes still show up as green puncta. After
fusion into autophagolysosomes, which are also acidic, the co-localisation of green
GFP-derived signal and red Lysotracker-derived signal causes autophagolysosomes
to show up as yellow puncta. While is was easy to distinguish between and count
the green and yellow puncta, the lysosomal red puncta were more difficult to iden-
tify since they varied in hue and occurred in very low numbers, typically 2–5 per
cell.
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4.2.1 The inhibition of autophagosomal and lysosomal
fusion by bafilomycin A1
As before, fluorescence microscopy was performed to measure the initial rate of
increase in autophagosome count after inhibition of fusion by bafilomycin A1, and
to confirm that inhibition of fusion was complete at 400 nM bafilomycin A1, as
suggested by the preliminary experiments described in section 4.1.1.
Fig. 4.5 shows a representative time lapse image sequence of MEF GFP-LC3
cells treated with bafilomycin A1. As before, each image is a projection of z-
stack image frames, while the total count of puncta in the cell is the sum of
puncta counts in each layer (co-localised puncta shared between two layers are
counted as one). Fig. 4.6 shows the effect of incremental increases in bafilomy-
cin A1 concentration on the rate of autophagosome accumulation. In contrast to
the preliminary experiment (Fig. 4.2), we were able to count both autophagosomes
(nA, green puncta) and autophagolysosomes (nAL, yellow puncta). In these exper-
iments we did not attempt to count the red lysosomal puncta, since they would
not provide useful additional information. At all four bafilomycin A1 concentra-
tions (100, 200, 400 and 800 nM) there was a significant increase in nA 30 min
after treatment with bafilomycin A1: the initial rates of increase were 25.8 ± 4.1
autophagosomes/hr/cell at 100 nM, 24.8±4.9 autophagosomes/hr/cell at 200 nM,
25.4 ± 3.8 autophagosomes/hr/cell at 400 nM, 24.0 ± 2.2 autophagosomes/hr/cell
at 800 nM. The initial rate of increase in nA after bafilomycin A1 treatment had
therefore already reached a maximum at 100 nM. This was in contrast to what was
observed in the preliminary experiments which suggested that, to be absolutely
sure that fusion was completely inhibited, 400 nM bafilomycin A1 was needed.
Even though the experiments described here suggested that we could use a lower
bafilomycin A1 concentration to inhibit fusion, we decided to keep on using 400 nM
bafilomycin A1.
At all four bafilomycin A1 concentration we observed an increase in the to-
tal puncta count (green plus yellow). This was obviously due to the rate of de-
crease in yellow puncta being lower than the rate of increase in the green puncta,
which is to be expected, at least partly, for the following reason: after inhibi-
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tion of fusion autophagosomes continue to be produced at a constant rate, while
the concentration-dependent rate of degradation of autophagolysosomes decreases
because of decreasing numbers of autophagolysosomes.
Fig. 4.6 shows that the rate of autophagosome accumulation and of autophago-
lysosome depletion apparently increases in the period following the 30 min time
point after bafilomycin A1 treatment and could be interpreted as a further increase
in autophagic flux. This could be due to additional stress-induced autophagy, but a
more likely reason is the following: the fluorescent Lysotracker dye is acidotrophic
and, under normal conditions, accumulates in the low-pH lumen of acidic vesicles
such as lysosomes. Treatment with bafilomycin A1 causes inhibition of fusion by
inhibiting the V-ATPases in the (autophago)lysosomal membrane that maintain
the low pH in the lumen of these vesicles, thereby causing de-acidification and
concomitant leaching of the dye from both lysosomes and autophagolysosomes.
When vesicles, in particular autophagolysosomes, that show up as yellow puncta
lose the Lysotracker dye in this manner, they will turn green and be included
in the autophagosome count, thereby overestimating it and underestimating the
autophagolysosome count.
From these experiments we were therefore able to calculate from the initial
rate of increase in nA after treatment with 400 nM bafilomycin A1 a value of
25.4 autophagosomes/hr/cell for the basal autophagic flux, Jbasal. This value was
substantially lower than the value calculated from our preliminary experiment,
and can be attributed to the fact that we measured only autophagosomes and
that we measured at 30 min after inhibition of fusion, instead of at 1 hr as in our
preliminary experiment.
We also assessed the inhibition of autophagosomal and lysosomal fusion in
MEF GFP-LC3 cells by bafilomycin A1 with Western blot analysis. No significant
differences could be discerned between the LC3 II band intensities at 30 min after
200, 400 or 800 nM bafilomycin A1 treatment (Figure 4.7).
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Figure 4.5: Time lapse image sequence of autophagy at basal state with refined method.
At 2 hr cells were treated with 400 nM bafilomycin A1. Puncta are counted as auto-
phagosomes (•), lysosomes (•) and autophagolysosomes (•). Cells were micro-patterned
and z-stack images were projected. (A) raw data; (B) deconvolved images. Scale bar:
20 µm.
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Figure 4.6: Time series of autophagosomal (nA) and autophagolysosomal (nAL) pool
size at the basal state of the autophagic system and after treatment at 2 hr with 100 nM,
200 nM, 400 nM or 800 nM bafilomycin A1. Autophagosomes (•), autophagolysosomes
(•) and total puncta (•). (n = 5).
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Figure 4.7: Determining the concentration of bafilomycin A1 required to achieve full
inhibition of the autophagosomal and lysosomal fusion process using Western blot anal-
ysis. Treatment with 400 nM bafilomycin A1 resulted in a substantial increase in LC3
protein level at 30 min relative to the control. The difference in the LC3 increase be-
tween 400 nM and 800 nM bafilomycin A1 treatment was negligible. Glyceraldehyde
phosphate dehydrogenase (GAPDH) was used as a loading control.
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4.2.2 Measuring autophagosomes, autophagolysosomes
and lysosomes under the induction of the
autophagic system
The effect of rapamycin on autophagic flux was assessed with our modified flu-
orescence microscopy technique. As before, autophagic flux was calculated from
the initial rate of increase in green puncta after the complete inhibition of lyso-
somal and autophagosomal fusion. However, since we could here distinguish be-
tween autophagosomes and autophagolysosomes, we were more certain that, at
least for 30 min after inhibition of fusion, the green puncta represented only auto-
phagosomes, and that their increase with time was a more accurate measure of
autophagic flux.
Fig. 4.8 shows a time-lapse image series of autophagy over a 8 hr period (the
control), while Fig. 4.5 shows the effect on autophagy of inhibition of fusion by
bafilomycin A1 at 2 hr. Fig. 4.9 shows the increase in nA following rapamycin
induction of autophagy at 2 hr and, again, that following inhibition of fusion by
bafilomycin A1 at 6 hr (note that the image at t = 8 hr is blurred compared to the
other images; this was observed in all cases and made counting of puncta difficult).
A comparison between these three figures and Fig. 4.4 clearly shows the improve-
ment in standardisation of the technique for assessing changes in autophagy in a
single cell. Micro-patterning standardised cell shape, while deconvolution of the
images improved puncta analysis (see the B-panels in Figs. 4.8–4.9).
Fig. 4.10 is a quantitative visualisation of data obtained from the raw fluores-
cent z-stack images. In the control (Fig. 4.10C) the basal number of autophago-
somes (nA-basal), autophagolysosomes (nAL-basal), and lysosomes (nL-basal) remained
in steady state throughout the 8 hr duration of the experiment with no signifi-
cant variation in levels. Lysosomal count was very low, varying between one and
five per cell, averaging 1.6 ± 0.5. The puncta counts for autophagosomes and
autophagolysosomes averaged at 22.7 ± 2.9 and 167.5 ± 15.6 respectively.
In the experiments where fusion was inhibited by bafilomycin A1 the aver-
age nA-basal was 12.1 ± 2.5 autophagosomes per cell for non-induced autophagy
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(Fig. 4.10A) and 14.3 ± 1.5 autophagosomes per cell for rapamycin-induced au-
tophagy (Fig. 4.10B). These differences are insignificant, but they do differ signif-
icantly from the nA-basal-value of 22.7±2.9. This difference, which can be ascribed
to the fact that a single cell is chosen for counting and that individual cells do
differ from each other, is however irrelevant, since the control study was only
done to show that autophagic steady-state persisted for the 8 hr duration of the
experiments.
After an hour of induction with rapamycin, nA nearly doubled to 23.1 ± 2.8
autophagosomes per cell and slowly decreased as it approached an nA-induced of
16.7± 1.7 autophagosomes per cell (a 1.3-fold increase relative to the basal level).
The average nAL-basal was 164.5 ± 15.5 autophagolysosomes per cell, which upon
induction of autophagy with rapamycin gradually increased until the new induced
steady state was established at 6 hr with an average nAL-induced of 251.2 ± 15.8
autophagolysosomes per cell (a 1.5 fold increase in nAL relative to the basal level).
nL-basal averaged at 1.2±0.3 lysosomes per cell, decreasing upon induction to 0.9±
0.2 lysosome per cell and slowly increasing as it approached nL-induced of 2.0 ± 0.3
lysosomes per cell. Our data showed that under basal condition autophagosomes
constituted only a small fraction (7.5%) of the total GFP-LC3 positive puncta, the
rest (92.5%) being associated with the autophagolysosomes. This of course means
that in our preliminary experiments, which used only GFP-LC3 as marker, we
actually measured the sum of autophagosomes and autophagolysosomes; this in
turn means that we overestimated autophagic flux. Our refined protocol allowed
a more reliable calculation of Jbasal as 25.4 autophagosomes/hr/cell and Jinduced as
105.4 autophagosomes/hr/cell (compared to 54 and 143 autophagosomes/hr/cell in
our preliminary experiments), a four-fold increase in autophagic flux. As before we
used the first time point (30 min) after bafilomycin A1 treatment for the calculation
of the initial rate (at 2.5 hr for basal autophagy and 6.5 hr for induced autophagy).
One would expect the profile of changes in the puncta count for autophago-
somes and autophagolysosomes after bafilomycin A1 treatment to be the same
for basal autophagy (Fig. 4.10A) and rapamycin-induced autophagy (Fig. 4.10B).
However, at 8 hr in Fig. 4.10B the increase in green puncta did not match the
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decrease in yellow puncta, as they did at 4 hr in Fig. 4.10A. The reason for this
is not quite clear, but could be due to the unreliability of counting puncta in the
consistently blurry images at the 8 hr time point mentioned above.
Figure 4.8: Time lapse image sequence of basal autophagy (control). Autophagosomes
(•), lysosomes (•) and autophagolysosomes (•). (A) raw data; (B) deconvolved images.
Scale bar 20 µm.
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Figure 4.9: Time lapse images of autophagy before and after induction with 25 nM
rapamycin at 2 hr, and after inhibition of fusion with 400 nM bafilomycin A1 at 6 hr.
Autophagosomes (•), autophagolysosomes (•) and lysosomes (•). Cells were micro-
patterned and z-stack images were superimposed. (A) raw data; (B) deconvolved images.
Scale bar: 20 µm.
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Figure 4.10: The change over time in autophagosomes (•), autophagolysosomes (•),
lysosomes (•) and total green and yellow puncta (•). (A) Pool sizes of the three au-
tophagic intermediates under non-induced basal conditions (0–2 hr) and after inhibition
of fusion with 400 nM bafilomycin A1 at 2 hr; (B) Enhanced autophagy after 25 nM
rapamycin treatment at 2 hr and after inhibition of fusion with 400 nM bafilomycin A1
at 6 hr; (C) Control: pool sizes of the three autophagic intermediates under non-induced
basal conditions (0–8 hr). (n = 10)
Stellenbosch University  https://scholar.sun.ac.za
CHAPTER 4. RESULTS AND DISCUSSION 83
In the experiments described in the rest of this chapter data was collected at
specific points during the time-course of either basal autophagy or rapamycin-
induced autophagy. Fig. 4.11 shows these time points and the names by which















































Figure 4.11: Time points at which autophagic variables are measured in (A) basal and
(B) rapamycin-induced states.
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4.3 Morphometric analyses of autophagosomes,
autophagolysosomes and vacuolar
structures
Electron microscopy (EM) is an established method for studying the morphology of
autophagic vesicles, and is still considered the gold standard in autophagy research.
This section describes the use of EM to assess the time-dependent morphometric
changes in the vacuolar structures of the autophagy system, and compares it to
similar assessments of puncta using FM (as described in section 4.2). Fig. 4.12
compares representative electron microscopic and fluorescence microscopic images
of various time points during a measurement of rapamycin-induced autophagy and
inhibition of fusion with bafilomycin A1. Since EM does not allow live cell imaging,
the time points selected corresponded to key points in the FM measurements
of autophagy (see section 3.8 for the treatment protocol). However, the generic
EM protocol used in this study only identifies vacuolar structures and therefore
cannot distinguish between autophagosomes and autophagolysosomes, although
it can identify lysosomes. In contrast, the method used in the previous section,
which utilises GFP-LC3 in MEF cells in conjunction with Lysotracker dye, is
able to distinguish between all three entities. The morphometric analyses are
divided in three sections: (1) puncta/vacuolar structures count and the average
area of a punctum or a vacuole (Fig. 4.13), (2) the size distribution (in percentage)
of the puncta/vacuolar structures (Fig. 4.14), and (3) the average volume of a
punctum/vacuole and the total surface area of the puncta/vacuole, assuming it to
be circular (Fig. 4.15). In comparing EM and FM we considered a vacuole to be
equivalent to a punctum. Lysosomes were not included in the analysis because of
the low numbers observed.
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Figure 4.12: Representative images of the autophagic process acquired at the time
points shown in Fig. 4.11 with (A) fluorescence microscopy and (B) electron microscopy.
Con: control; Baf: bafilomycin A1; Rapa: rapamycin. Scale bar: 10 µm.
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4.3.1 Puncta/vacuolar structures count and the average
surface area of a punctum/vacuole on a micrograph
Fig. 4.13 shows the number of puncta or vacuolar structures and the average
surface area of a punctum or a vacuole on a micrograph at various time points
during control, basal, and induced autophagy.
Puncta/vacuole counts (Fig. 4.13). The striking difference in the number of
puncta or vacuoles counted with the two methods was due to the fact that FM
made use of an automated stage control that allowed for the acquisition of multiple
z-stack images of a single cell and thus counted the total number of puncta in the
cell, while EM acquired an image at a single plane, and therefore only counted
the vacuoles in a single cell layer (note that with EM the sum of autophagosomes
and autophagolysosomes is counted, while, as described earlier, the combination
of GFP-LC3 and Lysotracker allowed for the separate FM counting of autophago-
somes and autophagolysosomes). Moreover, FM allowed the visualisation of viable
cells, and therefore did not introduce fixation related changes. Following bafilomy-
cin A1 treatment at basal steady state the FM total puncta count did not change
significantly, while the EM vacuole count did increase significantly. Fig. 4.13C
shows that, following bafilomycin A1 treatment, nA increased while nAL decreased,
as expected. The sum of these two opposite effects accounted for the constancy
of the total puncta count observed in Fig. 4.13A. The contrary increase in vac-
uoles observed with EM was most probably due to the difficulty of distinguishing
autophagy-specific vacuoles from other structures with similar appearance, and
the fact that only a single slice of the cell was used in the measurement.
In cells treated with rapamycin there was a 1.5-fold increase in puncta (FM)
and a 2.5-fold increase in vacuoles (EM) 4 hr after rapamycin treatment. However,
after subsequent inhibition of fusion with bafilomycin A1 the number of puncta de-
creased, while the number of vacuoles increased (similar to the increase in vacuoles
observed without rapamycin). As discussed in the previous section, the decrease
in the total number of puncta can most probably be ascribed to unreliable puncta
count in the consistently blurry images at 8 hr in rapamycin-induced autophagy.
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Average surface area of a punctum/vacuole (Fig. 4.13). The average area
of a punctum remained constant following rapamycin treatment (30 min and 4 hr)
and following 30 min bafilomycin A1 treatment of both the control and rapamycin
pretreated cells. However, two hours after bafilomycin A1 treatment a decrease
in the average area of a punctum for both the basal and rapamycin-induced cells
was observed. Compared to FM data, the average area of vacuoles varied consid-
erably and showed no discernible trend, which again emphasises the unreliability
of EM data for quantifying the entities of autophagy. Furthermore, the average
surface area of an autophagosome was four times smaller than that of an auto-
phagolysosome, and this size difference remained constant in the various treatment
conditions. In Fig. 4.13A the apparent decrease in the average surface area of a
punctum 2 hr after bafilomycin A1 treatment was a result of the displacement
of the larger autophagolysosome with the smaller autophagosome following the
inhibition of the formation of autophagolysosomes by bafilomycin A1.
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Figure 4.13: Quantification of the number of puncta and vacuolar structures, as well
as the area of a punctum or vacuole averaged over all the puncta/vacuoles in a micro-
graph, from images derived from fluorescence and electron microscopy. (A) Fluorescence
microscopy data (total puncta) and (B) electron microscopy data. (A) Can be separated
into (C) autophagosomes and (D) autophagolysosomes. ∗ vs. Con p < 0.05, # vs. Rapa
4hr p < 0.05 (n = 10).
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4.3.2 Size distribution
Fig. 4.14 shows the size distribution of puncta/vacuoles derived from the FM and
EM studies based on three size classes.
The sizes of most of the puncta fell in the mid-sized range of 4–8 µm2, except
after inhibition with bafilomycin A1 where there was an increase in small puncta
(both in basal and rapamycin-induced conditions). As already mentioned above,
this was due to the increase in the number of (smaller) autophagosomes relative
to (larger) autophagolysosomes following inhibition of fusion. However, the size
distribution of autophagosomes Fig. 4.14C and autophagolysosomes Fig. 4.14D
remained constant under all treatment conditions. The distribution of autophago-
somes in the small, mid and large size classes was 67.2%, 32.4% and 0.4%, while
that of autophagolysosomes was 9.7%, 76.1% and 14.2%.
The majority of the vacuoles were smaller than 4 µm2 (Fig. 4.14B). Whether
the apparent shift in vacuolar size immediately after rapamycin treatment was real
or, as surmised above, due to the unreliability of EM data, is unclear.
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Figure 4.14: Size distribution of puncta/vacuolar structures, expressed as the percent-
age occurrence in one of three size classes: < 4µm2, 4–8µm2, > 8µm2. (A) Total puncta
observed using fluorescence microscopy; (B) Vacuoles using electron microscopy. Puncta
are divided into (C) autophagosomes and (D) autophagolysosomes (n = 10).
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4.3.3 Average punctum/vacuole volume and the derived
total sphere surface area of puncta/vacuoles
The volume of a punctum or vacuole was calculated by assuming it to be spherical
and that the experimentally measured area could be used to calculate the radius
of the sphere. Using the radius, the volume and the surface area of an individual
punctum or vacuole could therefore be calculated. Using the count of puncta or
vacuoles in one cell the total combined surface area of autophagosomes and auto-
phagolysosomes at any time point could also be calculated. The total surface area
was equated to the combined total vesicular membrane area of autophagosomes
and autophagolysosomes. Fig. 4.15 shows the average punctum/vacuole volume
and the calculated total surface area of puncta/vacuoles.
Because the volume and surface area of the assumed sphere were derived from
the puncta/vacuole count and area no additional information could in principle be
deduced from these data, which therefore cannot add to that which was discussed in
the previous section. The reason that volumes and total surface area are reported
here is that they can be used to calculate the rate at which cytoplasmic volume
and cellular membrane was consumed in the formation of autophagosomes, which
we propose as new and potentially useful functional variables of autophagy (see
Section 4.5).
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Figure 4.15: Average puncta volume and total puncta surface area of autophagosomes
plus autophagolysosomes assessed by (A) fluorescence microscopy and (B) electron mi-
croscopy. The same variables are shown for (C) autophagosomes on their own and for
(D) autophagolysosomes on their own. ∗ vs. Con, p < 0.05; # vs. Rapa 4hr, p < 0.05
(n = 10).
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4.4 Assessing key autophagy-related proteins
In reporting autophagic activity, Western blot analysis forms part of the standard
protocol used today to assess autophagy-related proteins, particularly LC3 and p62
[167]. LC3 II is used as an autophagy vesicle marker, since it is a structural com-
ponent of the autophagosomal membrane. p62 is used to assess the degradative
capacity of the autophagic system due to its mediating role between autophago-
somal cargo and LC3 II, a role that facilitates protein degradation. LC3 I, LC3 II
and p62 levels were measured at the time points shown in Fig. 4.11. Furthermore,
pmTOR and total mTOR (mTOR+pmTOR) levels were also assessed, since rapa-
mycin induces autophagy by preventing phosphorylation of mTOR. Two cell lines
were used: GFP-LC3 MEF cells in live cell imaging (see section 4.1.1 and 4.2) and
wild type MEF cells (to serve as a control against our transgenic cell line). The
Western blots of LC3, p62, pmTOR and mTOR are shown in Fig. 4.16 together
with histograms of the band intensities that quantify the proteins.
4.4.1 Analyses of phospho-mTOR and total mTOR
Western blot analyses using antibodies specific to phosphorylated mTOR (pm-
TOR) and antibodies that recognise mTOR irrespective of its phosphorylation
status (i.e., total mTOR) showed that upon treatment with rapamycin there was
a decrease in pmTOR (as a fraction of the total mTOR) as compared to the basal
condition (Con) (Fig. 4.16 A). The decrease in pmTOR was associated with the
increase in nA, nAL and autophagic flux as assessed by fluorescence microscopy
(Fig. 4.10), which agrees with its role as negative regulator of autophagy.
4.4.2 Analyses of LC3 I and II
The most widely used assay for assessing autophagic activity involves Western
blot analysis of LC3 before and after treatment with a fusion inhibitor such as
bafilomycin A1. Fig. 4.16B and C show the Western blot analysis of LC3 I and
II in GFP-LC3 MEF cells and wild type MEF cells respectively. Note that for
the GFP-LC3 MEF cells (Fig. 4.16B) the Western blots only show LC3 I and II
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that are not coupled to GFP, which, as discussed in Chapter 6, complicates the
interpretation of the results. As an example, we expected LC3 II, a membrane
component of autophagosomes, to increase after rapamycin induction and after
bafilomycin A1 treatment since we had observed an increase in the number of
autophagosomes for such experiments (Fig. 4.10A and B). Wild type MEF cells
clearly showed these trends (Fig. 4.16C), whereas GFP-LC3 MEF cells showed
an initial decrease and subsequent increase in LC3 II following bafilomycin A1
treatment and no increase upon rapamycin induction, although bafilomycin A1
treatment of induced autophagy did show the expected increase in LC3 II.
Standard Western blot analysis of LC3 was used to assess whether autophagic
flux increased or not relative to a control condition. Measuring LC3 II band densi-
ties before and after inhibition of fusion with bafilomycin A1 was used to indirectly
assess the time-dependent accumulation of autophagosomes. Based on the differ-
ences between the relative increases in LC3 II band densities after bafilomycin A1
treatment of control and rapamycin-treated cells, we could conclude that the cells
treated with rapamycin had a two-fold higher autophagic flux compared to the
control (Fig. 4.16C compares the relative difference between Con and Baf 30min
to that between Rapa 4hr and Rapa Baf 30min).
Cytoplasmic LC3 I is not directly associated with autophagosomes and it is not
known whether variations in its level can be linked with changes in the number of
autophagosomes. What is clear from Fig. 4.16C is that in our experiments with
wild type MEF cells there was no correlation between variations in LC3 I and II.
The data in Fig. 4.16B have no clear interpretation.
4.4.3 Analyses of p62
Fig. 4.16 D and E show the Western blot analysis of p62 of GFP-LC3 MEF and
wild type MEF cell lines respectively. The p62 blots showed the same trends as
the LC3 blots of both GFP-LC3 and wild type MEF cells, which is not surprising
since p62, which occurs in the lumen of autophagosomes, associates with LC3 II
and would thus be expected to vary with it.
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Figure 4.16: Western blot analysis of autophagy related proteins. (A) mTOR; (B) LC3
in GFP-LC3 MEF cells; (C) LC3 in wild type MEF cells; (D) p62 in GFP-LC3 MEF cells;
(E) P62 in wild type MEF cells. Glyceraldehyde phosphate dehydrogenase (GAPDH)
was used as a loading control. A representative blot is shown. ∗ vs. Con, p < 0.05; #
vs. Rapa 4hr, p < 0.05 (n = 3).
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4.5 Autophagic variables
From the data obtained by the experiments described above, we were able to quan-
tify a number of autophagic variables. Traditional methods such as Western blot
analysis and electron microscopy allowed the measurement of variables associated
with vacuolar structures, but without making any distinction between autophago-
somes and autophagolysosomes (Table 4.1). Our new fluorescence microscopy ap-
proach allowed us to make this distinction, while at the same time providing more
reliable and accurate assessments of a number of autophagic variables (Table 4.2)
Autophagic flux is commonly assessed with Western blot analysis of LC3 with
and without the inhibition of fusion between autophagosome and lysosomes (de-
scribed in section 2.6.2.1); the relative increase in LC3 levels after treatment with
a fusion inhibition such as bafilomycin A1 is used to describe autophagic flux. As
indicated in Table 4.1 we measured a 2.15-fold increase in autophagic flux with
this method, compared to the 4.14-fold increase measured with our fluorescence
microscopy method (see Table 4.2).
With electron microscopy, vacuolar flux, Jvac, in the basal and induced states
was measured as the rate of increase in the number of vacuoles, nvac, after inhi-
bition of fusion (Baf 30 min and Rapa Baf 30 min in Fig. 4.11). The decrease in
the vacuolar flux after rapamycin induction was in stark contrast to the increase
in autophagosomal flux observed with fluorescence microscopy, and demonstrates
that vacuolar flux is a poor measure of autophagic flux. This is to a large part
due to the fact that the number of vacuoles counted in a single EM section is
probably a poor indicator of the total number of vacuoles in a cell. Although we
calculated the vacuolar transition time τvac as the ratio of nvac/Jvac, we cannot
deduce much from these values. Induction by rapamycin had little effect on the
average volume of a vacuole, but the total membrane area of the vacuoles in an
EM section increased about 28-fold.
The measurement of nA and J with our fluorescence microscopy technique
allowed us to calculate the transition time τ = nA/J , which is the time required
to turn over the autophagosomal pool in the system; the autophagolysosomal
transition time τAL is similarly calculated as nAL/J (Table 4.2). Both τA and τAL
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respectively decreased 3-fold and 2.8-fold after induction. The average volume of
an autophagosome was not affected by induction, while the cytoplasmic volume
consumption rate increased by a factor of 4.5, while the autophagosomal membrane
flux increased by a factor of 5.9. Fig. 4.17 summarises these results graphically.
Table 4.1: Functional variables of autophagy as measured by traditional methods
(Vac: vacuolar structures counted in a single EM section). Derived variables are shown
in italics.
Variable Unit Basal Induced
Western blot
Relative flux, Jrel dimensionless 1 2.15
Electron microscopy
Vacuolar flux, Jvac Vac/hr/section 92.3 61.6
Number of vacuoles, nvac Vac/section 15.2 42.6
Average volume of a vacuole fL 17.3 18.7
Total membrane area µm2 52.8 1486
Vacuolar transition time, τvac hr 0.16 0.69
Table 4.2: Functional variables of autophagy as measured by the new fluorescence
microscopy method (A: autophagosomes; AL: autophagolysosomes). Derived variables
are shown in italics.
Variable Unit Basal Induced
Autophagic flux, J A/hr/cell 25.4 105.4
Number of autophagosomes, nA A/cell 13.4 16.7
Number of autophagolysosomes, nAL AL/cell 164.5 251.2
Average volume of an autophagosome fL 4.3 4.7
Average volume of an autophagolysosome fL 17.3 18.8
Autophagosomal transition time, τA hr 0.53 0.16
Autophagolysosomal transition time, τAL hr 6.7 2.4
Cytoplasmic volume consumption rate, Jvol fL/hr/cell 109 495
Autophagosomal membrane flux, Jmem µm
2/hr/cell 1397 8268
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Figure 4.17: Basal and rapamycin-induced autophagy variables. (A) shows a cartoon
of basal and induced autophagy variables. (B) depicts representative image of basal and
rapamycin-induced autophagy. J = autophagosomes/hr/cell, ni = number of steady
state species , τi = hr and J
vol
i = pL/hr/cell.
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4.6 Amino acid and protein levels under basal
and induced autophagy
4.6.1 Single amino acids
A complete amino acids analysis was performed on the treatment groups described
in Fig. 4.11. Fig. 4.18 shows the amino acid profiles for each treatment condition
(Fig. A in Appendix A shows the quantitative analysis of individual amino acids).
Glutamic acid and arginine were the only amino acids that showed significant
changes between treatment groups (Fig. 4.19), although the changes in arginine
were marginal compared to those in glutamic acid. The trend in the arginine
change profile (Fig. 4.19B) was shared by all the other amino acids analysed.
The most likely explanation for the high glutamic acids levels after rapamycin
treatment is an increase in amino acid catabolism which leads to an increase the
production of nitrogen waste, glutamic acid being a key intermediate in the nitro-
gen waste disposable pathway. This increase in amino acid metabolism is discussed
in more detail in section 6.7. Rapamycin mimics starvation induced-autophagy by
preventing the negative feedback by high amino acids levels on autophagy [197].
Therefore, no conclusions about the regulation of autophagy by amino acids can
be drawn from experiments in which rapamycin is used to induce autophagy, such
as described in this thesis.
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Figure 4.19: Quantitative measurements of (A) glutamic acid and (B) arginine. ∗ vs.
Con, p < 0.001; # vs. Rapa 4hr, p < 0.001 (n = 3).
4.6.2 Glucogenic and ketogenic amino acids
Amino acids can be grouped on the basis of how they feed into energy metabolism.
Glucogenic amino acids feed into the gluconeogenesis pathway through pyruvate.
Ketogenic amino acids contribute to the synthesis of ketone bodies and fatty acids.
Some amino acids are metabolised through both ketogenic and glucogenic path-
ways. Figs. 4.20A and 4.20B respectively show the ketogenic and glucogenic amino
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acid levels for the different treatment groups, while Fig. 4.20C shows that of amino
acids that are both ketogenic and glucogenic. Ketogenic amino acids and amino
acids that are both ketogenic and glucogenic show similar trends after induction
and inhibition of autophagy. An increase in glucogenic amino acids was observed
in the rapamycin-induced steady state (Rapa 4 hr), to which glutamic acid was
the major contributor.
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Figure 4.20: Quantitative analysis of (A) ketogenic amino acids, (B) glucogenic amino
acids, and (C) amino acids that are both ketogenic and glucogenic. ∗ vs. Con, p < 0.05;
# vs. Rapa 4hr, p < 0.05 (n = 3).
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4.6.3 Total amino acid and total protein profiles
Cytoplasmic proteins serve as substrates for the autophagic system; amino acids
are the end products of the degradation of proteins through autophagy. We there-
fore measured total amino acid and total cellular protein levels during basal and
rapamycin-induced autophagy (Fig. 4.21). Following induction of the autophagic
system protein levels decreased while the amino acid level increased, as expected.
After inhibition of fusion, and the subsequent suppression of autophagic flux,
amino acid levels descreased significantly, while the observed decrease in proteins
levels was not significant according to one-way Anova with Bonferoni post-test.
The decrease in amino acids was to be expected, but the observed decrease in
protein level was contrary to expectation. We do not know why, but we cannot
exclude the possibility that this was just due to experimental error.
Stellenbosch University  https://scholar.sun.ac.za























































Figure 4.21: Total amino acid and protein levels. Graph shows control (Con), 30
min (Baf 30min) and 2 hr (Baf 2hr) bafilomycin A1 treatment, and 30 min (Rapa 30
min) and 4 hr (Rapa 4hr) rapamycin treatment, as well as cells pretreated for 4 hr with
rapamycin followed 30 min (Rapa Baf 30min) and 2 hr (Rapa Baf 2hr) bafilomycin A1
treatment. ∗ vs. Con, p < 0.05; # vs. Rapa 4hr, p < 0.05 (n = 3).
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Chapter 5
A kinetic model of autophagy
The autophagic pathway is a stepwise series of transformations of membrane-bound
vesicles along which there is a flow of cytoplasmic material, which is degraded
during the process. We have defined autophagic flux as the rate of flow through
the pathway at steady state [142]. This definition of autophagic flux is similar to
that of flux in metabolic studies, where metabolic flux refers to the rate of flow of
metabolites along a metabolic pathway in steady state. Presently, combinations
of assays such as Western blot analysis, fluorescence and transmission electron
microscopy are used to assess the autophagic degradative capacity [167]. Although
these techniques do generate invaluable data for deciphering aspects of autophagy,
they do not generate the type of data that allow a study of the continuous time-
dependent behaviour of autophagy.
As described in Chapter 4, we have developed a fluorescence microscopy tech-
nique with which we can quantitatively measure the changes with time in the num-
ber of autophagosomes, autophagolysosomes and lysosomes in a single cell during
basal and rapamycin-induced autophagy. Inhibiting the fusion of autophagosomes
and lysosomes with bafilomycin A1 and measuring the rate of accumulation of
autophagosomes allowed us to calculate the steady-state autophagic flux. This
chapter describes the development of a kinetic model, similar to the type of mod-
els used to study metabolism, that simulates the time-course of the autophagic
vesicles during the process of autophagy, with and without induction.
106
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Our modelling strategy was to start with the simplest possible model of au-
tophagy with the simplest possible rate equations, and then to extend the network
scheme and modify the kinetics step by step in order to achieve a near-perfect fit of
our experimental data. This afforded us a deep understanding of the contribution
of each part of the autophagic network to its time-dependent behaviour.
In recent years computer modelling has become an integral tool for the analysis
of the behaviour, control and regulation of reaction networks that underlie cellu-
lar processes. There are many software platforms for building such models, one
of which we have developed, namely PySCeS (the Python Simulator for Cellular
Systems [191], http://pysces.sourceforge.net), a console-based simulation platform
written in the Python programming language (http://www.python.org). PySCeS
uses the Numerical Python (NumPy) and Scientific Libraries for Python (SciPy),
which are collections of mathematical algorithms for science and engineering ap-
plications. The kinetic model of autophagy described in the next section was
developed using PySCeS.
5.1 The kinetic model
The first step in the modelling process is to create a model object that describes
a model in terms of its stoichiometry and rate equations. This is done by defining
the model in a text file, which is parsed and converted into the model object. In
the process PySCeS checks the validity of the model and automatically performs
a structural analysis of the stoichiometry matrix that describes the topology of
the reaction network. PySCeS can then simulate the dynamical behaviour of the
system over time, calculate the steady state, do 1, 2, or n-dimensional parame-
ter scans and bifurcation analyses, and investigate the control and regulation of
cellular systems with a metabolic control analysis (MCA) module that calculates
elasticity coefficients, flux and concentration-control and response coefficients.
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Figure 5.1: Network representation of the autophagic process: (A) The minimal model
describes autophagosome synthesis, fusion with lysosomes, and autophagosome break-
down with the release of amino acids. Lysosomes are regarded as fixed. (B) The model
is extended with the biogenesis and degradation of lysosomes, which are now regarded
as variable. (C) The mTOR/pmTOR cycle is added, with mTOR incorporated into the
rate equation for step 1. P: phagophores, A: autophagosomes, AL: autophagolysosomes,
AA: amino acids, L: lysosomes, LB: biogenesis of lysosomes, LD: lysosome degradation.
LB and LD are dummy variables necessary for defining the models.
Fig. 5.1 shows the schemes used to describe the autophagic process. Our strat-
egy was to describe each step in autophagy as a chemical reaction in which the
“reactants” were the autophagic intermediate vesicles. The pathway shown in
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Fig. 5.1A is a simple representation of autophagy and served as a starting point for
modelling the dynamics of autophagy. This minimal kinetic model was extended to
include lysosomal biogenesis and degradation (Fig. 5.1B), and the mTOR/pmTOR
system (Fig. 5.1C).
The PySCeS model input files for the reaction schemes in Fig. 5.1 define the
reactions, rate equations and parameters as well as variable initializations (the
input files are listed in Appendix C). All steps were assumed to be irreversible and
product-insensitive. The rate equations were all based on mass-action kinetics.
The model input files incorporated an event that simulated the complete inhibition
of the fusion of A and L at a specified time point. An induction event was also
created to simulate rapamycin induction of the autophagic system.
Our modelling strategy was to start with the simplest possible kinetics, assum-
ing the rate equations of the minimal model in Fig. 5.1A to be first-order with
respect to all species:
v1 = k1[P ]
v2 = k2[A][L]
v3 = k3[AL]
Kinetic parameters of the rate reactions were set as follows to simulate the
experimental basal flux: P = 1.0, L = 1.0 (average experimental basal value),
AA = 0.0, k1 = 25.4 hr
−1, k2 = 25.4/13.0 hr
−1, k3 = 25.4/165.0 hr
−1. Initial
values of A and AL were set to zero entities/cell. The rationale for choosing the
values of k1, k2 and k3 was the following:
• Since the first step in the pathway (the biogenesis of autophagosomes from
phagophores) was assumed to be irreversible and insensitive to downstream
events, it is rate-limiting and completely determines the steady-state au-
tophagic flux under all conditions. Setting k1 to 25.4 hr
−1 (with P = 1.0)
therefore set the autophagic flux to the average basal flux as measured ex-
perimentally (calculated from v1 = k1[P ] = k1(1.0) = 25.4).
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• The average experimental basal steady-state value of A was 13 autophago-
somes/cell. The rate v2 of step 2 in the basal steady-state had to be equal
to the steady-state flux set by step 1, i.e., 25.4 hr−1. In order to set A
to 13.0, k2 was be set to 25.4/13.0 hr
−1 (calculated from v2 = k2[A][L] =
k2(13.0)(1.0) = 25.4).
• The average experimental basal steady-state value of AL was 165 autophago-
lysosomes/cell, which, similarly, required k3 to be set to 25.4/165.0 hr
−1
(calculated from v3 = k3[AL] = k3(165.0)(1.0) = 25.4).
The time-dependent behaviour of the system with these parameter values was
simulated with PySCeS. At t = 2 hr the inhibition of fusion by bafilomycin A1 was
simulated by setting k2 to zero. Fig. 5.2A shows that with these parameter settings
the simulated data were a reasonably good fit to the experimental data up to 30
min after bafilomycin A1 treatment. After that there are processes that change
the rates of autophagosome formation and autophagosome degradation which our
model (and all the extensions discussed below) could not account for.
The induction of autophagy by rapamycin and subsequent inhibition of fusion
by bafilomycin A1 when the new induced steady state had been established was
simulated by increasing P to 105.4/25.4 at t = 2 hr and k2 to zero at t = 6 hrs.
The experimentally-determined induced autophagic flux was 105.4 autophago-
somes/hr/cell, and to set that value P had to be increased by the factor 105.4/25.4.
As Fig. 5.2B shows, the induced flux was well-simulated (the experimental and sim-
ulated slopes at t = 6 hrs were equal), but the induced steady-state values of A
and AL were too high (A = 54 instead of 17, AL = 385 instead of 251). The
only way to lower these values without affecting the basal and induced flux was
by adjusting the kinetic orders of A and AL in the rate equations for step 2 and
3 respectively. We therefore introduced terms for these kinetic orders in our rate
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equation definitions:





These alterations of course implied that k2 and k3 also needed to be recalculated
as k2 = 25.4/13.0
h2 and k2 = 25.4/165.0
h3 . By trial and error we arrived at the
values h2 = 5 and h3 = 3.4, which lowered A and AL to the required 17 and 251
respectively. Using these modifications to our minimal model we were able to bring
our simulation very close to the experimental profile (Fig. 5.2D). The simulation of
basal flux (Fig. 5.2C) was virtually indistinguishable from that in Fig. 5.2A, except
that the decrease in AL in the 30 min period after bafilomycin A1 treatment was
better approximated with the incorporation of h2 and h3.
Where our simulation still did not match the experimental profile was in the
two-hour period after induction with rapamycin, during which A nearly doubled
to 23 autophagosomes/cell and then decreased to its new steady-state value of 17.
This initial increase in A after induction was accompanied by a slower increase
in AL. The only way to introduce this effect was by making the lysosome pool
variable as in the extended scheme in Fig. 5.1B. It was important that not only
regeneration of lysosomes in step 3 was included, but also de novo biogenesis and
degradation of lysosomes (steps 4 and 5):







The properties of steps 4 and 5 had to be set to values that ensured both that L
returned to a value of 1 in the induced steady state and that the initial increase in
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A after induction (and the concomitant decrease in L and slower increase in AL)
occurred during the two hours after induction. The first criterion was satisfied if,
at an LB-value of 1, k4 = k5. Note that in steady state, v1 = v2 = v3, which implies
that v4 = v5 (for L to be in steady state), and therefore that k4(1.0) = k5[L]. For
L to be 1 in steady state, k4 therefore had to equal k5. By trial and error we found
that the second criterion was satisfied if k4 = k5 = 80.0.
Fig. 5.2F shows that, although we could now simulate the initial overshoot of
A after induction it was too fast. This was due to our making the induction event
instantaneous, whereas in reality it would be a slower process that depends on the
rate of dephosphorylation of pmTOR to mTOR, which is the species that activates
autophagy. We therefore incorporated the pmTOR/mTOR cycle into our model
(Fig. 5.1C). In the rate equation for step 1 mTOR appears as a reactant, so that
the rate of autophagy depends linearly on mTOR concentration. This served our
purpose, but is probably too simple and a more realistic rate equation will be
developed in the future.









When P = 1 and mTOR = 1 the set k1-value of 25.4 ensured the correct basal
autophagic flux. Instead of increasing P by a factor of 105.4/25.4 to simulate
induction, we now had to ensure that mTOR increased with time from a value
of 1.0 to 105.4/25.4 (with P now set to 1.0). The simplest way of accomplishing
this was to set k6 to 1.0 and k7 to 105.4/25.4. Because in steady state v6 = v7,
this ensured that mTOR and pmTOR had steady-state concentrations of 1.0 and
105.4/25.4 respectively. We therefore initialised mTOR and pmTOR to these
values. Because the mTOR/pmTOR cycle is a moiety-conserved cycle, i.e., the
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sum of mTOR and pmTOR is constant, switching the k7/k6 ratio from 105.4/25.4
to 25.4/105.4 switched mTOR and pmTOR to 105.4/25.4 and 1.0 respectively,
i.e., mTOR increased by the required factor of 105.4/25.4. This switch in k7/k6
was done by multiplying k6 with the factor (105.4/25.4)
2.
We now had to also multiply k6 and k7 by the same time-scaling factor to
simulate the rate of the induction process itself, i.e., the time taken for mTOR to
change from 1.0 to 105.4/25.4. A factor of 0.08 (determined by trial and error)
gave the desired result. Fig. 5.2G and H show that with all these extensions of
and modifications to our simple model we now had a near-perfect simulation of
our experimental data for both basal and induced autophagy.
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Figure 5.2: Fitting simulation curves to experimental data. Left-hand graphs: de-
termination of basal flux; right-hand graphs: determinations of induced flux. (A,B)
the minimal model of autophagy in Fig. 5.1A with first-order rate equations; (C,D) the
minimal model of autophagy in Fig. 5.1A with higher-order rate equations; (E,F) the
minimal model expanded to include lysosomal formation and degradation (Fig. 5.1B);
(G,H) further addition of the mTOR/pmTOR system( Fig. 5.1C). The autophagosomal
( ), autophagolysosomal, ( ), and lysosomal ( ) time courses were simulated.
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5.1.1 Control analysis
PySCeS also allows the calculation of control and elasticity coefficients of a steady
state. Appendix B lists these coefficients for the basal steady state of the kinetic
model of autophagy described above. In our model full control of the autophagic
flux is trivially in the first step (CJbasalv1 = 1.0), since its rate equation is defined
to be insensitive to downstream intermediates (A and AL). Future refinements
of the model will include negative feedback by amino acids on the synthesis of
autophagosomes so that flux-control will at least be shared between step 1 and the
demand for amino acids. Step 6 and 7 also control the autophagic flux through
changes in mTOR, which is a multiplier in the rate equation of step 1, but the
magnitude of the control coefficients of these two steps is proportional to the flux-
control coefficient of step 1. Similarly, because of the way the rate equations are
defined, step 4 has full control over the flux through the lysosomal pool.
Concentration control of A by step 1 and 2 (0.2 and −0.2 respectively) is
completely determined by the elasticity coefficient of step 2 with respect to A,
because step 1 is insensitive to A. CAv1 and C
A
v2
are the positive and negative
reciprocals of εv2A = 5.0. Similarly, concentration control of AL by step 1 and 3
(0.29 and −0.29 respectively) is completely determined by the elasticity coefficient
of step 3 with respect to AL, where CALv1 and C
AL
v32
are the positive and negative
reciprocals of εv3AL = 3.4.
At this stage of the development of our kinetic model of autophagy it is pre-
mature to make confident statements about the control of autophagic flux and
concentration of autophagic vesicles. Too much depends on how we defined the
rate equations.




Conventional methods used in autophagy research, most notably Western blot-
ting and electron microscopy, generate invaluable information about the mech-
anistic behaviour of autophagy, but they lack the ability to accurately measure
autophagic flux. Therefore, the first aim of this study was to develop a new
approach to quantifying autophagic flux and to compare it to the conventional
methods. The quantification of autophagic flux was done at a single cell level us-
ing live cell fluorescence imaging. The experimental protocol was to establish an
autophagic steady state, and then to block the fusion of autophagosomes and lyso-
somes; autophagic flux was then calculated as the initial rate at which the number
of autophagosomes increased after inhibition of fusion. The second aim was to
create a kinetic model of the autophagic process and to analyse its dynamics and
the control of its steady states.
6.2 Assessing and distinguishing between
autophagic intermediates
It is well established that after induction of the autophagic system there is an in-
crease in GFP-LC3 puncta [36, 129, 146, 161, 167, 255, 263, 265]. However, only a
116
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few of these studies distinguish between autophagosomal and autophagolysosomal
pool size and their changes after induction [36, 255, 265]; these studies assessed
the autophagic vesicles with either LAMP2 anti-body staining [36] or with Lyso-
tracker dye for live imaging [255, 265] (Lysotracker is a red fluorescent acidotropic
probe for labelling and tracking acidic organelles). Staining for autophagosomes,
autophagolysosomes and lysosomes provided a more complete picture of the au-
tophagic system and its dynamic behaviour. The results of these studies accord
with what we observed (Fig. 4.5), namely that autophagosomes only constitute a
small fraction of GFP-LC3 puncta.
It is generally assumed that GFP-LC3 only identifies autophagosomes, since
it is to be expected that the low pH in autophagolysosomes would immediately
quence the pH-sensitive GFP fluorescence, and that, in the longer term, GFP
protein would be degraded by lysosomal proteases. However, the addition the red
Lysotracker dye shows that this is not the case, since the majority of puncta in
a cell are yellow (which is due to a co-localisation of green and red puncta) and
therefore indicate autophagolysosomes. If green GFP were quenched or degraded
immediately upon fusion, autophagolysosomes would show up as red puncta and
would be indistinguishable from red lysosomal puncta. This means that, contrary
to received wisdom, green puncta in the absence of a lysosomal marker actually
indicate either autophagosomes or autophagolysosomes so that the total green
puncta count indicates the sum of autophagosomes and autophagolysosomes.
However, most of the scientific community still seems to accept that GFP-LC3
puncta are appropriate indicators of autophagosomes and base their conclusions
on this surmisal (see, for example, [129, 146, 263]). The studies cited above and
our own data suggest that this could potentially lead to misconceptions about the
autophagy system during basal and diseased states, since both induced autophagy
and impaired autophagosome/lysosome fusion would result in an increase in GFP-
LC3 puncta. We therefore suggest that in future research the methodology should
distinguish between autophagosomes, autophagolysosomes and lysosomes.
Since our data and the studies discussed above indicate that GFP is not im-
mediately degraded after fusion, this opens the possibility of measuring the rate of
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protein degradation within autophagolysosomes. Recent advancements in fluores-
ence microscopy and software allow for automated tracking of fluorescing puncta
and measuring time-dependent changes in fluorescence intensities of individual
puncta. Therefore, the decay in the GFP fluorescent signal of a punctum can
in principle be used to determine the turnover rate of autophagosomal cargo af-
ter fusion with lysosomes. Free soluble GFP has been suggested as a marker for
autophagosomal cargo, since it seems to be more stable within autophagolyso-
some [182]. Such studies could be complemented with morphometric analysis of
autophagolysomes throughout the degradation of the cargo; we observed that af-
ter fusion yellow puncta slowly changed colour to orange (due to the decrease in
green GFP signal) and finally to red, completing degradation and the recycling
to lysosomes—during the degradative process these puncta slowly became larger,
and after completion of the degradative phase rapidly became small and red.
6.3 Quantifying autophagic flux
6.3.1 Determining the concentration of bafilomycin A1
required for the inhibition of the autophagosome
fusion with lysosome
A crucial part of the protocol to assess autophagic flux requires the complete inhi-
bition of the autophagosomal and lysosomal fusion process. Previous autophagic
studies [32, 158, 166, 182] have used concentrations ranging from 10 to 100 nM
bafilomycin A1. Typically, the effect of bafilomycin A1 is assessed either by mea-
suring LC3 Western blot band intensities or by counting the numbers of fluorescent
puncta 6 hrs [182] or more (even up to several days [104]) after treatment with
bafilomycin A1. Our data, discussed below, show that a new steady state can
already be established after 4 hrs (Fig. 4.10); this means that these studies ac-
tually measure the new steady-state autophagosomal pool size after inhibition of
fusion. However, studies such as [182] suggest that bafilomycin A1 concentrations
lower than 100 nM probably result in only partial inhibition of autophagosome
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and lysosome fusion (see Fig. 6.1B).
We approached the determination of the concentration of bafilomycin A1 that
causes complete inhibition of fusion differently by measuring the initial rate of
increase in autophagosomes in a single cell after treatment with different bafilo-
mycin A1 concentrations (Fig. 6.1A). Our preliminary experiments suggested that
400 nM bafilomycin A1 would completely block fusion (Fig. 4.2) and we used this
concentration in all experiments in this study. Later in our study we repeated these
experiments with our improved methodology and found no difference between the
effects of 100, 200, 400 and 800 nM bafilomycin A1, which suggests that 100 nM is
enough to completely block fusion. In future studies we will reduce the bafilomy-
cin A1 concentration to either 100 (or, to be safe, 200 nM). These conclusions are
further substantiated by the study of Yoshimori et al. [274] who found that 100 nM
bafilomycin A1 treatment of A431 cells resulted in significant de-acidification af-
ter 30 min, and complete de-acidification after 60 min. Similarly, Choi et al. [32]
reported that 200 nM bafilomycin A1 was sufficient to completely de-acidify lyso-
somes in HeLa cells. The difference in these results indicate that each cell line
may require a unique concentration of bafilomycin A1 for the complete inhibition
of fusion.
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Figure 6.1: Methods for evaluating inhibition of fusion of autophagosomes and lyso-
somes by bafilomycin A1. (A) Measuring the initial rate of increase of autophagosomes
after treatment with different bafilomycin A1 concentrations. (B) Measuring the increase
in GFP-LC3 puncta 6 hrs after treatment with different bafilomycin A1 concentrations
[182].
.
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6.3.2 Quantification of flux
Using our newly-developed fluorescence microscopy technique, we were able to
numerically quantify both basal and rapamycin-induced autophagic flux, some-
thing which up to now has not been possible. The success of our method was
due to our being able to distinguish between and measure the total pool sizes of
autophagosomes, autophagolysosomes and lysosomes over time. This allowed us
to characterise the autophagic steady state under basal and induced conditions,
and also measure the changes in pool size of the three autophagic vesicles af-
ter the fusion between autophagosomes and lysosomes was inhibited. From these
data we were able to quantitatively calculate the basal autophagic flux as 25.4
autophagosomes/hour/cell and the rapamycin-induced autophagic flux as 105.4
autophagosomes/hour/cell, which represented a four-fold increase.
Despite the clear utility of our new method, it does have shortcomings. Bafil-
omycin acts by inhibiting the membrane-bound V-ATPase, a proton-pump, which
leads to the de-acidification of the lumen of vesicles, such as lysosomes, that con-
tain this transporter. This means that in our system addition of bafilomycin A1
de-acidifies both lysosomes and autophagolysomes. In turn, de-acidification of
lysosomes prevents their fusion with autophagosomes. The problem with using
bafilomycin A1 is that this de-acidification of lysosomes and autophagolysosomes
results in the depletion of the red pH-dependent Lysotracker fluorescent dye, which
changes the colour of autophagolysosomes from yellow to green, so leading to the
false identification of autophagosomes, especially at later time periods following
bafilomycin A1 treatment. It would therefore be advisable to avoid pH-dependent
fluorescent dyes, and to rather use fluorescently-tagged lysosomal proteins such as
lysosome-associated membrane protein 2 (LAMP2). In an attempt to overcome
this limitation of live-cell imaging, we generated a cell line that stably expressed
RFP-LAMP2 (red) and GFP-LC3 (green), but due to high background noise and
time constraints we abandoned this line of experimentation, and continued to use
fluorescent dyes. In future work we plan to improve the cell line that expresses
both RFP-LAMP2 and GFP-LC3. Alternatively, we may rather opt to fix cells at
specific time points with acetone/methanol and quantify the autophagic intermedi-
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ates using immunofluorescence, i.e., fluorescently-tagged antibodies that recognise
proteins specific to autophagic vesicles. Fixing the cells would have an additional
advantage, namely the avoidance of counting an autophagic vesicle twice: when
acquiring multiple z-stack layer images of a cell, autophagic vesicles can potentially
be counted twice, since they can move around in the cell during the acquisition
time from on layer to the next.
Recent advances in FM have led to the development of novel techniques that
have been employed to assess autophagic activity. One of the most accurate ways
of indirectly assessing autophagic degradation is based on monitoring the decay of
cytosolic proteins [116, 249]. These methods use cytosolic photo-activatable fluo-
rescent proteins, that, once activated, can be used to measure the rate of decay
of the fluorescence signal in the cytoplasm, which gives an indication of the rate
of protein degradation in general [249]. From this the transition time, τ , can be
calculated, which in this context is the time required for the complete turnover
of the cytosolic protein pool, or more accurately, of the fluorescent protein pool.
If the sole path of protein degradation is via autophagy, then the rate of protein
degradation measured by this method could be regarded as an indication of au-
tophagic flux. However, this method provides no data on the detailed dynamics
of autophagy, such as the change over time in pool sizes of the autophagic vesi-
cles. Consider the following two examples where this deficiency is pertinent. First,
impaired autophagosome/lysosome fusion, such as can occur in a disease state,
would result in an increase in autophagosomes and lysosomes, while the basal au-
tophagic flux in the normal and diseased states as reported by photoswitchable
proteins would be the same. As we have shown, this is due to the flux being
determined by the rate of autophagosome synthesis and not to the rate of fusion.
Photoswitchable protein decay would not be able to distinguish the diseased from
the normal state. Second, during periods of autophagy arrest, protein degradation
can be shifted towards selective protein degradation pathways, such chaperone-
mediated autophagy [121, 180]. Therefore, although macro-autophagic flux may
have decreased, the rate of fluorescent decay may remain the same, so that mea-
suring fluorescent decay would not shed light on the impairment in the autophagic
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system. In principle, given the cytosolic protein concentration and because our
data allow the calculation of the cytoplasmic volume consumption rate, we should
also be able to determine cytosolic protein turnover.
6.4 Morphometric analyses
In accordance with our findings, a number of groups have reported an increase
in the vacuolar count observed by EM following induction of autophagy [51, 54,
145, 161, 186]. Various groups have also reported that, following an increase
in the synthesis of autophagosomes, there was also an increase in the volume
of autophagosomes and autophagolysosomes [54, 161, 273]. They made use of
automated 3D Correlative Light and Electron Microscopy (CLEM) that made 3D
rendering of autophagosomes and autophagolysosomes possible [54, 273]. In our
study we also observed an increase in vacuolar volume, but we were not able to
distinguished between autophagosomes and autophagolysosomes.
Although changes in the size of autophagic vesicles are usually based on EM,
not on FM, we consider live cell FM images to be more accurate in representing
the size of autophagosomes and autophagolysosomes compared to EM. By using
FM we were able to distinguish between autophagosomes and autophagolysosomes
and to assess their respective morphological characteristics. Images obtained by
other groups that distinguished autophagosomes and autophagolysosomes show
trends similar to those in our images [20, 36, 255, 265].
Groups that only assessed GFP-LC3 puncta (which do not distinguish be-
tween autophagic vesicles), found an increase in GFP-LC3 puncta size when the
autophagic system was induced [129, 146, 263]. In contrast, our data showed the
autophagosomal and autophagolysosomal volumes to remain constant (Figs. 4.15C
and 4.15D). However, while the autophagolysosomal volume remained constant,
the autophagolysosome pool size increased (Fig. 4.10). This explains the seeming
increase in volume observed in GFP-LC3 puncta in the above-mentioned studies.
Inaccuracies in the counting of vacuoles due to plane-sectioning affect the ob-
served numbers [273]. Like several other groups [26, 102, 224], we also had difficul-
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ties in positively identifying autophagosomes, autophagolysosomes, lysosomes and
endosomes in our EM images, and could only confidently distinguish autophagic
vacuolar structures from other membrane-bound organelles. However, there are
groups that have successfully used EM to identify autophagosomes, autophagolyso-
somes and lysosomes in HeLa cells and hepatocytes [53, 54, 186, 273]. Techniques
such as CLEM and Immunogold staining (IGS) have recently been used to improve
the identification of autophagosomes, autophagolysosomes and lysosomes in EM
images. IGS is an EM staining technique that uses gold-labelled antibodies to
mark proteins of interest, but it still relies on the sectioning of EM samples and
therefore the analysis of a single plane. CLEM combines the advantages of both
fluorescence microscopy and EM, allowing the identification of cellular structures
using fluorescence probes in EM images and exploiting the high resolution of EM.
The automated 3D-CLEM interface makes possible the 3D rendering of autophago-
somes [54, 273], allowing for detailed morphometric analysis. In principle precise
quantification of the total pool sizes of autophagosomes, autophagolysosomes and
lysosomes should also be possible with this technique, but it remains to be done.
6.5 Western blotting
Western blot analysis forms part of the standard protocol used today to assess
autophagic activity [167]. It is used to assess autophagy related proteins, particu-
larly LC3 and p62. LC3 is one of the structural components of the autophagosomal
membrane, and is involved in the development of the sequestering vesicle as well
as the facilitation of cargo recognition via p62. p62 is involved in the formation
of autophagosomes by linking proteins to be degraded with LC3; it is therefore
regarded as a marker of autophagosomal cargo. Traditionally, Western blotting of
LC3-II has been a particularly attractive means of assessing autophagic activity.
The amount of LC3-II generally corresponds to the number of autophagosomes,
or, more accurately, to the total autophagosomal membrane [98].
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6.5.1 pmTOR and mTOR
Since it is involved in the signal transduction cascade that induces autophagy, the
ratio pmTOR/mTOR, where pmTOR is the phosphorylated state of mTOR, is
commonly used in the autophagy research field to indicate the level of induction
of autophagy. The lower this ratio, the higher the level of induction.
Our Western blots revealed that pmTOR decreases upon treatment with rapa-
mycin compared to basal conditions (Fig. 4.16A) and led to an increased au-
tophagic flux as assessed by fluorescence microscopy (Fig. 4.10, summarised in
Table 4.2). The inverse correlation between the pmTOR level and autophagic ac-
tivity has been shown by various research groups [32, 35, 109, 179, 208, 208, 277].
In addition, other research groups have shown that autophagy can also be induced
independently of the mTOR pathway [140, 219, 262].
Generally, a single measurement of pmTOR is made 1 hr [32] to several days
[208] after induction [32, 35, 109, 179, 208, 208, 277]. We measured pmTOR
30 min and 4 hrs after induction by rapamycin, and since there was no significant
difference between these measurements, were able to conclude that the decrease in
pmTOR occurs within 30 min or shorter.
6.5.2 LC3
In accordance with published studies [32, 36, 46, 80, 166, 213], we observed an
increase in LC3-II in the wild type MEF cells following bafilomycin A1 treatment
(Fig. 4.16C). However, several research groups have reported the converse [11, 208],
similar to what we observed in the transgenic GFP-LC3 MEF cell line (Fig. 4.16B).
In accordance with our data, the rate of LC3-II accumulation after inhibition of
fusion by bafilomycin A1 was greater for the rapamycin-induced autophagic state
as compared to the basal state [14, 36, 104, 158, 167]. In contrast to these groups,
who measured LC3-II 1 hr [14] to several days [104] after induction, we measured
LC3-II 30 min after inhibition of fusion, which allowed us to make a more accurate
assessment of autophagic flux compared to measuring of LC3-II after 2 hours
inhibition. Furthermore, we found an increase in LC3-II 30 min after rapamycin
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treatment, which then returned to basal levels. This dynamic response, which has
not been seen before, corresponds to our FM results (Fig. 4.10).
LC3-II blots of GFP-LC3 MEF cells showed a decrease in LC3-II 30 min after
bafilomycin A1 treatment (Fig. 4.16B), but by 2 hrs after bafilomycin A1 treatment
LC3-II had increased relative to the control. In our studies with wild-type MEF
cells and in other studies with endogenous LC3-II blots in the GFP-LC3 cell line
[129, 146, 182, 255], this initial decrease in LC3-II levels after inhibition of fusion
was not observed and was therefore unexpected. Even more unexpected was the
decrease in LC3-II levels in blots of GFP-LC3 MEF cells at both 30 min at 4 hrs
after rapamycin treatment.
However, after induction of autophagy in GFP-LC3 MEF cells the decreased
LC3-II signal did increase as expected after bafilomycin A1 treatment, showing
that the autophagic flux had increased from its basal level, but not as much as was
observed in Western blots of wild-type MEF cells (Fig. 4.16C) and in FM studies
of GFP-LC3 MEF cells (Fig. 4.10). That previous studies did not observe these
decreases in LC3-II could be due to the measurement of LC3-II levels six hours or
longer after treatment with autophagy inducers or inhibitors, during which time
autophagosomes, and hence endogenous LC3-II levels, could have increased back
to or higher than basal levels.
It is generally accepted that blotting for endogenous LC3-II in GFP-LC3 cells
allows the estimation of the magnitude of autophagic flux. However, our blots
of endogenous LC3-II in GFP-LC3 cells showed that the band intensities do not
accurately reflect the number of autophagosomes obtained with fluorescence mi-
croscopy. In using Western blots it is therefore advisable to follow the example of
groups such as Morselli et al. [171] that measure GFP-LC3 I and II rather than
endogenous LC3. We tried to blot for GFP-LC3 with an anti-GFP antibody, but,
similar to other colleagues in the field [161], we were unable to resolve GFP-LC3
I and II.
A possible explanation for the initial decrease in LC3-II levels in GFP-LC3
MEF cells following either bafilomycin A1 or rapamycin treatment (Fig. 4.16B)
could be a preferential incorporation of GFP-LC3 instead of endogenous LC3. In
Stellenbosch University  https://scholar.sun.ac.za
CHAPTER 6. GENERAL DISCUSSION 127
both cases the number of autophagosomes would be expected to increase: after 30
minutes of bafilomycin A1 treatment the decline in amino acid levels could activate
autophagosome synthesis through feedback onto the mTOR system, while 30 min
after rapamycin treatment the increased flux would be accompanied by an increase
in the number of autophagosomes. If GFP LC3-II is preferentially incorporated
into autophagosomal membranes at the expense of endogenous LC3 this would
explain both the observed decrease in endogenous LC3-II discussed above and the
observed increased GFP LC3-II fluorescent signal.
This speculation is further substantiated by the decrease observed by FM in
endogenous LC3-II 4 hrs after induction even though autophagosomal numbers
return to just above basal levels (Figs. 4.10 and 4.13). Directly after adminis-
trating bafilomycin A1, the residual rate of fusion that remains prior to achieving
complete inhibition may keep on preferentially consuming already existing auto-
phagosomes that are located closer to lysosomes in the paranuclear region. The
observed decrease in LC3-II may therefore be associated with the newly synthe-
sised “induced form of autophagosomes” since they may displace autophagosomes
that existed before inhibition of fusion. In future a potential preferential incor-
poration of GFP-LC3-II into autophagosomal membranes could be evaluated by
assessing the ratio LC3-II to GFP-LC3-II.
Currently, Western blot analysis of LC3-II forms part of the standard protocol
to assess autophagic flux [36, 158, 161, 167], but it can only provide information
about whether or not autophagic flux has increased or decreased. For potential
clinical approaches this is a drawback: in order to determine whether and by how
much autophagic flux needs to be altered one would need to have a quantitative
measure for the basal autophagic flux in the tissues or cells under investigation,
and Western blot analysis cannot provide this.
6.5.3 p62
Impairment of the fusion of autophagosomes and lysosomes leads to the accumu-
lation of p62, which therefore is a useful marker for autophagic degradation. In
our Western blots, at any experimental time point following inhibition of fusion
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by bafilomycin A1, the changes in the levels of p62 (Fig. 4.16D and E) and LC3-
II (Fig. 4.16B and C) of both wild type and GFP-LC3 MEF cells were always
correlated: both either increased or decreased together. Other groups have also
reported this correlation between LC3-II and p62 levels when treating cells with
bafilomycin A1 [86, 235]. In contrast, treating cells with a drug such as Linifanib,
which targets upstream signalling pathways and thereby leads to the induction
of autophagosome synthesis and a concomitant increase in LC3-II, resulted in a
decreased p62 after 24 hours treatment [169, 193, 256]. If bafilomycin A1 was then
added, p62 again increased with LC3-II as before [169].
In our experiments p62 only correlated with endogenous LC3-II and not with
GFP-LC3. This may indicate steric hindrance of the binding between p62 and
GFP-LC3-II because of the GFP tag. This could potentially affect the autophagic
degradative capacity and consequently increase flux through a reduction in the
level of amino acids in GFP-LC3 cells. If this hypothesis turns out to be correct,
it would be advisable to determine autophagic flux in wild type cells by fixing
them at key time points and performing LC3-II and LAMP2 immunofluorescence
staining.
In summary, when the signalling pathways involved in the synthesis of auto-
phagosomes are affected, both p62 and LC3-II levels are influenced, which in turn
affects the degradative capacity of autophagy, since p62 is involved in cargo recog-
nition. If these changes in p62 and LC3-II are independent, it would be possible
for the regulation of p62 to modulate the degradative capacity independently of
the autophagosomal number. However, this is still to be investigated.
6.6 Functional variables of autophagic flux
Although Western blot analysis provides a means of assessing autophagic activity,
it only allows for the expression of autophagic activity relative to a basal level.
Similarly, whereas EM provides high-resolution morphometric analysis of vacuolar
structures at various stages of and conditions for autophagy, it cannot be used
to assess autophagic flux accurately. With our new protocol we could quantity
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basal as well as rapamycin-induced autophagic flux. Furthermore, we could also
calculate functional variables of the autophagic system, such as transition times
for the various pathway entities, as well as the flow of volume of cytoplasm through
the autophagic pathway and the total membrane utilised per hour. These variables
are new to the field of autophagy. Although there are techniques that can quantify
the turnover rate of autophagic substrate, for instance through the measurement
of decay of a fluorescent marker [116, 249], they do not measure autophagic flux
in terms of the turnover in the autophagosomal pool.
The functional variables of the autophagic system described in this thesis could
prove to be very useful in the comparison of different cell types and treatment
interventions.
6.7 Amino acids
Amino acids are end-products of the autophagic degradation pathway; some are
potent nutrient regulators of autophagy, inducing autophagy during periods of
starvation. A great deal is known about the modulation of autophagy by the
availability of amino acids [69, 100, 159, 172, 174, 183, 200, 270], implicating
several key amino acids involved in feedback regulation of autophagy. Although the
detailed mechanism is unknown, an increase in amino acid levels is accompanied
by an increase in phosphorylated mTOR. Rapamycin mimics starvation induction
of autophagy, thereby preventing the negative feedback of amino acids through a
conformational change of mTOR that prevents its phosphorylation [197].
Individual amino acid levels. We found that glutamic acid was significantly
increased after rapamycin treatment, whereas arginine was significantly decreased
after bafilomycin A1 treatment. Furthermore, aspartate and glutamate levels after
4 hours of rapamycin treatment were higher compared to other amino acids.
High levels of aspartate and glutamate have been reported to accompany high
rates of protein degradation [143, 197, 204, 261]. Glutamate and aspartate act
as carriers of the nitrogen waste products that are generated when amino acids
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are processed by the citric acid cycle (TCA). During the initial breakdown of
amino acids their α-amino group is transferred to α-ketoglutarate to yield glutamic
acid. Glutamic acid acts as an intermediate in the α-amino disposal pathway by
transferring the amino group to oxaloacetic acid to produce aspartic acid which
acts as the penultimate carrier of the amino group before its incorporation into the
urea cycle. The protein-nitrogen flux model created by Walsh and Wright showed
that the flux of amino acids from proteins into the TCA cycle depends on the
concentration of available amino acids [252]. Therefore it is likely that the high
levels of aspartate and glutamate observed are the result of an increase in amino
acids being fed into the TCA cycle and the concomitant build-up of nitrogen waste.
These high levels of aspartate and glutamate have also been suggested by other
groups to be the result of an increased rate of protein degradation [204], as well
as the up-regulation of autophagy. This was observed in cancer cells, and it was
suggested that these cells self-cannibalise through autophagy to produce glutamic
acid and fatty acids, which can serve as energy sources [261].
Two hours after bafilomycin A1 treatment of basal autophagy, there was an
increase in glutamic acid similar to that observed in the rapamycin-treated cells.
This may have been a result of a reverse in flow of TCA cycle intermediates to
amino acids in order to compensate for the loss in the supply of amino acids.
Glutamic acid plays a key role in the regeneration of non-essential amino acids
[181]. Interestingly, our amino acid profiles (Fig. A) show that essential amino
acids increased relative to non-essential amino acids. This may have been the
result of up-regulation in the ubiquitin-proteasome system to compensate for the
loss in supply of essential amino acids via autophagy [121, 180]. This could be
assessed with kits such as the VIVAdetect 20S proteasome assay kit PLUS [211].
Increased glucogenic amino acids have been reported following the induction
of autophagy [55, 192]. Our results support the notion that autophagy plays a key
role in glucose homeostasis during periods of starvation by degrading proteins for
gluconeogenesis, as mimicked by rapamycin treatment [122].
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Total amino acid and protein levels. Autophagy is responsible for the se-
questering of and the subsequent degradation and recycling of proteins. Our data
showed that the induction of autophagy resulted in an increase in amino acids
and a decrease in protein levels. Blocking autophagy by inhibiting fusion lead to
a decrease in amino acids. These trends have also been reported by other groups
[121, 204, 261]. Furthermore, other research groups have reported a decrease in
protein synthesis upon induction of autophagy due to mTOR inactivation[136].
When Baf 30 min groups and Rapa Baf 30 min groups in Fig. 4.21 are com-
pared, there was a greater decrease in amino acids in the rapamycin treated cells,
which can also be interpreted as an increase in flux after rapamycin treatment.
Although it is common procedure to measure the change in LC3-II after bafilomy-
cin A1 treatment, the concomitant changes in amino acids levels, as shown in our
results, have not yet been previously measured.
Unexpectedly, we observed a decrease in protein levels after inhibition of the
fusion between autophagosomes and lysosomes. In contrast, there is a report in the
literature of the opposite observation, namely a decrease in protein degradation
following partial inhibition of autophagy with 3-methyladenine [221]. Two possible
reasons could account for our observation: first, within the first few minutes after
inhibition of fusion autophagy is up-regulated to compensate for the decrease in
amino acid supply, thereby leading to higher protein turnover; second, autophagy,
the primary pathway responsible for protein degradation, occurs in parallel with
chaperone-mediated autophagy, and during autophagy arrest, protein degradation
can be shifted towards chaperone-mediated autophagy [121, 180]. Moreover, a
combination of both of these responses may occur directly after inhibition that
temporarily increases protein turn over.
6.8 Kinetic modelling of autophagy
There are a number of papers in the autophagy literature that describe computer
models of aspects of autophagy. The most comprehensive of these are the mod-
els of the Choi group [70–73]. The network on which their minimal autophagy
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model is based is the same as that in our simple model (Fig. 5.1A), but they
also include protein synthesis from the amino acids released from autophagolyso-
somes and non-autophagic protein degradation. However, the aim of their model is
to “[investigate the] hypothesis that autophagy mediates cellular phase transitions
and demonstrate that the autophagic phase transitions are essential to the mainte-
nance of normal cellular functions and critical in the fate of a cell, i.e., cell death or
survival” [72]. Their model does not attempt to simulate experimentally obtained
data such as that obtained in our studies, but rather to find a set of parameters
that allow the bifurcations and oscillations required by their hypothesis.
Phagosym is available as a Java program [125] that simulates the creation of
omegasomes and phagosomes in response to a stimulus. The paper does not explain
the mathematics behind the model and only shows the results of the simulations,
which purport to shows that autophagosomes are formed within omegasomes,
which are membrane sites on the endoplasmic reticulum. They conclude that
“having a transient precursor permits a bigger dynamic range of the autophagic
response and allows a more efficient approach to steady state after autophagy
stimulation”.
While these studies are interesting in their own right, they were of peripheral
interest to our own modelling efforts.
One aspect of our model that needs further comment is the necessity for hav-
ing to use variable kinetic orders for autophagosomes and autophagolysosomes in
the rate equations for fusion and for autophagolysosomal degradation to fit the
simulated curve to the experimental data. This suggests that other factors are
involved in these processes.
Various factors play a key role in autophagic degradation; one such factor is
the transport of autophagosomes to the perinuclear region where they fuse with
lysosomes to form autophagolysosomes—these transport processes are associated
with microtubules [157], dynein motors [52] and a number of fusion proteins [268].
Microtubules are involved in the organization of intracellular structures and form
an intracellular transport “road network”, whereas dynein motors are responsible
for the physical transport of vesicles such as autophagosomes along micro-tubules
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[52]. Furthermore, the clearance of autophagolysosomes could be affected by fac-
tors such variation in protease activity.
In future developments of our kinetic model we plan to incorporate the details
of these factors. This is important because they have been suggested to form part
of the pathogenesis of neurodegenerative diseases [93, 111, 115, 157, 185, 205].
There are already methods available for the quantitative description of mi-
crotubule networks (FibrilTool) [19], in vitro motility assays of the microtubule
motors, kinesin and dynein [144], as well as lysosomal protease degradation [182].
Such an expansion in our approach could greatly improve our understanding of
the autophagy system and how to target the autophagic machinery for therapeutic
purposes.
6.8.1 WatershedCounting3D analysis software
The segmentation and counting of organelles is mostly derived by using the global
thresholding method [63]. Such methods rely on homogeneous background inten-
sity values within a cell, which is not always the case. WatershedCounting3D,
developed by Gniadek and Warren [63], makes use of a modified watershed al-
gorithm to more accurately identify intracellular structures in an inhomogeneous
background. The WatershedCounting3D algorithm has been implemented as a
Java-based plug-in for ImageJ. Recently, we, in collaboration with Gniadek, ex-
panded on the WatershedCounting3D allowing for high through-put processing
power. The new through-put WatershedCounting3D allows for multiple images
with respective image masks to be uploaded and analysed, generating a text output
file. In conclusion, the combination of the high through-put WatershedCounting3D
and Python/Java scripts to process generated text file can be used for the high
through-put analysis and quantification, including statistical analysis of puncta in
images.
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6.9 Future work
The main aims of the work described in this thesis were to develop and perfect a
technique for measuring autophagic flux and construct a kinetic model that fits the
experimental data generated by our determination of autophagic flux under basal
and induced conditions, i.e., a model that could simulate the steady state and
time-dependent behaviour of the system. With this new method it is now possible
to conduct an experimental supply-demand analysis [84, 85] of autophagy around
the autophagosome pool. This would entail perturbing the system both upstream
and downstream from the autophagosome pool. The first of these perturbations
has already been done through the induction of autophagy by rapamycin. The
downstream perturbation would require us to increase, or decrease, the rate of
fusion between autophagosomes and lysosomes. We already have the tool for
doing so in bafilomycin A1, which in our flux determination is used to completely
inhibit fusion. Here we would first have to change the demand of autophagosomes
by partially inhibiting fusion using a low concentration of bafilomycin A1, wait for
a new steady state to be established, and then completely inhibiting fusion so as
to measure the new steady-state autophagosomal pool size and steady-state flux.
Other future work will be to measure autophagic flux and autophagic variables
in other cell types, both in healthy and diseased states. Such information could be
very useful in both research and clinical settings, since it would provide insight into
the dynamic behaviour of autophagy in different situations, which in turn could
identify potential therapeutic targets and so assist the development of new ther-
apeutic strategies. Our technique could be used to screen drugs and characterise
their effects on autophagy.
Although the kinetic model that we developed was based on a simplification
of the autophagic process, it still gave an excellent fit to our experimental data.
Our model will serve as a starting point for further work: we plan to include
other signalling pathways that regulate autophagy, the negative feedback effects
of amino acids on the biogenesis of autophagosomes, and the degradative processes
that occur in the lumen of the different autophagic vesicles, which will allow us to
also simulate the substrate clearance flux. An important aspect of future work is
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the validation of the kinetic model with experimental data obtained at autophagic
states other than that used to parameterise our current model. Ultimately, we
envisage the combination of data obtained from different cell types in healthy or
diseased states into a unified kinetic model of autophagy.
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Changes in amino acid levels
during autophagy
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Appendix B
Control and elasticity coefficients
The coefficients of a control analysis of basal steady state of the extended au-
tophagy model described by the PySCeS input file listed in Appendix C.2. Only
the coefficients with non-zero values are shown.
138
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B.1 Flux-control coefficients
Flux-control coefficients for the basal autophagic flux (Jbasal), mTOR/pmTOR
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Appendix C
PySCeS-input files




# P ---> A ---> AL ---> AA




FIX: P L AA
R1: P = A
k1*P
R2: A + L = AL
k2*(A**h2)*L
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# Event 1 - Simulating Rapamycin Induction
Event: Induction, _TIME_ > 2, 0 {P = 105.4/25.4}
# Event 2 - Simulating Inhibiton with Bafilomycin
Event: Inhibition, _TIME_ > 6, 0 {k2 = 0.0}
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C.2 Extended model of autophagy
# Extended autophagy model
# LD <---- L <---- LB
# | |
# P ---> A ---> AL ---> AA
# ^
# -> T -
# | |
# - pT <-




# AA: amino acids
# pT: phosphorylated mTOR
# T: mTOR
# LD: lysosome degradation
# LB: lysosome biosynthesis
FIX: P AA LB LD
R1: P = A
k1*P*T
R2: A + L = AL
k2*L*A**h2
R3: AL = AA + L
k3*AL**h3
R4: LB = L
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k4*LB
R5: L = LD
k5* L
R6: pT = T
k6*pT
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pT = 105.4/25.4
T = 1.0
# Event 1 - Simulating Rapamycin Induction
Event: Induction, _TIME_ > 2, 0 {k6 = 0.08*(105.4/25.4)*(105.4/25.4)}
# Event 2 - Simulating Inhibiton with Bafilomycin
Event: Inhibition, _TIME_ > 6, 0 {k2 = 0.0}
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López-Ot́ın, C. [2007] “Tissue-specific autophagy alterations and increased tu-
morigenesis in mice deficient in Atg4C/autophagin-3” J. Biol. Chem. 282, 18573–
18583.
[151] Martinez-Vicente, M. and Cuervo, A. M. [2007] “Autophagy and neurodegenera-
tion: when the cleaning crew goes on strike” The Lancet Neurology 6, 352–361.
[152] Massey, A. C., Zhang, C. and Cuervo, A. M. [2006] “Chaperone-mediated au-
tophagy in aging and disease” Curr. Top. Dev. Biol. 73, 205–235.
[153] Mathew, R., Karantza-Wadsworth, V. and White, E. [2007] “Role of autophagy
in cancer.” Nat. Rev. Cancer 7, 961–967.
[154] Matsui, Y., Takagi, H., Qu, X., Abdellatif, M., Sakoda, H., Asano, T., Levine, B.
and Sadoshima, J. [2007] “Distinct roles of autophagy in the heart during ischemia
and reperfusion roles of AMP-activated protein kinase and Beclin 1 in mediating
autophagy” Circ. Res. 100, 914–922.
[155] Matsunaga, K., Saitoh, T., Tabata, K., Omori, H., Satoh, T., Kurotori, N., Mae-
jima, I., Shirahama-Noda, K., Ichimura, T., Isobe, T. et al. [2009] “Two Beclin
1-binding proteins, Atg14l and rubicon, reciprocally regulate autophagy at differ-
ent stages” Nat. Cell. Biol. 11, 385–396.
Stellenbosch University  https://scholar.sun.ac.za
BIBLIOGRAPHY 163
[156] Matsuura, A., Tsukada, M., Wada, Y. and Ohsumi, Y. [1997] “Apg1p, a novel
protein kinase required for the autophagic process in Saccharomyces Cerevisiae”
Gene 192, 245–250.
[157] Matsuyama, S. S. and Jarvik, L. F. [1989] “Hypothesis: microtubules, a key to
Alzheimer disease.” Proc. Natl. Acad. Sci. U.S.A. 86, 8152–8156.
[158] Mauvezin, C., Nagy, P., Juhász, G. and Neufeld, T. P. [2015] “Autophagosome-
lysosome fusion is independent of V-ATPase-mediated acidification” Nat Comms
6, 7007.
[159] Meijer, A. J., Lorin, S., Blommaart, E. F. and Codogno, P. [2014] “Regulation
of autophagy by amino acids and mTOR-dependent signal transduction” Amino
Acids .
[160] Mercer, C. A., Kaliappan, A. and Dennis, P. B. [2009] “A novel, human Atg13
binding protein, Atg101, interacts with ULK1 and is essential for macroautophagy”
Autophagy 5, 649–662.
[161] Mizushima, N. [2003] “In vivo analysis of autophagy in response to nutrient star-
vation using transgenic mice expressing a fluorescent autophagosome marker” Mol.
Biol. Cell 15, 1101–1111.
[162] Mizushima, N., Levine, B., Cuervo, A. M. and Klionsky, D. J. [2008] “Autophagy
fights disease through cellular self-digestion” Nature 451, 1069–1075.
[163] Mizushima, N., Noda, T. and Ohsumi, Y. [1999] “Apg16p is required for the
function of the Apg12p–Apg5p conjugate in the yeast autophagy pathway” EMBO
J. 18, 3888–3896.
[164] Mizushima, N., Sugita, H., Yoshimori, T. and Ohsumi, Y. [1998] “A new protein
conjugation system in human the counterpart of the yeast Apg12p conjugation
system essential for autophagy” J. Biol. Chem. 273, 33889–33892.
[165] Mizushima, N., Yamamoto, A., Hatano, M., Kobayashi, Y., Kabeya, Y., Suzuki,
K., Tokuhisa, T., Ohsumi, Y. and Yoshimori, T. [2001] “Dissection of autophago-
some formation using Apg5-deficient mouse embryonic stem cells” J. Cell Biol.
152, 657–668.
Stellenbosch University  https://scholar.sun.ac.za
BIBLIOGRAPHY 164
[166] Mizushima, N. and Yoshimori, T. [2007] “How to interpret LC3 immunoblotting.”
Autophagy 3, 542–545.
[167] Mizushima, N., Yoshimori, T. and Levine, B. [2010] “Methods in mammalian
autophagy research” Cell 140, 313–326.
[168] Monastyrska, I., He, C., Geng, J., Hoppe, A. D., Li, Z. and Klionsky, D. J. [2008]
“Arp2 links autophagic machinery with the actin cytoskeleton” Mol. Biol. Cell
19, 1962–1975.
[169] Moriya, S., Che, X.-F., Komatsu, S., Abe, A., Kawaguchi, T., Gotoh, A., Inazu,
M., Tomoda, A. and Miyazawa, K. [2013] “Macrolide antibiotics block autophagy
flux and sensitize to bortezomib via endoplasmic reticulum stress-mediated CHOP
induction in myeloma cells” Int. J. Oncol. 42, 1541–1550.
[170] Morselli, E., Mariño, G., Bennetzen, M. V., Eisenberg, T., Megalou, E., Schroeder,
S., Cabrera, S., Bénit, P., Rustin, P., Criollo, A. et al. [2011] “Spermidine and
resveratrol induce autophagy by distinct pathways converging on the acetylpro-
teome” J. Cell Biol. 192, 615–629.
[171] Morselli, E., Marino, G., Bennetzen, M. V., Eisenberg, T., Megalou, E., Schroeder,
S., Cabrera, S., Benit, P., Rustin, P., Criollo, A. and et al. [2011] “Spermidine and
resveratrol induce autophagy by distinct pathways converging on the acetylpro-
teome” J. Cell Biol. 192, 615–629.
[172] Mortimore, G. E., Hutson, N. J. and Surmacz, C. A. [1983] “Quantitative corre-
lation between proteolysis and macro- and microautophagy in mouse hepatocytes
during starvation and refeeding” Proc. Natl. Acad. Sci. U.S.A. 80, 2179–2183.
[173] Mortimore, G. E. and Poso, A. R. [1987] “Intracellular protein catabolism and its
control during nutrient deprivation and supply” Annu. Rev. Nutr. 7, 539–568.
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